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We are in much the same position as an observer trying to gain an idea of 
the life of a household by careful scrutiny of the persons and material 
arriving or leaving the house; we keep accurate records of the foods and 
commodities left at the door and patiently examine the contents of the dust-
bin and endeavour to deduce from such data the events occurring within the 
closed doors. 
    -Marjory Stephenson (Bacterial Metabolism, 1930) 
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SUMMARY 
Oral malodorous gases such as hydrogen sulfide and methanethiol are positively 
associated with plaque-induced periodontal diseases. It is well known that these Volatile 
Sulfur Compounds (VSCs) are produced by the oral microbiota during proteolysis, and 
the specific association of methanethiol in the breath with periodontal diseases was 
investigated in a clinical study described in this thesis. The association between breath 
methanethiol and clinical parameters of disease, abundance and prevalence of putative 
peridontopathic bacteria in periodontal niches were confirmed. A gas chromatographic 
method was developed to measure subgingival VSCs and associations with clinical 
parameters, microbial abundance in a range of oral niches and inflammatory markers in 
saliva and gingival crevicular fluid (GCF) were found. Breath methanethiol was also 
found to be more closely associated with a range of disease associated inflammatory 
markers in GCF. Tongue biofilm, subgingival and interdental plaque samples were 
analysed by Human Oral Microbiome Identification by Next Generation Sequencing 
(HOMINGS) methodology. Microbial diversity in the tongue was positively associated 
with breath VSCs in health, but subgingival and interdental niche diversity was more 
strongly associated with breath VSCs in gingivitis and chronic periodontitis. Tongue 
ecology in the disease associated cohorts was markedly different compared to health, 
especially with the increase in abundance and prevalence of putative VSC producing 
species. The ecology of VSC producing bacteria is described for the niches studied, 
finding that the methanethiol producing species are almost exclusively 
periodontopathic, with more dynamic population differences in these group of 
organisms observed from health to disease. The VSC producing potential in the 
periodontal niches was also found to be more dynamic compared to the tongue. The role 
of methanethiol production by the keystone species, P. gingivalis was investigated using 
a 10-species biofilm co-culture model by substituting a methionine gamma lyase (mgl) 
deficient strain for the wild type and marked changes in the overall biofilm composition 
was observed in terms of community evenness and biomass. The wild type biofilm 
displayed a more insidious phenotype whereas the higher biomass mutant biofilm 
exhibited an overtly pathogenic phenotype.  P. gingivalis mgl is proposed as a potential 
keystone virulence factor. 
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1 INTRODUCTION 
The mouth is one of the most important parts of the human body that serves as an 
interface to the external environment, with unique hard and soft tissue surfaces that 
form numerous ecological niches that support dynamic micro successions of commensal 
microbial communities that exist in a homeostatic relationship with the immune 
functions of the body (Zijnge et al. 2010).  
The mouth is used for mastication and consumption of food, which makes for a 
relatively unstable environment for microbial colonisation in terms of nutrients. In 
addition, there is a tendency for introduction of different and ‘unfamiliar’ microbes into 
the oral environment. This state of flux in the oral environment and the microbiome 
leads to the possibility of a diverse array of microbe-associated oral pathologies that can 
have a lasting adverse effect on the quality of life of individuals (Sbordone & Bortolaia 
2003). 
1.1 Etiopathogenesis of Periodontal diseases 
Periodontal diseases form a group of pathologies of the periodontium with a host of 
different etiologies (Highfield 2009). The most prevalent of periodontal diseases are 
gingivitis and chronic periodontitis caused by the host response to bacterial plaque 
accumulation in the gingiva, resulting in terminal attachment loss of the periodontal 
ligaments and alveolar bone loss, leading to loss of teeth in chronic periodontitis (Table 
1-1). Gingivitis is a milder, reversible form of periodontitis exhibited in the early stages 
of the disease. The reported prevalence of chronic periodontitis in the developed 
countries such as UK and USA ranges from 5% of the total population to 35%. Existing 
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heterogeneity in the diagnostic criteria used by epidemiological studies in the literature 
prevent an accurate estimate of this disease, however socio-economic factors appear to 
be a major influence in the prevalence of chronic periodontitis, clearly shown by the 
WHO Disability Adjusted Life Years statistic for this disease worldwide (Marcenes et 
al. 2013). 
The pathogenetic changes in the periodontium leading up to chronic periodontitis can be 
classified into four main histological phases (Ohlrich et al. 2009):  
 Initial lesion 
 Early lesion 
 Established lesion 
 Advanced lesion 
1.1.1 Initial lesion 
It is generally agreed that the initial lesion corresponds to clinically healthy gingiva, as 
the presence of bacterial plaque biofilm subgingivally necessitates the normal host 
response mechanisms to be activated. This low-level of chronic inflammation in the 
initial lesion is characterised by increased vasodilation and permeability, enabling 
leukocytes such as neutrophils and monocytes to migrate into the gingival sulcus via the 
gingival connective tissue and the junctional epithelium. As a result of increased 
leakage in the gingival microvasculature, a fluid with characteristics similar to that of 
serum is observed to flow into the gingival sulci. This fluid, called the Gingival 
Crevicular Fluid (GCF), has the effect of diluting bacterial products and having a 
flushing effect on the subgingival biofilm. The initial lesion is said to develop within 2-
4 days of plaque accumulation. 
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Table 1-1 Histopathological stages of periodontal disease progression 
1.1.2 Early Lesion 
The early lesion describes the changes in the gingiva that occur after about a week of 
plaque accumulation and is primarily characterised by erythematous and oedematous 
gingiva due to increased vascular permeability and the accompanied GCF flow. An 
enhanced activity of the immune cells including the presence of a large number of 
lymphocytes and neutrophil infiltration into the gingival sulci is also observed. This 
coincides with a considerable depletion of collagen in the connective tissue, due to its 
breakdown by the inflammatory activity of the host immune cells and the products of 
the proliferating bacterial biofilm.  
Fibroblasts appear altered, exhibiting electron-lucent nuclei, swollen mitochondria, 
vacuolization of the rough endoplasmic reticulum and rupture of their cell membranes, 
appearing up to three times the size of normal fibroblasts and found in association with 
moderately-sized lymphocytes. 
1.1.3 Established Lesion 
Termed ‘clinical gingivitis’, the established lesion displays an increase in the intensity 
of histopathological symptoms associated with the early lesion with an increased 
involvement of the humoral and cell-mediated immune response. Progression to the 
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established lesion is dependent on plaque build up and systemic or local host 
susceptibility factors.  
Similar to the initial and early lesions, the established lesion features an inflammatory 
reaction confined to the area near the base of the gingival sulcus, but unlike prior stages, 
displays plasma cells clustered around blood vessels and between collagen fibres 
outside the immediate area of the reaction site. While most of the plasma cells produce 
IgG, a significant number do produce IgA (and rarely, some produce IgM). The 
presence of complement and antigen-antibody complexes is evident throughout the 
connective and epithelial tissue. 
In health, the junctional epithelium creates the most coronal attachment of the gum 
tissue to the tooth at or near the cementoenamel junction. In the established lesion of 
periodontal disease, the connective tissue lying subjacent to the junctional epithelium is 
disintegrated, failing to properly support the epithelium against the tooth surface. In 
response to this, the junctional epithelium proliferates and grows into the vacant 
underlying spaces, effectively causing the level of its attachment to migrate towards 
apically, revealing more tooth structure than is normally evident supragingivally (above 
the level of the gumline) in health. 
While many established lesions continue to the advanced lesion (below), most either 
remain as established lesions for decades or indefinitely; the mechanisms behind this 
phenomenon are not well understood. 
1.1.4 Advanced Lesion 
Many of the features of the advanced lesion are described clinically rather than 
histologically: 
 Periodontal pocket formation 
 Gingival ulceration and suppuration 
 Destruction of the alveolar bone and periodontal ligament 
 Tooth mobility, drifting and eventual loss 
Because bone loss makes its first appearance in the advanced lesion, it is equated with 
periodontitis, while the preceding two lesions are classified as gingivitis in levels of 
increasing severity. 
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The advanced lesion is no longer localized to the area around the gingival sulcus but 
spreads apically as well as laterally around a tooth and perhaps even deep into the gum 
tissue papilla. There is a dense infiltrate of plasma cells, other lymphocytes and 
macrophages. The cluster of perivascular plasma cells still appears from the established 
lesion. Bone is resorbed, producing scarring and fibrous change. 
1.2 Microbial role in Periodontitis 
Historically, periodontitis has been thought of as an invasive disease, with the bacterial 
biofilm playing a major role in the pathogenesis (Schneider 1965). This has been due to 
the observation that effective plaque control appeared to reverse clinical gingivitis and 
that professional cleaning of the tooth slowed (and in some cases) halted the progression 
of destructive periodontal disease (Socransky 1977; Ramfjord et al. 1968). It was 
generally accepted that in health, Gram positive bacteria predominate in the subgingival 
plaque, whereas, Gram-negative bacteria begin to predominate in diseased states as the 
lesion progresses through gingivitis to periodontitis (Baker et al. 1976; Löe 1981). 
Efforts to find specific bacterial species responsible for causing periodontitis according 
to Koch’s postulates led researchers to propose the concept of ‘bacterial complexes’ of 
two or more interacting species of bacteria that occur in disease states and indeed are 
responsible for the pathogenetic changes observed in periodontitis and the preceding 
lesions (Socransky et al. 1998; Socransky et al. 1988). Among the bacteria involved 
reported to be associated with periodontal disease, the species grouped together as the 
‘red complex’, namely Porphyromonas gingivalis, Tanerella forsythia and Treponema 
denticola were reported to be strongly associated with increasing pocket depth and 
bleeding on probing (Figure 1-1). The bacterial species grouped under ‘orange complex’ 
namely Fusobacterium nucleatum and Prevotella intermedia also show a strong 
association with clinical measurement indices of periodontal disease such as pocket 
depth and bleeding on probing. 
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Figure 1-1 Socransky’s Bacterial Complexes adapted from (Socransky et al. 1998) 
1.2.1 Microbial models of plaque-induced chronic periodontitis 
Recent technological advances bringing molecular biological techniques to study the 
bacterial microbiota in health and periodontal disease has made it increasingly clear that 
there is no uniformity in the subgingival bacterial species profile of patients with 
periodontitis (Paster et al. 2001). While presence of the classic ‘periodontopathogens’ in 
the subgingival plaque, do not necessarily entail a predictable pattern of breakdown of 
the periodontal tissues due to the episodic nature of the disease, microbial involvement 
in chronic periodontitis is essential but not sufficient for pathogenesis (Colombo et al. 
2009). 
1.2.1.1 Ecological plaque hypothesis 
The Ecological Plaque Hypothesis was proposed previously, taking into account 
emerging evidence from classical microbiology and molecular biological approaches 
used to study the microbiota in periodontal health and disease (Marsh 1994). This 
hypothesis unified elements from previous schools of thought that held either that 
specific bacterial species or the bacterial plaque in general to be responsible for causing 
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periodontitis, in addition to bringing the concepts of ecological succession and Natural 
Selection to explain the pathogenetic phenomena associated with periodontal disease 
from a microbiological perspective. This hypothesis recognises the environmental 
changes that favour ‘pathogenic’ bacteria to proliferate and this in turn changing the 
environment to suit bacteria with ‘pathogenic’ traits to proliferate in ecological 
competition, and therefore moving away from a specific bacterial hypothesis, into 
genetic traits inherent in the normal microbiota that enable survival and in turn act as 
virulence factors in the advanced stages of disease, fuelling chronic inflammation 
(Figure 1-2) 
Figure 1-2 The Ecological Plaque Hypothesis adapted from (Marsh 1994) 
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1.2.1.2 The Polymicrobial Synergy and Dysbiosis model 
Although previous hypotheses endeavoured to develop a framework to understand the 
role of the microbiome in periodontal disease, a new hypothesis has been proposed 
recently that takes into account a key aspect of periodontal disease progression namely 
the host-microbiome interaction. This hypothesis named The Polymicrobial Synergy 
and Dysbiosis model was proposed to take into account the effects observed of specific 
bacterial species though in low abundance appearing to exert control over the overall 
biofilm composition by manipulating the host response to the developing biofilm and 
thereby creating a more favourable environment for the survival of the microbial species 
(Hajishengallis & Lamont 2012). These specific low abundance microbes are termed 
keystone species, as unlike other species that may begin to exert a change in the biofilm 
community structure simply due to dominance in occupying a large percentage of the 
total plaque biomass, the keystone species tend to exhibit a similar or greater level of 
control whilst occupying a small fraction of the total biomass. Another aspect of this 
hypothesis is that, these ‘keystone’ species can exhibit overtly pathogenic phenotypes 
that ensure continual supply of nutrients from the host, whilst not proliferating enough 
to exceed a particular biomass threshold that may lead to wholesale activation of the 
host immune system resulting in clearance of the keystone species—this is often termed 
a subversive phenotype in this model (Hajishengallis 2015). 
The advent of Next Generation Sequencing, while increasing the understanding of the 
known microbial diversity in the oral cavity, has also largely confirmed the more 
historical associations with the putative periodontopathogens, in addition to finding a 
number of novel disease associated phylotypes and species (Perez-Chaparro et al. 2014; 
Wade 2013). To date, only P. gingivalis has been proposed as a keystone species with 
the most extensive evidence available (Table 1-2), while other species such as A. 
actinomycetemcomitans and the novel periodontopathogen Filifactor alocis are 
potential keystone species candidates (Aruni et al. 2014; Fine et al. 2013). Other species 
such as T. forsythia, T. denticola and F. nucleatum are also thought to be involved in the 
ecological changes associated with periodontal disease, with some of the known 
mechanisms of virulence listed in Table 1-2. 
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Virulence mechanisms Review/References 
P. gingivalis 
Suppression of CXCL8 mediated innate immune reponses by 
dephosphorylation of NFκB via serine phosphatase (SerB) 
secretion; activation of anti-apoptotic pathways after cell 
invasion; inhibition of E-selectin secretion; stimulate 
inflammatory response by C5aR/TLR2 crosstalk; arrest 
complement cascade by gingipain mediated proteolysis of C3; 
multimodal signalling by LPS to disable TLR4 mediated 
responses. 
 
(Hajishengallis & Lamont 
2012) 
T. forsythia 
Stimulation of CXCL8 expression by a cysteine protease 
(PrtH); stimulation of TNF-α secretion by macrophages and 
inhibition of complement cascade by a matrix metalloprotease 
like enzyme, karilysin; stimulation of fibrinolysis via a 
plasminogen activator enolase. 
(Sharma 2010; Lee et al. 
2015; Ksiazek et al. 
2015) 
T. denticola 
Formation of sulfhaemoglobin and hemolysis by the H2S 
producing cystalsin; degradation of IL6, TNF-α, IL1β, CCL2 
and CXCL8 by cell surface bound protease, dentilisin. 
(Dashper et al. 2011) 
F. nucleatum 
Neutrophil and T-cell apoptosis via adhesin mediated 
aggregation; interferon induction via activation of retinoic 
acid inducible gene I by NFκB. 
 
(Han 2015; Huynh et al. 
2011; Lee & Tan 2014) 
A. actinomycetemcomitans 
Macrophage apoptosis mediated by the leukotoxin (LtxA) 
resulting in release of considerable IL1β stimulating 
osteoclastogenesis. 
 
(Åberg et al. 2014) 
Table 1-2 listing a few of the known virulence mechanisms of bacteria involved in 
periodontal disease progression. 
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1.3 Role of the host immune response in periodontitis 
From the findings of numerous studies on the interaction between the oral microbiota 
and the host immune system in the gingiva, it is clear that the host immune system plays 
a critical role in maintaining homeostasis and in periodontal disease progression (Garlet 
2010). At a basic level, the imbalanced alveolar bone resorption that signifies the 
advanced stage of disease is mostly host mediated and the microbial role is realised in 
encouraging the dysregulated immune processes that lead to this stage (Table 1-2; 
Figure 1-3). 
Figure 1-3 a diagram of the mechanisms involved in plaque induced periodontal 
disease that lead to alveolar bone resorption. Reproduced from (Hajishengallis 2014) 
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It is generally accepted that the most acute or the most specific response to microbial 
plaque accumulation is not necessarily better suited for maintenance of gingival health 
than a well regulated and appropriate immune response that minimises self-damaging 
processes and effectively addresses the microbial challenge. The human oral epithelial 
cells constitutively express a number of cytokines and chemokines, with a local gradient 
of the neutrophil chemokine CXCL8 (aka IL-8) existing in the normal gingiva helping 
to recruit neutrophils in response to microbial challenge (Darveau 2010). In addition, 
low numbers of monocytes transmigrate into tissues mediated by intercellular adhesion 
molecule-1 (ICAM1) expressed by endothelial cells and are resident normally in the 
gingiva, with constant replenishment of their numbers (Lawson & Wolf 2009). 
Microbial biofilm formation in the gingival crevice is recognised by the receptors of the 
innate immune system such as mannose-binding lectins (MBL), Complement and toll-
like receptors (TLR) that recruit cell mediated immune processes. While Complement 
and MBLs are soluble proteins present in tissue fluids, TLRs are cell surface proteins 
that are expressed on neutrophils, macrophages, monocytes and B-cells, and these 
receptors recognise specific ligands that are common to all bacteria and viruses such as 
gram negative bacterial cell walls containing lipopolysaccharides, peptidoglycans and 
nucleic acids (Gaffen & Hajishengallis 2008; O’Mahony et al. 2008). Activation of the 
complement cascade can lead to opsonisation of the bacteria, in addition to some of the 
cleaved complement proteins acting as chemotactic signals in recruiting monocytes and 
neutrophils. These cells then recognise gram-positive and gram-negative bacterial cell 
wall LPS via two important cell surface receptors namely, TLR2 and TLR4 and binding 
leads to a number of effector functions in these cells, which include secretion of 
cytokines and chemokines that recruit more numbers of these cells and others such as T-
cells and B-cells (Takeuchi et al. 1999). Cytokines and chemokines secreted by 
activated neutrophils and macrophages include IL1, IL6, TGF-b, TNFa, CXCL8, 
CXCL10, CCL2, CCL3 and CCL4 which serve as chemotactic signals and result in 
activation of different types of immune cells and their effector functions (Tecchio et al. 
2014; Arango Duque & Descoteaux 2014). Natural killer T-cells are important cells in 
the innate immune response in detecting and eliminating host cells harbouring invasive 
organisms, in addition to secretion of cytokines such as interferon-Ɣ and TNFα that can 
influence development of other T-cells toward distinct lineages that are crucial in the 
type of adaptive response elicited (Vivier et al. 2011). In addition to activated 
macrophages, dendritic cells are another innate immune cell type that can interact with a 
   12 
wide array of T-cell subsets by way of antigen presentation and influencing the type and 
magnitude of the adaptive immune response (Merad et al. 2013). It is notable that many 
of the bacterial strains termed ‘early colonizers’ and ‘bridging colonizers’ such as 
Streptococcus sanguinis, Streptococcus gordonii, Veillonella atypica, Actinomyces 
naeslundii, Fusobacterium nucleatum, Prevotella nigrescens, Prevotella intermedia and 
Parvimonas micra that form part of the oral biofilm that adhere to and form primary 
ecological successions in oral gingival niches do not elicit a strong CXCL8 response 
from human gingival epithelial cells and display an enhanced susceptibility to 
neutrophil phagocytosis compared to some of the late colonisers which include the ‘red 
complex’ bacterial species (Ji et al. 2014). The observed invasive ability of these strains 
also follows a similar trend, with the early colonizers displaying poor invasiveness 
compared to bridging and late colonizers (Ji et al. 2007; Dickinson et al. 2011). 
1.3.1 The TH1-TH2-TH17 Paradigm 
Naïve T-cells homing toward the periodontium are activated by antigen presenting cells 
(APCs) such as dendritic cells and macrophages, which imparts a number of functional 
changes in the T-cell, dependent on the co-stimulatory cytokine environment on 
activation. These activated cells are known as T-helper cells (TH-cells), and these cells 
are thought to secrete a number of different cytokine signals that control subsequent 
immune processes. A number of different T-helper cell phenotypes are currently known 
such as Th1, Th2, Th9, Th17, Th22 and Treg, with each phenotype secreting specific 
cytokine markers and displaying a degree of plasticity (Figure 1-4; Geginat et al. 2014). 
It should be noted that T-cells are observed to be present in histological studies of the 
healthy gingiva, and it is thought that the regulatory T-cell (Treg) subset likely dominates 
in health and periodontitis, as this subset is thought to have regulatory control over the 
developing inflammatory response (Kinane & Lappin 2002; Nakajima et al. 2005; 
Belkaid 2007).  
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Figure 1-4 showing a schematic of the classical (A) and novel views (B) of the T-
helper cell differentiation and plasticity. Reproduced from (O’Shea & Paul 2010) 
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In classical immunology, periodontitis has been thought of as primarily a ‘B-cell lesion’ 
owing to the dense plasma cell infiltrate observed in the periodontium of patients and 
with a more basic model that only included Th1 or Th2 immune response, which did not 
explain all available data, especially pertaining to secretion of the Interleukin-17 and the 
associated T-cell subset, Th17 (Steinman 2007). The previous Th1/Th2 model held that 
a skewing of TH-cell subset towards a Th2 response characterised by cytokines such as 
IL4 and IL6 is responsible for disease progression and enhanced B-cell activation 
whereas a Th1 response characterised by increased interferon-Ɣ production is indicative 
of a stable lesion (Gemmell & Seymour 1994). However, a rigid interpretation of this 
supposed ‘Th1-protective/Th2-destructive’ dichotomy was not consistent with the 
heterogeneity observed in studies reporting the presence of cytokines that characterise 
both Th1 and Th2 responses in equal abundance or Th1 response alone as determined in 
periodontal lesions (Gaffen & Hajishengallis 2008). A further layer of control and 
complexity is added with the introduction of the separate Th17 T-cell subtype that are 
thought to have specific differentiating signals including IL12 during APC mediated 
priming and unique cytokine secretion signatures after activation (Steinman 2007). 
Current understanding of the Th17 subset suggests that development of the Th17 
lineage is inhibited by cytokine signalling characteristic of Th1 and Th2 cells, however 
in the periodontal inflammatory response, Th17 development is thought to be stimulated 
by Tranforming Growth Factor-β, IL6 and IL21 co-stimulation suggesting that while 
Th17 could further promote Th2 type response owing to its development in a Th2-like 
cytokine environment, it could also have regulatory roles owing to its association with 
TGF-β signalling and promotion of IL10 production (Bettelli et al. 2006; Raphael et al. 
2015). 
1.3.1.1 Polarisation of the M1/M2 macrophage phenotypes 
Analogous to the development of Th1/Th2 subsets, it is thought that different 
macrophage subsets also differentiate based on their cytokine environment during 
activation. The M1 macrophage phenotype is reported to develop under stimulation 
from interferon-Ɣ, bacterial LPS and Granulocyte Macrophage-Colony Stimulating 
Factor (GM-CSF), and secreting considerable amounts of TNF-α and IL6 on activation 
in addition to induction of reactive oxygen and nitrogen intermediates (ROI/RNI) in 
response intracellular pathogens, and further promoting a Th1 response by production 
of IL12 (Martinez & Gordon 2014). Three subsets of the M2 phenotype are currently 
characterised namely, M2a, M2b and M2c: M2a and M2b are thought to drive Th2 
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immune processes as they are stimulated by IL4, IL13 and TLR signalling, whereas 
M2c is thought to be a regulatory phenotype stimulated by IL10. The shift in phenotype 
between M1 and M2 is reported to have important regulatory roles primarily due to a 
shift in metabolic activity of the macrophages with the M1 phenotype exhibiting 
microbicidal effects, whereas the M2a phenotype displays increased catabolism of 
arginine and collagen synthesis. Macrophage invasion by pathogenic bacteria are 
thought to subvert the M1 phenotype towards the less microbicidal M2a phenotype and 
hence promote intracellular survival and persistence (Muraille et al. 2014). The M2b 
and M2c macrophage phenotypes are believed to play important roles in producing 
fibrosis, extracellular matrix formation and tissue remodelling (Sindrilaru & 
Scharffetter-Kochanek 2013). 
1.3.1.2 Dysregulated Osteoclastogenesis 
Whilst the immune mechanisms that drive towards the pathological terminus as regards 
the unregulated alveolar bone loss observed in chronic periodontitis are yet to be fully 
understood, it is known that inflammatory mediators secreted by the activated 
macrophages and the resident gingival fibroblasts play an important role in activating 
osteoclast development which ultimately causes alveolar bone resorption (Graves 
2008). The microbicidal activity of neutrophils and secretion of matrix 
metalloproteinases by activated macrophages in earlier stages of inflammation can lead 
to extensive collagen and extracellular matrix degradation, in addition to fibroblast 
apoptosis and this would depend on the intensity of the inflammatory response 
stimulated by the dental plaque microbiota. Further, inability to control invasive 
bacteria (Th1) and/or prevent extracellular plaque accumulation (Th2) could lead to a 
response that may have phases of activation and suppression of pro-inflammatory 
processes that cannot be resolved completely leading to dysregulated osteoclastogenesis 
characterised by high Receptor Activator of Nuclear Factor κB Ligand to 
Osteoprotegrin ratio (RANKL:OPG) resulting in net bone loss (Darveau 2010). 
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Cytokine Source Activity 
Interleukin-1α 
macrophages, neutrophils 
epithelial & endothelial cells 
fibroblast proliferation, 
acute phase response 
Interleukin-1β 
epithelial, dendritic cells, 
macrophages 
osteoclastogenesis, acute 
phase response 
Interleukin-4 
γδ T cells, eosinophils, 
basophils, NKT cells, mast 
cells and naive CD4 T cells 
↑ B-cell and T-cell 
development (Th2) 
Interleukin-6 
T cells, B cells, macrophages, 
fibroblasts, endothelial cells 
↑ Th17  ↓Treg 
Interleukin-8 (CXCL8) 
Monocytes, lymphocytes, 
granulocytes, fibroblasts, 
endothelial cells 
neutrophil and basophil 
chemoattractant 
Interleukin-10 Activated CD4 & CD8 T cells 
↑ B cells, mast cells 
↓Th1 T cells 
Interleukin-12p70 
Macrophages & Dendritic 
cells 
↑Th1 differentiation 
↑Interferon-Ɣ by T cells 
Interleukin-13 
Activated T cells, Mast cells 
and Natural killer cells 
↑Th2 
Interleukin-17A CD4 T cells ↑Th17 
Granulocyte-Colony 
Stimulating Factor 
macrophages neutrophil development 
Interferon-α 
lymphocytes, dendritic cells 
& macrophages 
resistance to viral infection, 
inhibits cell proliferation 
Interferon-Ɣ CD4 & CD8 T cells, NK cells 
↑development of T cells, B 
cells, macrophages and NK 
cells. ↑Th1 
Tumour Necrosis Factor-α 
monocytes, macrophages, T 
cells, neutrophils and 
fibroblasts 
potent mediator of 
inflammation and bone 
resorption 
CXCL10 
monocytes, fibroblasts, 
endothelial cells  
macrophage/T cell/NK cells 
and dendritic cell 
chemoattractant 
CCL2 macrophages, dendritic cells 
macrophage and basophil 
chemoattractant 
CCL3 & CCL4 
monocytes, macrophages, 
neutrophils, T cells & B cells 
T cells, B cells and 
eosinophils 
Transforming Growth 
Factor-β 
macrophages osteoclast induction 
E-selectin endothelial cells 
leukocyte adhesion and 
extravasation 
Intracellular Adhesion 
Molecule-1 
transmembrane protein 
expressed in leukocytes and 
endothelial cells 
leukocyte transmigration 
Table 1-3 listing some important molecules involved in periodontal inflammation, 
their source and activity. 
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1.4 Volatile sulfur compounds in periodontal disease 
Volatile Sulfur Compounds (VSCs) are thought to be the main contributors to malodour 
originating from the mouth and a variety of anti-malodour treatments and products 
target VSCs and the bacteria responsible for their production in the mouth (Peruzzo et 
al. 2008; Greenman & Saad 2009). The correlation between oral malodour and 
periodontal disease is well documented, with numerous studies reporting an increase in 
the concentration of VSCs or malodour as detected organoleptically in the breath 
alongside the presence of periodontal disease in different regional populations (Table 
1-4).  
Regional Population Reference 
South Africa (Ayo-Yusuf et al. 2011) 
Switzerland (Bornstein et al. 2009) 
Turkey (Kara et al. 2006*; Nalçaci & Sönmez 2008*) 
China (Liu et al. 2006) 
Japan 
(Miyazaki et al. 1995; Takeshita et al. 2010; Takeuchi et al. 2010; 
Amou et al. 2014) 
Belgium (Quirynen et al. 2009) 
Taiwan (Tsai et al. 2008) 
Brazil (Figueiredo et al. 2002) 
Canada (Bosy et al. 1994) 
Sweden (Johansson 2005) 
India (Matthew & Vandana 2006) 
Israel (Amir et al. 1999)* 
Table 1-4 listing clinical studies in the literature that showed an association between 
VSCs and/or oral malodour and clinical periodontitis parameters in different 
regional populations. Asterisk indicates studies in children/adolescents. 
Studies have also reported that the severity of periodontitis as measured by standard 
clinical parameters is higher in individuals with malodour and periodontitis than 
individuals with periodontitis but no malodour (Kurata et al. 2008). Oral malodour and 
VSC concentration is also reported to decrease significantly in periodontitis patients 
who receive periodontal treatment, and interestingly tongue hygiene alone is reported to 
have less effect on oral malodour in patients than periodontal treatment, suggesting a 
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role for periodontal microbiota in oral malodour associated with disease (Pham et al. 
2012; Takeuchi et al. 2010; Quirynen et al. 2005). However, other studies also report 
that oral malodour in periodontal disease is more directly related to the level of tongue 
biofilm present in individuals, but these studies are not interventional, unlike the former 
studies that report a greater effect of periodontal treatment (Stamou et al. 2005; Calil et 
al. 2009). It is likely that both tongue biofilm and periodontal microbiota have a role to 
play in malodour, in disease and health (Bordas et al. 2008; Yasukawa et al. 2010; 
Danser 2003). 
The chief source of VSCs in the mouth is thought to be protein metabolism of the oral 
microbiota, with the Gram-negative bacteria thought to be the most significant 
contributors to VSC production (Nakano et al. 2002). Sulfur-containing amino acids 
such as cysteine and methionine are the primary substrates in the VSC production by 
the oral microbiota with complex substrates such as the saliva, sloughed oral epithelia & 
cells, trapped food particles and dead bacteria providing the majority of the 
proteinaceous raw material to the oral biofilm (Krespi et al. 2006).  
The most important VSCs involved in oral malodour include hydrogen sulfide (H2S), 
methanethiol (CH3SH) and dimethyl disulfide, with H2S and CH3SH being the 
predominant VSCs detected in the breath of individuals with oral malodour in the 
presence of periodontal disease (Van den Velde et al. 2009). Other VSCs such as 
dimethyl sulfide and dimethyltrisulfide are reported to be detected in the breath air of 
patients with advanced stages of periodontitis. Also, the breath of individuals suffering 
from oral malodour with no obvious symptoms of periodontal disease can present with 
an appreciable amount of VSCs such as H2S and CH3SH, with the concentrations of the 
detected VSCs increasing with an increase in the organoleptic score (van den Velde et 
al. 2007). 
1.4.1 VSCs in the periodontal pocket 
Studies have also reported on the VSCs produced in the periodontal pockets and their 
association with clinical and microbial aspects of periodontitis. A gas chromatographic 
method was used to detect H2S and CH3SH in periodontal pockets and the concentration 
of these VSCs are reported to correlate positively with periodontal pocket depths, with a 
stronger association with methanethiol (Persson 1992). A few studies have used a 
periodontal probe with an attached ‘sulfide’ sensor to measured sulfides in the 
periodontal pocket, and one such study reported the concentrations measured to be 
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significantly associated with clinical disease parameters such as plaque index, bleeding 
on probing and gingival index in an experimentally induced gingivitis model in a split-
mouth study (Pavolotskaya et al. 2006). The concentrations of sulfides measured in 
periodontal pockets of smokers with periodontitis were reported to be significantly 
higher than non-smokers with periodontitis (Khaira et al. 2000). Torresyap et al. (2003) 
studied the microbiota in oral sites in association with sulfide concentrations in 
periodontal pockets using the probe based sulfide sensor, and found higher counts of the 
anaerobic red-complex and orange-complex bacteria in sulfide-positive sites compared 
to sulfide-negative sites in the same individual, independent of probing depths. Another 
study that measured salivary thiols found that the sulfur containing amino acids and 
peptides such as cysteine, cysteinylglycine and glutathioine increased significantly in 
saliva of periodontitis patients compared to health, suggesting more available substrate 
for VSC production in the oral cavity in relation to disease (Zappacosta et al. 2007). 
This is particularly relevant, since free cysteine or methionine is not normally detected 
in the saliva of a healthy individual (Nakamura et al. 2010). 
1.4.2 VSCs and microbial ecology 
The presence of VSCs in the breath is more closely related to the microbial ecology in 
the different oral sites such as the tongue and periodontal niches. It has been 
demonstrated that the rate of VSC production by the putative periodontopathic bacterial 
species is much higher than the more health-associated species (Persson et al. 1990). In 
particular, the bacteria associated with a dysbiotic microbiota are more efficient in 
producing copious amounts of VSCs from more complex proteinaceous substrate such 
as the serum than free amino acids, suggesting that VSC production could be an 
important mechanism involved in the proteolytic activity of the periodontopathic 
bacteria in association with disease activity in the periodontal niches (Persson et al. 
1989). However, a molecular study of the tongue microbiota suggested that the H2S 
producing species detected were not necessarily associated with gingival inflammation 
(Washio et al. 2005). This study detected the most abundant species in the tongue of 
healthy individuals to be from the genera Veillonella, Prevotella and Actinomyces, 
although these findings were from a culture dependent method, so may not represent the 
full diversity of the tongue microbiota. At present only one study in the available 
literature has investigated the tongue microbiota by using a culture independent, 
metagenomic methodology in association with oral malodour as defined by the VSC 
concentration in the breath (Yang et al. 2013). The findings reported in this study is 
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largely consistent with Washio et al. (2005), whereby the predominant genera and 
species that showed an association with H2S concentrations in the breath were different 
to those that are normally prevalent in the periodontal niches. However, this study only 
reported differences observed among species or genera that were of high prevalence 
with no information on rare taxa which more often involves periodontopathic bacteria 
such as P. gingivalis, T. forsythia and T. denticola. This study also did not find any 
relationships with other important VSC producing genus namely, Fusobacterium spp. 
Another study that utilised a next generation sequencing approach to characterise the 
salivary microbiota found more peridontopathic bacterial species predominating in 
individuals with severe malodour with a high H2S or CH3SH concentration (Takeshita 
et al. 2012). However, while this study did not report the full periodontal assessment 
such as the plaque coverage of the enrolled participants, the individuals with higher 
organoleptic scores were reported to have higher mean periodontal probing depths, 
suggesting possible shedding of periodontal microbiota in saliva that could explain 
these results. There are no metagenomic ecological surveys of the tongue in relation to 
health and disease available in the literature to assess if the tongue ecology changes 
significantly in association with disease.  
1.4.3 Effect of VSCs on host response 
Due to the association of VSC production with oral microbiota, a number of studies 
have investigated the potential adaptive and functional role of VSC production in the 
oral cavity for the oral microbiota—a number of destructive roles are shown for both 
H2S and CH3SH, with both VSCs equally potent in in vitro experiments (Yaegaki 
2008). Some of the direct effects reported include apoptosis, genomic DNA damage, 
collagen degradation, increased mucosal permeability, irreversibly binding to key 
respiratory enzyme cytochrome c oxidase and forming sulfhaemoglobin that can cause 
erythrocyte membrane instability (Yaegaki 2008). The in vivo evidence for the effects 
of VSCs is provided by toxicology studies that document occupational or community 
exposure to VSCs and their systemic effects (Lambert et al. 2006; Inserra et al. 2004). It 
could be argued that given some of these systemic effects are observed at concentrations 
not too dissimilar to that found in the breath of individuals, VSCs produced by the oral 
microbiota likely has local effects that may be involved in periodontal disease 
progression. 
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1.4.3.1 Signalling effects of hydrogen sulfide on host tissue 
The emergence of literature on H2S as a signalling molecule with anti-inflammatory and 
other beneficial effects casts some doubt on the role of VSCs produced by the oral 
microbiota in general as a toxic agent in the oral cavity (Kimura 2011). Hydrogen 
sulfide is thought to be produced in the neural tissue where it is thought to suppress 
synaptic potentials and help relax vascular smooth muscle not unlike the effects of nitric 
oxide and these effects are thought to be cytoprotective in lowering oxidative stress 
(Kimura 2002; Lo Faro et al. 2014). Interestingly, anti-inflammatory effects have been 
observed in models of gastric inflammation where hydrogen sulfide was observed to 
reduce TNFα and ICAM1 expression, thereby preventing leukocyte extravasation and 
reducing inflammation (Fiorucci et al. 2005). There is also evidence for NO-H2S 
interactions in inflammation. For example, H2S delivered in gaseous form to LPS 
activated macrophages was able to inhibit NO production and iNOS expression, and this 
was attributed to NFκB attenuation (Oh et al. 2006). Indeed, Sen et al. (2012) 
demonstrate that endogenous H2S can bind to a cysteine residue in NFκB via 
sulfhydration and this stimulates transcription of antiapoptotic genes in TNFα 
stimulated macrophages. Given the ubiquity of NFκB mediated signalling in 
inflammation, these studies have potentially identified a major mechanism of host-
microbiome interaction mediated by H2S in inflammation (Lawrence 2009). Further, 
murine macrophages cultured without RANKL, when exposed to gaseous H2S at 
concentrations well below that was observed in GCF in prior studies were observed to 
express osteoclastogenic activity (Ii et al. 2010). These observations suggest that 
hydrogen sulfide production by anaerobic microbial proteolysis could dampen the 
immune response, while simultaneously facilitating periodontal tissue destruction. In 
addition, a number of studies report of the importance of cysteine moieties in proteins 
and inflammatory cytokines, with redox labile disulfide bonds in particular that could be 
reduced by VSCs produced by the oral microbiota, inducing functional changes that are 
not necessarily destructive (Metcalfe et al. 2011; Butera et al. 2014; Kellett-Clarke et al. 
2015). However, the increased severity of periodontal disease observed in individuals 
with malodour compared to without malodour (or low VSC concentration) suggests that 
this host-microbial interaction could ultimately encourage disease progression (Li et al. 
2011; Zanardo 2006) 
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1.4.3.2 Effects of methanethiol on host tissue 
In light of the positive association between breath concentrations of methanethiol and 
periodontal disease, there are a limited number of studies on the effects of this VSC on 
host tissue. Production of the Th2 cytokine IL6 by tooth pulp fibroblasts were observed 
to be significantly upregulated in the presence of methanethiol when stimulated with 
LPS (Coil et al. 2004). Interestingly, the cytokines IL1 and TNFα were not affected, 
suggesting specific activation. This specificity in stimulating cytokine secretion was 
also observed in another study with gingival fibroblasts and monocytes (Ratkay et al. 
1995). In the latter study, it was reported that methanethiol was able to induce 
production of procollagenase via a prostaglandin-cAMP mediated pathway in human 
gingival fibroblasts, and while it stimulated increased activity of CathepsinB in 
macrophages, it did not affect elastase. Methanethiol also displays a more potent 
activity in increasing oral mucosal permeability compared to hydrogen sulfide (Ng & 
Tonzetich 1984). 
1.5 Project aims 
The overall aims of this project were: 
 To study the microbial, inflammatory and clinical aspects of periodontal disease 
in relation to Volatile Sulfur Compounds (VSCs) present subgingivally and in 
the breath. 
 Conduct an ecological survey of the tongue and periodontal niches in relation to 
oral malodour (as defined by VSC concentrations in the breath) and periodontal 
disease to describe the ecological shifts associated with disease in putative VSC 
producing species. 
 To investigate the role of VSC production in host-microbial interactions in vitro 
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2 MATERIALS AND METHODS 
The majority of this thesis involves an exploratory clinical study that included 
collection of human biological samples and laboratory analyses of these samples. 
Ethical approval for the study protocol was obtained from the London Central Research 
Ethics Committee (Ref: 12/LO/1611) in December 2012 and the clinical part of the 
study commenced in February 2013.   
2.1 Study design and clinical protocol 
This is a case control study with three groups of participants: (i) Health (ii) Gingivitis 
(iii) Chronic periodontitis. Suitable participants for the chronic periodontitis cohort were 
recruited from patients identified from various Consultant, Treatment and Maintenance 
clinics at the Dental Hospital, Barts Health NHS Trust. Students and staff from Queen 
Mary University of London were screened and recruited for the health and gingivitis 
cohorts. All participants were informed of the study procedures with a 1 week interval 
before the clinic visit when written consent was obtained and clinical assessments were 
carried out.  
2.1.1 Inclusion and exclusion criteria.  
Only individuals aged 18 years or above and able to give informed consent were 
screened and recruited. Specific health related exclusion criteria for participation in this 
study were as follows: 
1) Individuals with general / systemic diseases such as 
a) Diabetes mellitus type 1 and 2 
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b) Presence or recent history of infectious diseases such as AIDS, Hepatitis and TB 
or other respiratory infection including those that can be transmitted in saliva  
2) Women intending to be pregnant or are pregnant or breast feeding 
3) Cigarette smoking or chewing of tobacco or paan, drugs and alcoholism 
4) Recent use of antibiotics and/or anti- inflammatory medication (within 4 weeks of 
visit) 
5) Periodontal treatment received within the last 3 months. 
6) Medications resulting in xerostomia 
7) Denture wearers 
8) Other exclusion criteria were: patients who were deemed suitable for the study but 
withheld consent or were unable to participate (time, availability), and also 
individuals who were screened for the healthy or gingivitis cohort but were 
diagnosed with periodontitis on oral examination. 
Inclusion criteria pertaining to the oral health of individuals for the different cohorts are 
listed below: 
 Health 
o Good oral health 
o Absence of carious lesions and periodontal disease 
o Presence of at least 20 teeth 
o No more than four periodontal pockets with a maximum of 4 mm of 
depth excluding 3
rd
 molars. 
o ≤20% sites bleeding on probing (BOP) 
o ≤20% gingival bleeding index (GBI) 
 Gingivitis 
o Presence of at least 20 teeth 
o Generalised gingival inflammation with ≥20% of sites bleeding on 
probing 
o Presence of more than four periodontal pockets with probing depths 
≥4mm excluding 3rd molars. 
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o Absence of any obvious signs of periodontitis such as generalised 
periodontal pocketing >5mm excluding 3
rd
 molars. 
 Chronic periodontitis 
o Presence of at least 10 teeth 
o >2mm Clinical Attachment Loss 
o Presence of at least two periodontal pockets ≥6mm excluding 3rd molars 
o Radiographic evidence of bone loss 
The main criteria used for inclusion into the health and gingivitis cohorts were the 
clinical parameters such as Bleeding on Probing (BOP), Gingival Bleeding Index (GBI) 
and number of probing sites deeper than 4mm. In case of conflicting scores between 
GBI and BOP, the latter was given precedence in determining diagnosis due to it 
preceding GBI in the clinical protocol sequence and as such would be a more accurate 
measure of periodontal health. However, presence of more than four periodontal 
pockets ≥4mm excluding 3rd molars determined a diagnosis of gingivitis regardless if 
BOP and/or GBI scores were ≤20%.  
2.1.2 Clinical protocol 
The clinical protocol sequence is shown below for collection of samples and oral 
examination (Figure 2-1). At the arrival of the participants for their dental appointment, 
the clinical procedures were explained to them again, informing that they can withdraw 
any time without explanation. Participants were given a copy of the information sheet 
and consent forms, to enable them to contact the investigator in the future for any 
feedback. It was also explained that the information sheet given to the participants also 
contained the unique number assigned to them, which can be used to identify 
themselves to the investigator at a later date, if they would like their samples to be 
withdrawn from the study. After consent, a general screen was conducted by way of a 
medical history questionnaire and the timing of their last oral activity such as eating or 
oral hygiene. Only participants who had no oral activity in the last two hours were 
considered for further sample collection. In general, participants were informed not to 
eat or perform any oral hygiene measures for at least 2 hours prior to the appointment. 
Samples that are not dependent on diagnosis, such as saliva, tongue scrape and breath 
samples were collected immediately after enrolment (see section 2.1.3 for more detail in 
the sample collection procedures). 
   26 
Figure 2-1 showing a flow chart of the clinical protocol sequence with the oral 
examination and the different sampling aspects. 
The six point pocket charting was carried out using a manual Williams 14W periodontal 
probe (Henry Schein Rexodent, Dorset, UK), determining probing depths (PD) at six 
sites around each tooth in all teeth present. Any bleeding observed on sites after probing 
were recorded for calculating the percentage of sites bleeding after probing and reported 
as BOP scores. After a rinse, the periodontal probe was inserted 1mm beneath the 
gingival margin and run along the gingival perimeter, with the presence of bleeding at 
four sites per tooth (labial, mesial, distal and lingual) within 20 seconds of this 
procedure were recorded. The percentage of sites that bled was calculated as the full 
mouth Gingival Bleeding Index or Marginal Gingival Bleeding score (GBI/MGB) 
(Ainamo & Bay 1975). The diagnosis of the participant was determined at this point in 
the sequence, based on the probing depths and gingival bleeding observed using the 
BOP and GBI scores, with the BOP and PD scores overruling GBI scores in case of 
conflict in determining health or gingivitis. For further sample collection procedures, 
one tooth per quadrant was chosen based on the deepest probing depths recorded. In 
case of quadrants with probing depths ≤3mm, a tooth was picked at random. The third 
molars were not included in determining diagnosis and in sampling plaque as false 
pockets can occur more frequently around this tooth and more plaque accumulation due 
to restricted access for toothbrushes (Smart 2005). However, bleeding, probing depths 
and plaque coverage in this tooth was recorded in all cases. Plaque and GCF samples 
were collected on and around the selected tooth per quadrant, and finally the amount of 
plaque present in the oral cavity was assessed by disclosing the teeth for the presence or 
absence of visible plaque on the labial, mesial, distal and lingual surfaces. The Plaque 
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Index scores were calculated as the percentage of the total surfaces that showed visible 
plaque (O’ Leary et al. 1972). 
2.1.3 Clinical sample collection methods 
The following descriptions of the sample collection methods occur in the order of the 
clinical protocol sequence: 
2.1.3.1 Breath Sample 
Before the collection of the breath sample, the participant was seated upright and asked 
to breathe through their nose with their mouth closed for approximately one minute. A 
sterile FEP mouthpiece (Cole-Parmer, London, UK) with a 20ml PTFE syringe 
(NORM-JECT
®
, Henke-Sass Wolf, Tuttlingen, Germany) attached was then inserted 
into the mouth till the mouthpiece reached the back half of the tongue (Figure 2-2). It 
was ensured that the participants held the mouthpiece with the lips closed (but not 
sealed) around the mouthpiece to prevent creating a vacuum in the oral cavity during 
breath sampling. The participants were then instructed to take a deep inhalation through 
their nose when ready and hold for 5 seconds, during which approximately 15ml of 
mouth air sample was withdrawn. A 1ml aliquot of the collected breath sample was 
injected into a portable gas chromatograph (Oral Chroma
™
; Abimedical Corporation, 
Japan) for measuring the presence of hydrogen sulfide, methanethiol and dimethyl 
sulfide. The data output of the Oral Chroma
™
 was recorded in the included data 
manager software (Abimedical Corporation).  
An organoleptic assessment was approximated by calculating a Malodour Score based 
on the following formula: 
𝑀𝑎𝑙𝑜𝑑𝑜𝑢𝑟 𝑆𝑐𝑜𝑟𝑒 = ∑
[𝑂𝑑𝑜𝑟𝑎𝑛𝑡𝑎]
10 × 𝑅𝑡𝑎
+
[𝑂𝑑𝑜𝑟𝑎𝑛𝑡𝑏]
10 × 𝑅𝑡𝑏
+ ⋯ +
[𝑂𝑑𝑜𝑟𝑎𝑛𝑡𝑛]
10 × 𝑅𝑡𝑛
 
The Malodour Score is equal to the sum of the concentration of each odorant (in this 
case, a VSC) divided by 10 times its recognition threshold, Rt. This formula is proposed 
based on the logarithmic nature of the relationship between the organoleptic scale and 
the concentration of odorants and the need for a clear threshold whereby an untrained 
individual would recognise the odour as malodorous (Greenman et al. 2004). While this 
formula takes into account the differential stimulation of the olfactory senses by 
different odorants, it is assumed that as the concentration of each odorant increases, the 
stimulation of the olfactory sense is additive. However, this may not be valid for 
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odorant concentrations approaching saturation. The recognition threshold used in the 
present study for calculating the Malodour Score was 4.7ppb for H2S and 2.1ppb for 
CH3SH (Leonardos et al. 1969). Whilst this value was determined using a trained judge, 
in the current study, a Malodour Score of 1 is defined as the malodour threshold and this 
score indicates the presence of one or both VSCs at concentrations that cumulatively 
exceeded the quoted recognition threshold by ten-fold which should compensate for the 
potential lack of olfactory acuity in untrained individuals. A breath sample with 
calculated Malodour Score >1 would be considered to be malodorous, while a score of 
>5 is defined as moderate to severe malodour. 
2.1.3.2 Saliva 
The saliva sample was obtained with the participant instructed to tilt their head slightly 
forward and asked to rest for five minutes and minimise orofacial movements. 
Unstimulated saliva was allowed to accumulate in the floor of the mouth and the patient 
was then asked to expectorate about 3ml of saliva into a 20ml sterile universal tube. 
2.1.3.3 Tongue biofilm 
Tongue biofilm was sampled by scraping a Whatman Omniswab (General Electric 
Healthcare, Little Chalfont, UK) three times along the tongue dorsum, from as close to 
the circumvallate papillae as possible towards the tip, with the swab held perpendicular 
to the lingual plane. The Omniswab pad was then ejected into 500μl of Tris-EDTA (TE) 
buffer (pH 7.2; Sigma-Aldrich, Poole, UK) in a 5ml sterile universal tube. 
2.1.3.4 Supragingival plaque 
Supragingival plaque samples were obtained by swabbing the buccal and lingual facial 
surfaces along the gingival margins using one regular sized Microbrush
®
 per tooth 
(Patterson Dental Supply Inc, Minnesota, USA) and all four samples pooled together in 
500μl TE buffer (Sigma-Aldrich) in a sterile microcentrifuge tube (Eppendorf, 
Hamburg, Germany). 
2.1.3.5 Gingival Crevicular Fluid 
Gingival crevicular fluid (GCF) samples for gas chromatographic headspace analysis 
were collected by inserting three sterile absorbent paper points (size #40; Sybron Dental 
Specialities, Charlotte, USA) into the site with the deepest periodontal pocket among 
the four teeth chosen for sampling. The paper points were removed after 10 seconds to 
minimize serum and salivary contamination and placed in glass crimp top vials (with 
   29 
300μl inserts; Supelco, Sigma) and sealed with crimp caps (PTFE/silicone septa; 
Sigma). Sterile Periocol filter paper strips (Oralflow, New York, USA) and sterile 
Whatman 3MM filter paper (General Electric Healthcare) cut to dimensions (2mm x 
25mm) were also used in sampling GCF for VSC analysis (Figure 2-3). 
2.1.3.6 Subgingival plaque 
Subgingival plaque samples were collected by inserting two size #40 sterile absorbent 
paper points (Sybron Dental Specialities) in the deepest pockets in the buccal and 
lingual sites in each tooth. Samples from all four chosen teeth were pooled into 500μl of 
TE buffer (Sigma) in a microcentrifuge tube (Eppendorf). 
2.1.3.7 Interdental plaque 
Interdental plaque was collected from the mesial and distal aspects of all four teeth 
supragingivally, using an interdental brush (Pink Tepe
®
 brush, size=0, wire 
size=0.4mm; Tepe Oral Hygiene Products, Malmö, Sweden) and the brush stored 
immediately in 500μl of TE buffer (Sigma) in a microcentrifuge tube (Eppendorf). 
2.1.3.8 Gingival Crevicular Fluid 
GCF samples for cytokine analysis were collected using sterile Whatman 3MM or 
Periocol filter paper strips as described in 2.1.3.5, but using two strips per tooth (buccal 
and lingual) and pooling the strips together into a swab storage tube (Salimetrics, 
Pennsylvania, USA).  
All samples were placed in ice after collection before transportation to the laboratory.  
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Figure 2-2 photo showing breath sampling syringe (B) and gas sample injection syringe 
(A) used in this study. Participant mouthpiece indicated with an arrow.  
Figure 2-3 photos showing shape and sizes of the devices used to sample GCF in this 
study. A=Whatman 3MM; B=Periocol strip; C=SybronEndo paper points. 
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2.2 Laboratory protocols for clinical samples 
The plaque and tongue biofilm samples were disrupted from their respective sampling 
devices by transferring a few sterile glass beads into the sample containing tubes and 
vortexing vigorously for 20s; the plaque samples were then transferred to separate 
microcentrifuge tubes. A 1ml aliquot of the saliva sample was microcentrifuged 
(>10,000 g) for 10 mins at 4°C, and the supernatant was separated from the pellet and 
500µL of TE buffer added to the pellet only. The salivary cells/debris and plaque 
samples were stored at -20°C until DNA extraction or incubation for headspace 
analysis. The salivary supernatant was stored immediately at -80°C until cytokine 
analysis.   
The GCF sample was eluted from the filter strips by adding 150μl of TE to the swab 
storage tube, ensuring to fully wet all the filter strips and leaving for 1 min on ice, then 
centrifuging at 3500 g and 4°C for 5 mins. The GCF eluted into the collection tube was 
then pipetted into a sterile microcentrifuge tube and stored at -80°C until use for 
cytokine analysis. The GCF sample collected for VSC analysis was also stored at -80°C 
until use. 
2.2.1 Quantitative PCR analysis 
The genomic DNA extracted from the salivary pellet, tongue biofilm and plaque 
samples was analysed using quantitative Polymerase Chain Reaction (qPCR), to detect 
specific oral bacterial species. The protocol for genomic DNA extraction in both clinical 
samples and bacterial cultures used for construction of standard curves for qPCR were 
as follows. 
2.2.1.1 Genomic DNA extraction 
The HOMIM Protocol (2008) was followed for DNA extraction from the clinical 
samples with the majority of the solutions used from the MasterPure
™
 Gram-positive 
DNA purification kit (Epicentre, Madison, USA). Briefly, cells were lysed by adding 
1μl of Ready-Lyse™ lysozyme (Epicentre) and incubating at 37°C overnight, adding 
250μl of the supplied 2 x T&C lysis solution (Epicentre) to each sample after incubation 
and mixing well by pipetting up and down to complete the cell lysis process. Protein 
digestion was carried out by adding 1.5μl of Proteinase K solution (Epicentre) to each 
sample and incubating at 65°C for 30 mins, vortexing briefly every 5 minutes during 
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incubation. The samples were then cooled to 37°C and placed on ice for 3-5 mins ready 
for DNA clean up. 
The protein in the lysed sample was then precipitated by adding 250μl of the supplied 
MPC protein precipitation solution and mixed by vortexing vigorously for 10 seconds. 
The samples were then pelleted by centrifugation at >10,000 g for 10 mins at 4°C and 
placed immediately on ice before discarding the pellet. DNA was then precipitated by 
adding 750μl of 2-propanol (Sigma) to the recovered supernatant and mixed by 
inverting the tube 30 – 40 times. The samples were then placed on ice for approximately 
10 minutes followed by pelleting the DNA at >10,000 g for 10 mins at 4°C. The DNA 
pellet was then rinsed with 500μl of 75% v/v ethanol and the residual ethanol removed 
before the DNA pellet was resuspended in 25μl of TE buffer. Extracted DNA was 
stored at -20°C till use. 
2.2.1.2 Bacterial cultures for standard curves and primer validation 
Six bacterial species namely, Fusobacterium nucleatum, Tannerella forsythia, 
Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, Veillonella 
parvula and Solobacterium moorei were detected in the clinical samples employing 
qPCR with primers that detected specific sequences in the 16S or RNA polymeraseB 
genes. Apart from new primers developed for V. parvula and S. moorei, primers used 
for detecting other species were previously validated (Decat et al. 2012). The amounts 
of DNA detected by qPCR were related to the number of Colony Forming Unit 
equivalents, by using standards of DNA extracted from pure cultures of the bacteria 
detected. All bacterial strains were grown in an anaerobic chamber (MAC MG500; Don 
Whitely Scientific Ltd, Shipley, UK) with an atmosphere containing 80% N2, 10% H2 
and 10% CO2 maintained at 37°C. Specific growth media and the primer sequences used 
are listed in Table 2-1 and Table 2-2, respectively. 
2.2.1.3 Primer design for S. moorei and V. parvula 
qPCR primers were designed for both V. parvula and S. moorei based on DNA 
sequences for the RNA PolymeraseB and 16S genes, respectively using online tools 
such as geneFisher2 and Primer-BLAST (Giegerich et al. 1996; Ye et al. 2012). Primers 
were also validated using an online tool probeCheck and their specificity checked by 
conducting qPCR and conventional PCR (with the same annealing temperatures and 
times to the qPCR method) on genomic DNA templates extracted from closely related 
bacterial strains (Loy et al. 2008). The amplicons were visualized on an agarose gel for 
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conventional PCR and melting curves determined for qPCR to ensure specificity. Both 
primers showed good specificity, sensitivity and no cross-reactivity for human DNA. 
 
Species Strain Broth Agar 
Aggregatibacter 
actinomycetemcomitans 
ATCC 
43718 
- 
Blood Agar (5% v/v 
defibrinated horse 
blood) – BA 
Fusobacterium 
nucleatum ssp 
polymorphum 
NCTC 
10562 
3.7% w/v Brain 
Heart Infusion 
(BHI) + 0.0005% 
w/v hemin 
BA 
Tannerella forsythia 
ATCC 
43037 
4% v/v Tryptone 
Soya Broth + 
0.0005% w/v 
hemin + 0.001% 
w/v N-
acetylmuramic 
acid 
BA 
Porphyromonas 
gingivalis 
W50, W83 
BHI + 0.5% v/v 
hemin 
BA 
Veillonella parvula 
NCTC 
11809 
BHI BA 
Veillonella atypica 
NCTC 
11830 
BHI BA 
Veillonella dispar 
NCTC 
11831 
BHI BA 
Solobacterium moorei 
DSM 
22971 
- BA 
Bulleidia extructa 
DSM 
13220 
- BA 
Erysipelothrix 
rhusiopathiae 
- - BA 
Table 2-1 listing the bacterial species, strains and culture media used to grow the 
respective strains for qPCR analysis in this study. 
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Species Primer Sequences Ta Reference 
Aggregatibacter 
actinomycetemcomitans 
F: CTTACCTACTCTTGACATCCGAA 
R: ATGCAGCACCTGTCTCAAAGC  
(Maeda et al. 
2003) 
Fusobacterium spp. 
F: AAGCGCGTCTAGGTGGTTATGT 
R: TGTAGTTCCGCTTACCTCTCCAG  
(Martin et al. 
2002) 
Tannerella forsythia 
F: GGGTGAGTAACGCGTATGTAACCT 
R: ACCCATCCGCAACCAATAAA 
 
(Shelburne et al. 
2000) 
Porphyromonas 
gingivalis 
F: GGAAGAGAAGACCGTAGCACAAGGA 
R: GAGTAGGCGAAACGTCCATCAGGTC  
(Park et al. 2011) 
Veillonella parvula 
F: TTTCATCGAAGCACCATACC 
R: GTTCAGTTGTGAAGTACCCC  
This study 
Solobacterium moorei 
F: GGCCTGTTAAGTAAGTGGT 
R: CGTCAGTCTTTGGCTAGC  
This study 
Universal 
F: GTGSTGCAYGGYTGTCGTCA 
R: ACGTCRTCCMCACCTTCCTC 
 
(Maeda et al. 
2003) 
Table 2-2 listing primer sequences and their respective annealing temperatures used 
in the qPCR assays of clinical samples in the present study. 
2.2.1.4 SYBR Green qPCR Assay 
96-well and 384-well plates (Roche Diagnostics, Mannheim, Germany) were used with 
final reaction volumes of 20μl and 10μl respectively, with each well containing 2 x 
LightCycler® FastStart DNA Mastermix (Roche), 1 μM of each primer, 2 μl of the 
template and de-ionised water to a final reaction volume. DNA extracted from the 
clinical samples was diluted 10-fold before using as the template in the qPCR assay. All 
multiwell plates were sealed, centrifuged at 1500 g for 10 seconds, and then amplified 
in the LightCycler LC480 Real-Time PCR system (Roche), with activation of 
polymerase (95°C for 5 min), followed by 40 cycles of 10s at 95°C, annealing for 5s at 
Ta (determined for each set of primers), and an extension time at 72°C. In general, the 
Ta was determined as 3 to 5°C below the Tm of the primer with the lowest Tm. Extension 
time was based upon the expected fragment length and was calculated as 1 second for 
every 25bp. Double-stranded PCR product was measured at 76°C for 1 second by 
detection of fluorescence associated with the binding of SYBR Green I to the product. 
Melting curve analysis was performed immediately after the amplification protocol 
under the following conditions: 30 seconds at 95°C, 30 seconds at 65°C and acquisition 
at 99°C. Temperature change rates were 4.4°C⁄ s, except in the final step, which was 
0.1°C⁄ seconds. Fluorescence curves and melting curves were analysed and the absolute 
amount of DNA determined by the LightCycler® software v. 1.5 (Roche). 
Standard curves were generated separately, and a few template dilutions that were used 
to generate the standard curves were included as internal controls in each run, used for 
melt curve analysis and relative quantification. No-template and negative sample 
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controls were used in every run with all reactions set up in duplicate. The Absolute Fit-
Points method was used in the LightCycler® software for relative quantification, with 
35 cycles set as the last cycle cut off in all analyses. Melt curve analysis was used to 
determine positive samples, and the fluorescence baseline adjusted manually to 
maximize the sensitivity of Ct value determination in the positive samples. 
Genomic DNA extracted from P. gingivalis cultures were used to generate standard 
curves for the universal primer. The data calculated as CFU from the qPCR analysis for 
general bacterial load and the specific bacteria were then converted into proportions for 
statistical analysis. However, the relative proportions determined by this method will 
vary dependent on how closely the 16S copy number of P. gingivalis relates to the mean 
(±SD) of the total 16S copies present in each sample as determined using the universal 
primers, in addition to the universal primer’s breadth of sensitivity to all organisms in 
all oral phyla found in each sample (Horz et al. 2005). Therefore, the proportions were 
determined only as a way of normalising to the total 16S copies present in each sample 
in relation to the bacterial species measured as CFU, and not as an absolute value. 
2.2.2 Human Oral Microbe Identification using Next Generation 
Sequencing 
DNA extracted from a subset of clinical samples (tongue biofilm, subgingival and 
interdental plaque) collected from all participants were screened for DNA quality 
(A280/A260>1.8) and sent to the Forsyth Institute, USA for 16S rDNA sequencing and 
determination of the diversity of oral microbiota in these samples using HOMINGS, 
which employs a high throughput barcoded Next Generation Sequencing approach to 
characterise the oral microbiome. The sequencing method involved amplifying the V3-
V4 region of 16S rDNA in each sample, using custom 341F-806R primers, with each 
sample library tagged with a unique barcode. The samples were then multiplexed and 
sequenced using a 2x250bp paired-end read methodology applied by the Illumina Miseq 
sequencer (Illumina, San Diego, USA). 
2.2.2.1 Bioinformatic methodology 
The output sequence data was demultiplexed and a high pass filter applied to the 
sequences (quality>20). The resulting paired-end sequences were then merged using the 
online tool fastq-join in the web based platform Galaxy, with a minimum overlap of 
70bp between the forward and reverse reads specified (Goecks et al. 2010). The merged 
sequences were then binned to Human Oral Taxa (HOT) based upon 638 species-level 
   36 
and 129 genus-level unique target sequences based on the 16S reference library found in 
the online Human Oral Microbiome Database (HOMD). Assigning sequences to HOT 
was carried out by a custom R-script (ProbeSeq) programmed to analyse the sequences 
as follows: 
1) Each sequence was searched for exact matches of the species-level probe 
sequences; the sequence was counted if only one probe sequence was found, 
discarded if multiple were found, or passed to Step 2 if none was found 
2) The read was searched for genus-level probe sequences and counted if only one 
probe sequence was matched. 
The relative abundances of unique sequences whether assigned to species level or genus 
level taxa were then calculated. 
The merged sequences supplied by Forsyth Institute were also independently analysed 
using a separate web platform named Visualisation and Analysis of Microbial 
Population Structures (VAMPS) that presents a web based operation of bioinformatic 
sequence processing tools on phylotype or operational taxonomic unit approaches (Huse 
et al. 2014). Using VAMPS, the Ribosomal Database Project classifier was employed to 
bin sequences to genus-level phylotypes and the resulting data used to calculate 
diversity metrics such as Shannon diversity, Simpson diversity, Inverse Simpson 
diversity, Observed species richness, Abundance Coverage Estimator and Chao I.  
The Quantitative Insights In to Microbial Ecology (QIIME) pipeline available in 
VAMPS was also utilized to perform analyses based on OTUs, mainly to generate 
rarefaction curves to assess the depth of sequencing required to describe the observed 
diversity in each niche. OTUs were picked using the UClust tool with a 97% sequence 
similarity cut off for sequence clustering. The OTUs were aligned using the PyNAST 
tool, with a minimum sequence length set as 60% of median input sequence length and 
minimum percent sequence identity as 75%. Taxonomy was assigned to OTUs using 
RDP (Confidence=0.8), and a phylogenetic tree built using the fasttree script. Based on 
OTUs, beta diversity analyses were conducted, using Bray-Curtis, Canberra, 
Kulczynski, Weighted UniFrac and Jaccard distance matrices and Principal Coordinate 
plots generated from these matrices to visualize differences between cohorts and niches. 
Putative VSC producing species were identified by searching annotated genomes 
available on HOMD and NCBI databases, using key words ‘methionine gamma lyase’, 
‘cystathionine gamma synthase’, ‘cystathionine beta lyase’ and ‘cystathionine’. All 
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protein hits displayed were then screened for the conserved amino acid sequence that 
determines affinity for cysteine or methionine namely, YGG or YGC or LYGCT or 
YGGS, with the cysteine residue indicating methionine gamma lyase activity (Sato & 
Nozaki 2009; Ferla & Patrick 2014). 
2.2.2.2 Multivariate analytic methodology 
Multivariate analyses of the data output of HOMINGS in the form of relative 
abundances of the species detected were carried out using a Microsoft Excel add-in, 
Multibase package (Numerical Dynamics, Japan). Differences between niches within 
each cohort were visualised using Principal Component Analysis. The raw data were 
not scaled but the average of each variable from all samples centered to the origin. The 
null hypothesis being, there is no difference in the community composition of the 
different niches within a cohort that share similar clinically measured periodontal 
parameters. Owing to limited variation observed between cohorts in the same niche, a 
Multibase implementation of Orthogonal Projections to Latent Structures (OPLS) 
namely Partial Least Squares Regression-Discriminant Analysis was used to analyse for 
differences in the microbial ecology (Sæbø et al. 2008). In this instance, the raw data 
were not scaled but to help visualise shifts in the microbial population structure of the 
gingivitis and chronic periodontitis cohorts from health, the average of the variables in 
the healthy cohort were centred to the origin. 
2.2.3 Multiplexed Fluorimetric Immunoassay 
Twenty analytes including cytokines, chemokines and adhesion molecules involved in 
human inflammatory response were detected in gingival crevicular fluid and salivary 
supernatant samples employing a multiplexed fluorimetric bead immunoassay 
(FlowCytomix Human Inflammation 20plex, eBioscience, San Diego, USA) as 
analysed using a flow cytometer (BD FACS Canto II, Becton Dickinson Biosciences, 
San Jose, USA).  
Samples were prepared according to the kit manufacturer’s protocol using the reagents 
provided. Briefly, a standard solution series was prepared using the lyophilized standard 
provided, while thawing the clinical samples. A homogenized stock solution of the 
provided bead mixture was prepared utilizing buffer solutions provided as diluents, and 
25μl of this bead mixture was added to sample, standard or blank solutions in round 
bottomed flow cytometry test tubes (BD Falcon), adding 50μl of the provided Biotin-
Conjugate solution mixture, and incubating at room temperature for 2 hours, protecting 
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from light. The tubes were washed by adding 1ml of the provided assay buffer and 
centrifuging at 200 g for 5 mins. The supernatant was carefully discarded, leaving 100μl 
of liquid in each tube, and repeating this again after which 50μl of the prepared diluted 
Streptavidin-PE solution was added to all tubes, mixing the contents well and 
incubating for 1 hour. After this incubation, the tubes were washed twice as described 
above and finally 500μl of the assay buffer was added to each tube, and the tubes then 
analysed using the flow cytometer set up according to the manufacturer’s instructions. 
Standard curves were constructed utilizing a five-parameter logistic model and the 
unknown analyte concentration in the samples calculated using the software provided 
by the manufacturer (FlowCytomix Pro 3.0; eBioscience, San Diego, USA). 
2.2.3.1 Multivariate analysis 
Multivariate OPLS analysis was carried out as described in section 2.2.2.2, except the 
data were scaled according to observed values and not centered, to visualize the changes 
observed in the different cohorts within the cytokine concentration ranges observed. 
Variables associated with particular cohorts were separately analysed via non-
parametric Kruskal-Wallis tests with Dunn’s multiple comparisons to explore 
significant differences. 
2.2.4 Gas chromatographic headspace analysis 
The Gas Chromatograph (Agilent G6890N, Agilent Technologies, Edinburgh, UK) was 
calibrated by gas standards of H2S and CH3SH generated from permeation tubes by a 
gas standards generator (Kin-tek 491M). 
The headspace of each vial was sampled manually using a gas tight syringe (NORM-
JECT
®
, Henke-Sass Wolf) after incubating at 80°C for 2 minutes. 2 ml of the headspace 
samples were introduced on to a Chromosil 330 packed column (8’ x 1/8” OD Teflon® 
(FEP) tubing with central 6’ packed) through a sulfinert-treated sample loop connected 
to a sampling valve with helium carrier gas flowing through the column at a constant 
flow rate of 45ml/min, via an inlet at 120°C. The packed column was maintained 
throughout the runs isothermally at 60°C. The Flame Photometric Detector was 
maintained at 175°C with H2 and air flow at 50 ml/min and 75 ml/min respectively, 
with N2 makeup gas at flow rate of 15ml/min. 
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2.2.4.1 Method development for analysis of gingival crevicular fluid 
In order to construct a standard curve that simulated GCF sampling and the manual 
headspace sampling method, a dilution range was made up from stock solutions of 
sodium sulfide nonahydrate (Sigma; 290mM) and sodium thiomethoxide (Sigma; 
230mM) and either the absorbent paper points or filter paper strips were dipped 5mm 
below the meniscus of a 2ml aliquot of each standard dilutions for 10s and then sealed 
within the gas chromatographic headspace vials (glass crimp top vials with 300μl 
inserts; Supelco, Sigma). It was determined that each absorbent paper point took up 
approximately 1.3μg (n=20) of fluid and therefore three paper points were deemed 
necessary to bring headspace levels of VSCs above detection limits at the lower end of 
the dilution range (5-10μM). However, only one filter paper strip (Whatman 3MM or 
Pericol) was necessary to absorb a similar amount of fluid in the same time. This 
determined the number of each of the devices used in collection of clinical samples. All 
samples were acidified by injecting 40μl of 1M Phosphoric acid (Sigma) on top of the 
paper points or strips in the sealed vials, before sampling headspace. 
In order to determine the varying absorbing capacity of the filter strips or paper points, 
5μl of the standard dilutions were pipetted into headspace vials, and either three paper 
points or one filter strip added to triplicate vials before sealing with crimp caps and 
acidified before headspace analysis. 
2.2.4.2 Analysis of samples incubated with cysteine & methionine 
20μl aliquots of the clinical samples namely saliva, tongue biofilm, subgingival plaque, 
supragingival plaque and interdental plaque were incubated with amino acid substrate 
solutions separately to determine the amount of H2S or CH3SH produced in the 
headspace from each sample. Substrates used were L-cysteine (Sigma) or L-methionine 
(Sigma) at 0.5% w/v in TE buffer (pH 7.4), and incubation times were 1 hour and 24 
hours, respectively at 37°C. Each 10ml GC headspace vial contained 20μl of the clinical 
sample in 0.5ml of TE buffer solution, added to 0.5ml of substrate solution along with 
0.5ml of TE. The vials were sealed immediately with an aerobic headspace and 
incubated with gentle shaking (~80 rpm), before adding 1ml of absolute ethanol (Fluka) 
to each vial using a syringe to halt bacterial metabolism of the substrate. The headspace 
of the vials were sampled and analysed for VSCs by GC-FPD as described above in 
2.2.4, except a 250μl sample loop was used for H2S detection and a 1ml sample loop for 
CH3SH detection in this experiment. 
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Protein concentrations of the clinical samples used for this analysis were determined 
using the colorimetric bicinchoninic acid assay according to the manufacturer’s protocol 
in a microplate format using the supplied albumin protein standards (Pierce BCA Assay, 
ThermoFisher Scientific, Waltham, USA). 
 
2.3 Biofilm Coculture Model 
The Biofilm Co-culture Model is an in vitro model enabling study of host pathogen 
interactions, and the model used in this thesis has been developed in the Glasgow 
Dental School (Millhouse 2015). This model involves growing a consortium of ten oral 
bacterial species as biofilms on cover slips, and using this biofilm to stimulate a 
monolayer of oral cells in multiwell plates (Figure 2-4). This enables study of mRNA 
and cytokine expression of the cells in response to biofilm challenge. Additionally, this 
model was applied in this thesis to also study the changes in biofilm composition, when 
a methanethiol negative mutant P. gingivalis strain was substituted for the wild type 
strain. 
2.3.1 Mutagenetic manipulation of P. gingivalis 
Porphyromonas gingivalis W50 was maintained on Fastidious Anaerobe agar (+5% v/v 
defibrinated horse blood; FAA) in an anaerobic atmosphere (80% N2, 10% H2 and 10% 
CO2) at 37℃. Liquid culture of P. gingivalis was carried out in Brain Heart Infusion 
(3.7% w/v) broth supplemented with 0.0005% w/v Haemin. 
2.3.1.1 ORF identification, validation and DNA manipulation 
The open reading frame coding for methionine gamma lyase (mgl) in P. gingivalis W50 
was identified as per (Yoshimura et al. 2000). The ORF was identified and amplified by 
Figure 2-2 showing a schematic of the biofilm co-culture model employed in the study 
of the role of methanethiol production in host-biofilm interactions. 
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using the following oligonucleotide primers (irrelevant sequence in italics and 
restriction enzyme recognition sequence in bold): 
PG0343F1 -- 5’-CATAGACGATCCTCGGTCG-3’ 
PG0343R1 -- 5’-atatatgagctcATATTGGGGTTGGCCGGAG-3’ (SstI) 
PG0343F2 -- 5’-atatattctagaTCACGGGGGCCAATATGAG-3’ (XbaI) 
PG0343R2 -- 5’-TGTCCTCCACGTTCTCCAG -3’ 
The amplicons were purified (Qiagen) and their sizes were confirmed by agarose gel 
electrophoresis. The purified amplicons were digested with their respective Sstl and 
XbaI enzymes (New England Biolabs, Ipswich, USA). The digested amplicons were 
then purified and ligated to a pre-digested ermF-ermAM cassette from the plasmid 
pVA2198. The ligation mixture was then purified and the product reamplified 
(ReddyMix Extensor PCR MasterMix 1, ThermoFisher Scientific), with the resulting 
~3kb fragment used to electroporate exponential P. gingivalis W50 cells (Bio-Rad Gene 
Pulser, Bio-Rad Laboratories, Hercules, USA) to promote mutagenesis by allele 
exchange. Following overnight recovery under anaerobic conditions, the cell suspension 
aliquots were plated on to Blood Agar (containing 5µg/ml clindamycin-HCl) and 
incubation was allowed to continue, anaerobically. The resultant colonies were screened 
by PCR (ReddyMix Extensor PCR MasterMix 1) to confirm incorporation of the ermF-
ermAM cassette. Mutagenesis was further confirmed by incubating suspensions of P. 
gingivalis W50 or mutant strain in headspace vials with L-methionine for 1 hour and 
analysing the headspace for the presence of methanethiol according to the method 
discussed in 2.2.4.2. The mutant strain will henceforth be referred to as PG343. 
2.3.2 Growth of the ten species biofilms 
Agar used in culture of organisms were Fastidious Anaerobe agar (+5% v/v defibrinated 
horse blood; FAA) and Columbia Blood agar (+5% v/v defibrinated horse blood; CBA). 
Broths used were Schaedler’s Anaerobic broth (SCH), Brain Heart Infusion broth (BHI) 
and Tryptic Soy broth (+0.8% w/v glucose and 0.6% w/v yeast extract; TSB). In 
maintaining and building up the 10-species biofilms, the medium Artificial Saliva (AS; 
(Millhouse et al. 2014) was exclusively used.   
Bacterial strains were:  Porphyromonas gingivalis W50 (FAA; SCH), Streptococcus 
mitis NCTC 12261 (CBA; TSB), Streptococcus intermedius DSM 20573 (CBA; TSB), 
Streptococcus oralis NCTC 11427 (CBA; TSB), Aggregatibacter 
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actinomycetemcomitans ATCC 43718 (CBA; TSB), Veillonella dispar NCTC 11831 
(FAA; BHI), Actinomyces naeslundii DSM 17233 (FAA; BHI), Fusobacterium 
nucleatum ssp polymorphum ATCC 10953 (FAA; SCH), Fusobacterium nucleatum ssp 
vincentii DSM 19507 (FAA; SCH), Prevotella intermedia DSM 20706 (FAA; BHI). 
Streptococcus spp. and A. actinomycetemcomitans were maintained and cultured in an 
aerobic atmosphere containing 5% CO2, whilst all other strains were maintained in an 
anaerobic atmosphere (80% N2, 10% H2 and 10% CO2) at 37℃. 
Ten-species biofilms were built up on Thermanox™ (Nalge Nunc International, 
Rochester, USA) coverslips by the following method: 24 hr agar cultures of S. mitis, S. 
intermedius and S. oralis were inoculated into 10ml TSB and grown for 1 day, when the 
cells were harvested by centrifugation (10 min at 3000 rpm) and washed in sterile PBS 
(pH 7.2±0.2), twice, making suspensions at OD550 equal to 0.5. These suspensions 
were diluted in AS to the optical density equivalent of 10
7
 CFU/ml each into a total 
volume of 500µL AS, which is added on the coverslip resting in a 24 well plate and 
cultured in a 5% CO2 atmosphere at 37°C, overnight. 
On the second day, 48 hr broth cultures of V. dispar (BHI), A. naeslundii (BHI), F. 
nucleatum ssp polymorphum (SCH) and F. nucleatum ssp vincentii (SCH) were 
harvested and standardised as described above in AS. The spent AS supernatant from 
the previous day was removed and 500 µL AS suspension containing the newly 
standardised bacteria was added to the well plate and incubated anaerobically overnight 
at 37°C. 
Finally, 48 hr broth cultures of P. gingivalis (SCH), P. intermedia (BHI) and A. 
actinomycetemcomitans (TSB) were harvested and standardized as above to make a 
mixed bacterial suspension in AS, 500µL of which was added to the overnight biofilm 
culture after removing the spent AS supernatant. This culture was allowed to grow for 4 
days with renewal of the AS medium every 24 hrs. After this maturation phase, the AS 
supernatant was removed and the biofilms stored at -80°C till use.    
2.3.3 Keratinocyte growth and co-stimulation 
The immortalized oral keratinocyte cell line OKF6-TERT2 (Rheinwald Laboratory, 
Brigham and Woman’s Hospital, Boston, USA) was grown as a monolayer in 24-well 
cell culture plates and challenged with the 10-species biofilms grown with the wild type 
or mutant P. gingivalis for 4h and 24h as described previously (Millhouse et al. 2014). 
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Six stimulations were performed on three occasions using independent batches of 
biofilms, with every two supernatant samples pooled to obtain triplicate samples per 
batch. 
2.3.4 Sample analyses 
Three techniques were employed to analyse samples collected from the model: 
 qPCR assays of DNA extracted from bacterial biofilms 
 Fluorimetric multiplex cytokine assay on the cell culture supernatants 
 mRNA expression of cells by employing a qPCR array 
2.3.4.1 Bacterial biofilm composition 
Triplicate biofilms grown thrice independently, were used for the biofilm composition 
study. Biofilms on the Thermanox coverslips were revived in AS overnight and washed 
with PBS (pH 7.2±0.2) thrice before biofilm disruption by sonication for 10 minutes in 
PBS. DNA extraction from the recovered sonicate was performed as per instructions 
from the MasterPure GramPositive DNA purification kit (Epicentre Biotechnologies, 
Madison, USA; see also section 2.2.1.1) 
qPCR was performed by using a SYBR Green I fluorophore (Roche) in the LightCycler 
480 (Roche). Assays were performed in 20µL total volume per well in 96 well plates. 
Recommended thermal cycling conditions were used: initial denaturation at 95℃ for 5 
mins followed by 40 cycles of 3s at 95℃, 30s at 55℃, 2s at 72℃ and 10s at 76℃. 
Standard curves were obtained by running decimal dilutions of bacterial DNA extracted 
from pure cultures with known CFU/ml. Primer pairs used in detection of the species 
used in the biofilm model are given in table below. 
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Species Primer Sequences Reference 
Aggregatibacter 
actinomycetemcomitans 
F: GAACCTTACCTACTCTTGACATCCGAA 
R: TGCAGCACCTGTCTCAAAGC 
(van der Reijden et al. 
2010) 
Fusobacterium spp. 
F: AAGCGCGTCTAGGTGGTTATGT 
R: TGTAGTTCCGCTTACCTCTCCAG 
(Sánchez et al. 2014) 
Actinomyces naeslundii 
F: GGCTGCGATACCGTGAGG 
R: TCTGCGATTACTAGCGACTCC 
(Periasamy et al. 
2009) 
Porphyromonas 
gingivalis 
F: GGAAGAGAAGACCGTAGCACAAGGA 
R: GAGTAGGCGAAACGTCCATCAGGTC 
(Park et al. 2011) 
Veillonella dispar 
F: CCGTGATGGGATGGAAACTGC 
R: CCTTCGCCACTGGTGTTCTTC 
(Periasamy & 
Kolenbrander 2009) 
Prevotella intermedia 
F: CGGTCTGTTAAGCGTGTTGTG 
R: CACCATGAATTCCGCATACG 
(Loozen et al. 2011) 
Streptococcus spp. 
F: GATACATAGCCGACCTGAG 
R: CCATTGCCGAAGATTCC 
(Periasamy et al. 
2009) 
Table 2-3 listing qPCR primers used to detect the species present in the 10-species 
biofilm co-culture model. 
2.3.4.2 Cell supernatant cytokine analysis 
Cell culture supernatants were collected at the end of biofilm stimulation and cytokines 
measured in 100µL of each sample by a multiplexed bead immunoassay (FlowCytomix, 
eBioscience) whereby the samples were prepared according to the kit manufacturer’s 
instructions (see section 2.2.3). Standard curves were setup with the reagents supplied 
by the manufacturer, with the samples and standards analysed with a flow cytometer 
(BD FACSCanto II). The raw data was then processed using the kit manufacturer’s 
software (FlowCytomix Pro v3.0) to determine the concentration of twenty cytokines: 
E-selectin, G-CSF, ICAM-1, TGF-β, IFN-α, IFN-γ, IL-1α, IL-1β, IL-4, IL-6, IL-8, IL-
10, IL-12p70, IL-13, IL-17a, CXCL10, MCP-1, MIP-1α, MIP-1β and TNF-α. 
2.3.4.3 Determination of mRNA expression by a custom qPCR array 
After collection of the cell culture supernatant, the monolayer of cells were lysed and 
RNA extracted using the RNeasy kit (Qiagen), using the provided spin columns, and 
performing on-column DNase digestion (Qiagen). Equimolar quantities of RNA (280 
ng) from all samples were converted to cDNA with the RT2 First-Strand kit (Qiagen) 
and then rt-PCR was conducted in a custom 384-well array format in the LightCycler 
480 (Roche) with RT2 SYBR Green qPCR MasterMix (Qiagen). Cytokines measured 
were TNF-alpha, IL-1alpha, IL-6, IL-8, IL-18, IL-13, MIF, CCL20 and CXCL10. 
Reference genes used to normalize measured Cp values were Actin-β, Glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) and hypoxanthine phosphoribosyltransferase 1 
(HPRT1). Relative gene expression was calculated and expressed as ΔCt relative to the 
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most stable reference gene, while genomic DNA contamination, RT-PCR efficiency and 
positive PCR controls run for each sample in the array. 
2.4 Statistical methods 
All statistical analyses were performed using the software GraphPad Prism 6.0 
(GraphPad Software Inc, La Jolle, USA) for Microsoft® Windows. Comparisons 
between cohorts or niches given more than two groups of data 
(health/gingivitis/periodontitis or saliva/tongue/subgingival/supragingival/interdental), 
unless specified were always performed via the non-parametric Kruskal-Wallis test, 
with the posthoc Dunn’s multiple comparison with multiplicity adjusted P-values to test 
for differences in multiple comparisons between any two group combinations. Given 
two groups of data, the Mann-Whitney U test was used to test differences in medians 
and the Kolmogorov-Smirnov test used to analyse for differences in the cumulative 
distributions of the data sets. All correlations were explored using the non-parametric 
Spearman’s correlation. 
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3 CLINICAL INVESTIGATIONS INTO THE 
RELATIONSHIP BETWEEN VSCS AND 
PERIODONTITIS 
The association between volatile sulfur compounds in the breath and periodontitis has 
been extensively reported in different regional populations of the world, in both adults 
and children (Stamou et al. 2005; Nadanovsky et al. 2007; Eldarrat et al. 2008; 
Takeuchi et al. 2010; Bornstein et al. 2009; Nalçaci & Sönmez 2008; Kara et al. 2006; 
Liu et al. 2006; Quirynen et al. 2009). The principal deductions from these studies has 
been that the prevalence and intensity of oral malodour in individuals with clinically 
diagnosed periodontitis or gingivits is higher than that of healthy individuals, and this 
observation holds despite a range of methodological differences in assessing malodour, 
whether hedonic methods or more objective sulfide monitors were used. Studies have 
also explored the microbial link between malodour and periodontitis, by measuring 
putative periodontopathogens in tongue and periodontal niches with qPCR methods and 
found an association between periodontopathic bacteria in healthy individuals and 
chronic periodontitis patients with malodour and VSC concentrations in the breath 
(Amou et al. 2014; Figueiredo et al. 2002; Kurata et al. 2008; Yasukawa et al. 2010). 
Whilst studies that focussed on oral malodour predominantly only included the tongue 
as a niche of choice, and studies focussing on periodontal disease were more concerned 
with the periodontal niches such as subgingival and supragingival plaque, studies that 
combined these two approaches did not have an assessment of inflammation present in 
the oral cavity through the use of cytokine analysis. Fewer still are studies measuring 
VSCs in the periodontal niches (Torresyap et al. 2003; Persson 1992). Therefore, the 
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present study aimed to combine these different approaches including microbial, breath 
and inflammatory assessments of the oral cavity to explore potential relationships 
between VSCs present in the breath and periodontal pockets in health and disease and 
their link with putative periodontopathic bacteria in a range of oral niches and the 
inflammatory status in saliva and the periodontal pocket. 
3.1 Participant and Cohort Demographics 
Participants were recruited to three different cohorts based on the clinical assessment of 
their oral health: health, gingivitis and chronic periodontitis. The following sections 
describe the clinical characteristics of each cohort and further describe the 
demographics with regard to age, sex, ethnicity and parameters relevant to the study 
such as the oral hygiene habits, oral malodour and the self-perception of oral malodour. 
3.1.1 Clinical Demographics 
Of the 41 participants recruited to the healthy cohort, 21 were identified as having good 
periodontal health with ≤30% plaque coverage, ≤20% gingival bleeding index (GBI), 
≤20% sites bleeding on probing (BOP) and no more than four periodontal pockets 
deeper than 4mm excluding 3
rd
 molars. Plaque Index (PI) exceeded 30% for 19 
individuals (Mean±SD=46.1%±13.8), 17 of whom had BOP and GBI below 20%, and 
only two had GBI exceeding 20% (Figure 3-2). As discussed in the methodology, in 
case of conflicting scores between BOP and GBI, the former was given precedence in 
determining diagnosis. The clinically healthy individuals with high plaque were 
included in some analyses where necessary such as assessment of inflammation by 
cytokine analysis and for sequencing the bacterial 16S rDNA in the microbiome studies. 
A total of 26 individuals recruited to the study were considered to have gingivitis. The 
primary clinical criteria used to assign individuals to this cohort were >20% BOP and/or 
>4 pockets of ≥4mm depth. Of these, 15 participants had >20% BOP whilst 11 
participants had more than four periodontal pockets ≥4mm deep but >20% BOP sites. 
Additionally, 20 of the 26 individuals had plaque coverage >30% (Figure 3-2). The 
chronic periodontitis cohort had more heterogeneity in terms of the clinical symptoms 
as measured by BOP, GBI and PI, although all individuals had radiographic evidence of 
bone loss and had at least 2 periodontal pockets in excess of 5mm (Figure 3-1). All 
participants recruited to this study had >20 teeth present with means (±SD) of 29±2 in 
the healthy, 29±2 in gingivitis and 28±2 in patients with chronic periodontitis. 
   48 
 
 
 
 
Figure 3-2 showing the distribution of plaque coverage in the healthy, gingivitis and 
chronic periodontitis cohorts. Median, interquartile range and a line indicating the 
30% cut off for classification are indicated. 
Figure 3-1 showing the distribution of periodontal probing depths ranging 4mm-10mm 
in the healthy, gingivitis and chronic periodontitis cohorts. Data shown includes 3rd 
molar probing depths. 
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3.1.1.1 Age, Gender and Ethnicity 
The age ranges in the chronic periodontitis cohort were significantly higher than the 
healthy or the gingivitis cohort, while the male to female ratio was the highest in the 
healthy cohort, and the gingivitis cohort having the lowest number of males to females 
recruited (Table 3-1). In terms of the ethnic diversity of the participants recruited to the 
cohorts, the most diverse were the healthy and gingivitis cohorts, with individuals of 
Asian, African and Caucasian ethnicities equally represented in the chronic periodontitis 
cohort compared to the other cohorts (Figure 3-3). 
 
Cohort Mean age ±SD (yrs) Male: Female Ratio 
Health 33.17±8.56 1.05 
Gingivitis 34.36±9.16 0.60 
Chronic Periodontitis 43±7.4 0.85 
Table 3-1 listing mean age of the participants in the different cohorts and the ratio of 
males to females in each cohort. 
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Figure 3-3 showing the composition of the different cohorts of this clinical study in 
terms of ethnicity. 
3.1.1.2 Dental visits and oral hygiene habits 
All participants were questioned about their frequency of dental visits with the six-
monthly and yearly options popular amongst the healthy and gingivitis cohorts (Figure 
3-4). More patients in the chronic periodontitis cohort reported visiting a dental surgery 
every three months, and this could be because they were from the maintenance clinics. 
No differences in the dental surgery visiting frequencies were observed between healthy 
individuals with plaque coverage <30% vs >30%.  
There was no difference in the self-reported brushing frequency of individuals in the 
healthy and gingivitis cohort. As some patients in the chronic periodontitis cohort had 
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already received some oral hygiene instructions, the self-reported brushing frequency of 
three or four times a day was higher in this cohort compared to the healthy or gingivitis 
cohorts (Figure 3-5). The self-reported use of interdental brushes and/or flossing was 
also higher in the chronic periodontitis cohort compared to health or gingivitis, and it is 
suspected that these individuals, likely received oral hygiene instructions regarding their 
periodontal condition in a previous visit (Figure 3-6). Interestingly, a higher proportion 
of individuals in the healthy cohort reported flossing and/or interdental brushing than 
the gingivitis cohort. A recent systematic review concluded that there is low quality 
evidence that interdental brushing and not flossing, in addition to tooth brushing can 
reduce gingivitis (Poklepovic et al. 2013). However, general awareness of interdental 
brushing or indeed tongue brushing was low in both the healthy and gingivitis cohorts, 
and very few reported using both flosses and interdental brushes.   
 
 
 
 
 
 
Figure 3-4 showing the dental surgery visiting frequency of individuals recruited to the 
different cohorts. 
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 Although participants were asked to not perform any kind of oral hygiene 
before attending the clinic for sample donation, it was endeavoured to ascertain if the 
participants are using potentially anti-VSC mouthwashes or toothpastes in their day-to-
day oral hygiene routines. Participants who used or did not use mouthwashes were 
equally represented in the health and periodontitis cohorts, with the gingivitis cohort 
showing a greater proportion of individuals who do not use mouthwashes (Figure 3-7). 
A small minority in all the cohorts reported using mouthwashes but were unable to 
name the brand—the lack of awareness may be due to infrequent use of the mouthwash.  
Figure 3-5 showing the brushing frequency per day of the individuals recruited to 
the different cohorts. 
Figure 3-6 showing the reported use of flossing and interdental brushing among the 
individuals recruited to the healthy, gingivitis and chronic periodontitis cohorts. 
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A particular observation was the general inability of the individuals across cohorts to 
name the full product name of the mouthwash. Whilst most of the participants were able 
to remember the major brand names of products they use such as Listerine
®
, 
Sensodyne
®
 or Corsodyl
®
, a number of products exist within some of these brands that 
are marketed towards different activities such as anti-malodour, anti-plaque and anti-
caries and very few individuals were able to remember the actual product names (Figure 
3-8). This was an important consideration to determine if the product used by the 
individual has zinc containing compounds which display potent anti-VSC activity 
particularly within the first few hours of product use (Young et al. 2001; Newby et al. 
2008; Burnett et al. 2011). More individuals were able to name specific product names 
for toothpastes, and this perhaps reflects the more common use of toothpastes as an oral 
hygiene product compared to mouthwashes (Figure 3-9). The responses to these 
questions were not complete enough to determine if more individuals in the healthy 
cohort used zinc containing anti-VSC toothpastes and mouthwashes compared to the 
gingivitis or chronic periodontitis cohorts. 
 
 
 
Figure 3-7 pie charts showing the reported use of mouthwashes in the different cohorts. 
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Figure 3-8 showing charts of the use of different mouthwash brands by the individuals 
recruited to the different cohorts. Legend colours cycle clockwise. 
Figure 3-9 showing charts depicting the use of different toothpaste brands in the different 
cohorts. Legend colours cycle clockwise. 
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3.2 Breath VSCs and Chronic Periodontitis 
VSCs present in the breath of individuals were measured using a portable gas 
chromatograph, Oral Chroma, which is able to distinguish between three different VSCs 
namely hydrogen sulfide, methanethiol and dimethyl sulfide. All three gases were 
generally prevalent (i.e. above detection limits) in the breath samples of individuals 
classified into the different cohorts, with the prevalence of methanethiol being higher in 
the gingivitis and chronic periodontitis cohorts compared to health (54% and 71% vs 
39%). Elevated concentrations of hydrogen sulfide and methanethiol were observed in 
the breath of individuals in the chronic periodontitis cohort compared to health, but not 
between health and gingivitis or gingivitis and chronic periodontitis (Figure 3-10; 
Figure 3-12). The ratio of CH3SH: H2S was also higher in the chronic periodontitis and 
gingivitis cohorts compared to health, but not between periodontitis and gingivitis 
(Figure 3-11). Although elevated concentrations of hydrogen sulfide and methanethiol 
were observed in healthy individuals with >30% plaque coverage compared to <30%, in 
addition to an increase in the CH3SH: H2S ratio, the difference was not significant at 
p<0.05 (Figure 3-13). The Malodour Scores calculated based on the concentrations of 
hydrogen sulfide and methanethiol measured using Oral Chroma, were significantly 
elevated in the chronic periodontitis cohort compared to health, but comparisons 
between health and gingivitis or gingivitis and chronic periodontitis cohorts showed that 
the differences were not statistically significant (Figure 3-14). 
 
 
Figure 3-10 showing scatter dot plots of H2S detected in the breath of individuals in the 
different cohorts (only individuals with <30% plaque coverage in the healthy cohort are 
shown). Median and interquartile ranges are indicated. 
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Figure 3-11 showing scatter dot plots of the ratio of CH3SH: H2S in the breath of 
individuals in the different cohorts (only individuals with <30% plaque coverage in 
the healthy cohort are shown). Median, interquartile ranges and comparisons that 
yielded statistical significance are indicated. 
Figure 3-12 showing scatter dot plots of CH3SH detected in the breath of individuals 
in the different cohorts (only individuals with <30% plaque coverage in the healthy 
cohort are shown). Median, interquartile ranges and comparisons that yielded 
statistical significance are indicated. 
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Figure 3-14 showing scatter dot plots of the malodour scores calculated from the breath 
analysis of individuals in the different cohorts (only individuals with <30% plaque 
coverage in the healthy cohort are shown). Median, interquartile ranges and 
comparisons that yielded statistical significance are indicated. 
Figure 3-13 Left: Average (±SD) ratio observed in healthy individuals with >30% versus 
<30% plaque coverage. Right: Malodour scores from the low (<30%) and high (>30%) 
plaque coverage groups in the healthy cohort. Median and interquartile range indicated. 
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The CH3SH: H2S ratio, malodour score and the concentration of methanethiol are 
consistent with the findings reported of the association of VSCs with periodontal 
disease, despite a number of methodological differences (Takeuchi et al. 2010; Tsai et 
al. 2008). While other studies have reported significantly elevated concentrations of 
hydrogen sulfide in chronic periodontitis patients compared to health, the current study 
only found a non-significant increase in the H2S concentrations (Tsai et al. 2008; Pham 
et al. 2011). It is possible that this is partly due to the less stringent criteria in terms of 
plaque coverage (30% vs 20%) or not taking probing depths of the 3
rd
 molar into 
account when determining diagnosis in the healthy cohort. More importantly, tongue 
coating was not assessed in this study and the variable tongue coating likely to be 
present in the healthy cohort could impact on the VSC concentration observed. 
However, while most other studies aimed to recruit individuals complaining of oral 
malodour and found an association with periodontal disease in a subset of individuals 
with malodour, the present study aimed to recruit individuals with disease/health and 
attempted to ascertain if a greater proportion of individuals with disease had intra-oral 
malodour associated with increased presence of VSCs in the breath. The findings of the 
present analyses also confirm that a greater proportion of individuals with disease have 
increased VSCs in the breath.  
An organoleptic assessment of oral malodour was not made in this study, however, the 
malodour scores calculated from the VSC concentrations serves as a surrogate 
measurement of malodour as experienced by a human owing to its incorporation of the 
human recognition threshold in the method. In terms of the relationship between the 
malodour scores and the organoleptic scale, malodour scores of 1-5 are equivalent to 1-
2 in a scale of 0-5, and malodour scores above 5 are equivalent to 3 or higher on the 
organoleptic scale. The degree of malodour as measured by the malodour scores also 
increased in the disease groups compared to health. For example, the proportion of 
individuals with malodour scores higher than 1, which represents the cumulative 
presence of hydrogen sulfide and/or methanethiol at concentrations 10-fold higher than 
the recognition threshold for each molecule, were similar in health (43%) and gingivitis 
(46%) but were higher in chronic periodontitis (58%; Figure 3-14). The proportion of 
individuals with malodour scores higher than 5 were also higher in the chronic 
periodontitis cohort (33%) compared to health (24%) or gingivitis (23%).  
A few studies in the literature report methanethiol being the VSC more associated with 
periodontal disease, and the elevated concentrations of this VSC and the CH3SH: H2S 
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ratio observed in the chronic periodontitis and gingivitis cohorts compared to health are 
consistent with these observations (Figure 3-12; Figure 3-11; Yaegaki & Sanada 1992; 
Sopapornamorn et al. 2007). Interestingly, clinically healthy individuals with high 
plaque coverage also had elevated CH3SH: H2S ratio, in addition to median malodour 
score >2 suggesting possible increased disease activity in these individuals (Figure 
3-13).  
Comparison Rho 95% CI P (two-tailed) 
% sites ≥6mm vs Ratio 0.211 -0.00211 to 0.4058 0.0459 
GBI vs CH3SH 0.257 0.04523 to 0.4466 0.0151 
GBI vs Ratio 0.273 0.06266 to 0.4605 0.0096 
PI vs CH3SH 0.229 0.01599 to 0.4229 0.0306 
Table 3-2 listing Spearman’s rho values for the most significant comparisons 
between breath VSC measurements and clinical indices (n=90 with all comparisons). 
 
To ascertain if the CH3SH: H2S ratio or the concentration of methanethiol in the breath 
of individuals could identify periodontal disease activity, correlational analyses were 
conducted with these breath measures and the conventional clinical measures of disease 
such as plaque index, gingival bleeding index , bleeding on probing and periodontal 
pocket depth. Confirming this hypothesis, positive correlations were observed between 
methanethiol concentrations in the breath and the clinical measures namely gingival 
bleeding index and plaque index when individuals recruited to the different cohorts 
were pooled together (Table 3-2). Increased CH3SH: H2S ratios were also positively 
associated with higher percentage of periodontal pockets ≥6mm and GBI. No 
correlations were observed with H2S concentrations in the breath of individuals. The 
weak positive correlations observed between these measurements possibly reflects the 
impact of periodontal conditions on physiological processes involved in oral malodour 
that are predominantly linked to the tongue, which plays a major role in oral malodour. 
This would entail that this correlation is likely to indicate the strength of microbial 
association between the periodontal and tongue niches as it relates to the VSC 
concentration. A prediction would be that the abundance of methanethiol producing 
microbial species in the tongue and the periodontal niches would increase in association 
with periodontal disease as measured by the clinical parameters such as percentage of 
periodontal pockets ≥6mm, gingival bleeding index and plaque index. 
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3.2.1 Demographics, oral hygiene habits and malodour  
Studies conducted in some regional populations report a positive association between 
oral malodour and age, while also associating higher prevalence of malodour in males 
compared to females (Nadanovsky et al. 2007; Quirynen et al. 2009). However, studies 
in other regional populations do not support these observations (Miyazaki et al. 1995; 
Liu et al. 2006). In the present study, a simple Spearman correlation analysis of the 
VSC measurements with age in the different cohorts did not yield statistically 
significant correlations, but H2S concentrations in the healthy cohort that included 
individuals with high plaque coverage approached significance (r=0.256; p two-
tailed=0.107; n=41). No significant differences in the VSC measures could be observed 
in the different cohorts between male and female sexes. However, an elevated CH3SH: 
H2S ratio could be observed in males (mean=0.33±0.4) compared to females 
(mean=0.098±0.13) in the chronic periodontitis cohort. The possible effect of different 
ethnicities on the prevalence of VSCs could not be determined owing to low numbers of 
the different ethnic minorities in each cohort. However, periodontal diseases are often 
associated with socioeconomic status, more often than not is associated with ethnic 
minorities and therefore could have a role to play in oral malodour in the ethnic 
minorities (Rayman & Almas 2008; Mason et al. 2013). While, socioeconomic factors 
were not ascertained in this study, these are likely to be more normalized for the healthy 
and gingivitis cohorts as these individuals were recruited from the staff and students of 
Queen Mary, University of London. No difference was observed in the prevalence of 
moderate or severe malodour as determined by the VSC measurements in the gingivitis 
and high plaque healthy cohorts between Caucasian and non-Caucasian ethnicities. 
However, in healthy individuals with low plaque (<30%), malodour (>1 malodour 
score) was more prevalent in individuals belonging to Caucasian ethnicities (67% vs 
33%), however prevalence of severe malodour (malodour score >5) was higher in ethnic 
minorities compared to Caucasians (33% vs 17%).   
Association of VSCs with brushing frequency could not be determined due to low 
numbers of participants in the healthy cohort reporting brushing once or thrice a day. In 
the healthy and gingivitis cohorts, slight to moderate malodour (malodour score >1<5) 
and severe malodour (malodour score >5) were equally prevalent in individuals who 
reported using mouthwashes and those who did not. With regards to flossing or 
interdental brushing, the prevalence of VSCs above the malodour threshold (malodour 
score >1) in the breath was higher in individuals in the healthy cohort (including high 
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plaque individuals) who reported flossing alone or in combination with interdental 
brushing (56%) compared to individuals who used neither (36%). The prevalence of 
moderate to severe malodour (malodour score >5) was similar in the floss and/or 
interdental brush using individuals (10 of 30) compared to individuals who used neither 
(3 of 11). It is possible that flossing or interdental brushing disturbs mature plaque 
accumulating interdentally, and aids in transmission of microbiota from the interdental 
space to the tongue and this could impact on malodour. However, this hypothesis could 
not be tested based on the available data in the present study as the frequency of 
flossing or interdental brushing was not recorded. 
To assess if the frequency of dental visits have an effect on the prevalence of oral 
malodour, individuals in the healthy and gingivitis cohorts were analysed. Only those 
individuals who reported visiting their dentist quarterly, half-yearly or yearly were 
included due to low number of respondents in the other groups. More numbers of 
individuals who reported visiting their dentist once a year were classified in the 
gingivitis group (50%) than half-yearly and quarterly visitors (36%). However, while 
the prevalence of moderate to severe malodour (malodour score >5) was similar in both 
the groups (23% vs 27%), the prevalence of slight to moderate malodour (malodour 
score >1<5) was higher in the individuals who report more frequent visits to their 
dentist (32% vs 8%). It is notable that more clinically healthy individuals with high 
plaque coverage reported visiting their dentist half-yearly or quarterly (36% vs 23%) 
and this could partly explain the observed higher prevalence of slight to moderate 
malodour in this group (Figure 3-13).  
3.2.2 Self-perception of oral malodour 
Participants of this study were asked if they thought that they had bad breath in the 
questionnaire, to assess the level of awareness in the different groups, as oral malodour 
is a condition that affects social interaction (Mckeown 2003). It has been reported that 
individuals who perceive a worsening of ‘gum health’ are more likely to believe they 
have oral malodour (Azodo & Ao 2013). Due to the association of periodontal disease 
with malodour and by extension the concentration of VSCs in the breath, this perception 
is more likely to be accurate in correlating with VSCs in the breath of individuals. Data 
from the current study appears to confirm this notion, with almost 75% of chronic 
periodontitis patients with breath VSCs exceeding the malodour threshold accurately 
determining that they had oral malodour (Figure 3-15). In contrast, the majority of 
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individuals in the gingivitis and healthy cohorts whose breath VSC concentrations 
exceeded the malodour threshold (malodour score >1), did not believe they have oral 
malodour. This observed perception among the healthy and gingivitis cohort is not 
likely to be related to the severity of oral malodour, as 28% of individuals who did not 
believe they had malodour in the gingivitis cohort, would be classified as having 
moderate to severe malodour (malodour score >5). In addition, the same is true for 43% 
of the negative responses among healthy individuals with high plaque coverage and 
28% of negative responses for healthy individuals with low plaque coverage. A small 
subset of individuals in all the cohorts, believed they had oral malodour when their 
breath VSC concentrations were below the malodour threshold (malodour score <1), 
suggesting a diagnosis of pseudo-halitosis (Seemann et al. 2006). It is thought that if the 
individual continues to believe that they have oral malodour when objective 
measurements such as VSC concentrations are shown, it could lead to a more serious 
psychosomatic disorder namely, halitophobia (Zürcher et al. 2014). However, all 
individuals in this study who displayed this inaccurate self-perception of pseudo-
halitosis were more relieved when shown results from the Oral Chroma analysis that 
they did not have malodorous breath.  
Figure 3-15 showing self-perception of oral malodour among individuals in the 
different cohorts. LP=<30% PI; HP=>30% PI; Yes/No indicates participants belief of 
whether they have oral malodour, +/- signs indicate if the VSC concentrations in the 
breath sample exceeded the malodour threshold. 
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3.3 Sulcular VSCs and periodontal disease 
The association between breath VSCs and periodontal disease is well established, 
leading investigators to measure VSCs in the periodontal environment to determine if 
VSCs in these niches correlate with greater disease activity (Torresyap et al. 2003; 
Persson 1992). These studies took different methodological approaches to measuring 
VSCs. Torresyap et al (2003) utilized a non-specific ‘sulfide’ sensor incorporated into a 
periodontal probe to measure amount of sulfide and hydrosulfide ions in the periodontal 
pocket whereas Persson (1992) collected GCF via filter paper strips placed in sealed gas 
chromatographic vials, and detected VSCs in the headspace after acidification of the 
strips using sulfur specific gas chromatography. Whilst the former methodology is 
advantageous in measuring sulfide ions in situ, its lack of specificity is a limitation, 
especially given that the VSC methanethiol in the breath was more associated with 
periodontal disease than hydrogen sulfide. The latter method was chosen in the current 
study to detect VSCs in the gingival sulci, owing to its greater specificity.  
3.3.1 Notes from method development 
 Initially, a few changes to the published methodology were evaluated, 
including GCF sampling paper and the gas chromatographic method employed. Due to 
the anticipated very low amounts of VSCs recovered from GCF, a capillary column 
method with sulfur specific photometric detection after headspace sampling using a 
thermal desorber was evaluated. Gas standards generated from permeation tubes were 
used in evaluation of the thermal desorption compared to direct injection, and reduced 
recovery of H2S and CH3SH was observed in terms of their expected peak heights 
relative to dimethyl sulfide standards with the thermal desorber compared to direct 
injection (Figure 3-16). Due to this lowered assay sensitivity for the two main VSCs 
previously detected by Persson et al (1992) in GCF, a manual injection method was 
followed for subsequent GC analyses, with high sample volume (2ml) injections via a 
sulfinert sample loop on to a packed column to enable maximum available sensitivity in 
this method.  
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Filter paper sampling is the preferred method for collecting GCF to carry out protein or 
cytokine analyses and Persson et al (1992) used the Whatman No. 3 chromatography 
paper to sample GCF for headspace analysis, in contrast to another paper namely 
Whatman 3MM that was previously shown to yield good recovery of protein (Griffiths 
et al. 1988). Whilst the Whatman 3MM filter papers have to be cut manually to 
dimensions leading to some variability in size, they were also found to be less amenable 
in practice for collecting GCF from the more healthy participants owing to the thickness 
of the paper and the smaller gap or periodontal probing depths in these individuals. 
Absorbent paper points were more convenient in this regard, as they are precut, rolled 
and shaped like a point, as were Periocol strips which are thinner filter paper strips than 
Whatman 3MM, with a curved end enabling easier insertion in to gingival sulci of 
probing depths 1-4mm. Whilst recognizing that Persson et al. (1992) used gas standards 
generated from permeation tubes to measure VSCs in headspace of GCF samples, 
attempting a simulation of the GCF sampling method for calibration purposes using 
standard solutions of sodium sulfide (Na2S) and sodium thiomethoxide (CH3SNa) to 
generate H2S and CH3SH in the headspace led to finding higher than acceptable 
variability in the detected concentration of the VSCs in the headspace using the 
absorbent paper points or filter strips. Further investigations by adding paper points or 
strips to vials preloaded with standard solutions revealed that a portion of sodium 
sulfide and sodium thiomethoxide absorbed by the paper points and the filter paper 
strips is not acid-labile and the variance observed due to this was determined (Figure 
3-17). These data suggested that the absorbing capacity of the Whatman and Periocol 
Figure 3-16 showing chromatograms of gas standards obtained using an injection from 
the thermal desorber (left) and directly via a sample loop (right). Labelled peaks: 1=H2S; 
2=CH3SH; 3=(CH3)2S. 
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paper strips were comparable and the absorbent paper points showed greater variance at 
higher concentrations (Figure 3-19). The Whatman and Periocol strips however 
exhibited this absorbance only at higher concentrations, with their Lower Limit of 
Detection (LLOD) not affected as much as the absorbent paper points—approximately 
7μM of H2S in the standard solution could be reliably detected with the filter paper 
strips compared to about 20μM for the absorbent paper points. The majority of GCF 
samples were obtained using endodontic paper points, with some using Periocol and 
Whatman strips.  
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Figure 3-17 showing comparison between the Whatman 3MM and Periocol papers in 
absorbing sodium sulfide and sodium thiomethoxide relative to standard solutions 
without the presence of the paper. Data points shown are mean values from triplicate 
measurements; Standard deviation shown as error bars. 
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Figure 3-18 showing scatter dot plots of hydrogen sulfide concentrations detected in 
the headspace of GCF samples collected using absorbent paper points. Comparisons 
that showed statistical significance, median and interquartile ranges are indicated. 
Figure 3-19 showing differences in peak areas (Mean±SD) detected corresponding to 
H2S and CH3SH, with solutions added neat or with paper points. Left: 238μM neat 
solution saturated the detector, 23.8μM solution with added paper points showed peak 
areas close to LLOD. Right: No peaks were observed for the 23μM CH3SNa solution 
with paper points. 
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3.3.2 Volatile sulfur compounds in gingival crevicular fluid 
Hydrogen sulfide was the most prevalent VSC detected in the GCF across the cohorts, 
with a significant increase detected in the gingivitis and chronic periodontitis cohorts 
compared to healthy individuals (including individuals with high plaque; Figure 3-18). 
Prevalence of methanethiol was low in all samples (7% of the total samples) with only 
trace amounts detected in the samples that showed the presence of methanethiol. 
However methanethiol was only detected in the chronic periodontitis and gingivitis 
patients. A few samples from the different cohorts were analysed with long assay run 
times, but no other higher molecular weight VSCs such as dimethyl disulfide or 
dimethyl trisulfide were detected in the samples. Another VSC was found to be more 
prevalent than methanethiol (22% of all samples), at trace amounts compared to H2S, 
and this was tentatively identified to be carbon disulfide (Figure 3-20). This VSC was 
more frequently detected among the periodontitis cohort (61% prevalence among 
periodontitis patients) although one sample from the healthy cohort (2.5% prevalence) 
and three samples from the gingivitis cohort (14% prevalence) also contained this VSC 
at trace amounts. 
 
 
 
 
A few differences could be observed between the results of these analyses compared to 
Persson et al. (1992), who observed that the amounts of H2S detected in the samples 
ranging 10μM to 1mM, is considerably higher than expected, particularly with the 
Figure 3-20 showing a scaled chromatogram of the VSCs detected in the headspace of 
the GCF sample collected from a 7mm periodontal pocket in a patient with severe 
chronic generalized periodontitis. Peak labelled 1=H2S, 2=CH3SH and 3=CS2. 
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potency of H2S in disabling key enzymes such as cytochrome oxidase. In view of the 
capacity of the paper points used in this study to irreversibly bind VSCs, in particular 
H2S, the amounts detected in the present study were comparable to Persson et al. 
(1992). The authors report the prevalence of methanethiol to be much higher than what 
was found in the present study, detecting this VSC in the range of >10μM to 160μM in 
periodontal pockets ranging 4mm to 10mm. The LLOD for methanethiol was higher in 
the present study for the paper points (~35μM), and this could partly explain these 
results as the majority of the values reported by Persson et al (1992) fall below this 
threshold. The finding of carbon disulfide in the GCF samples was not reported by 
Persson et al. (1992) and another study had detected this VSC in the breath of 
individuals but the authors suggested environmental contamination (van den Velde et al. 
2007). However, the detection of this VSC in GCF suggests that endogenous sources 
are also relevant, since a number of studies also report associations of this VSC in the 
breath with pathologies including cystic fibrosis, liver disease and even psychological 
maladies such as dissociative identity disorder (Miekisch et al. 2004; Kamboures et al. 
2005; Phillips et al. 1993). Possible endogenous sources of this VSC could be sulphate 
reducing bacteria which may be present in the oral cavity, and incomplete methionine 
transamination by hepatocytes (Vianna et al. 2008; Scislowski & Pickard 1994). Carbon 
disulfide is also a component of cigarette smoke and alcoholic beverages, and the 
participants recruited to this study have never smoked previously (Gerbersmann et al. 
1995; Dong & DeBusk 2009). These exogenous factors can be ruled out due to the 
prevalence of this VSC being strongly biased towards the chronic periodontitis cohort. 
CS2 concentration is also thought to be highly elevated in the breath of individuals 
taking the anti-alcoholism drug disulfiram, and this too could be ruled out in the chronic 
periodontitis cohort due to access to a more complete medical history before 
recruitment. In addition, only trace amounts were observed which would be more in line 
with the disulfiram negative hypothesis. 
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Clinical parameter Rho 95% CI P (two-tailed) 
% ≥4mm PD 0.6384 0.4819 to 0.7554 < 0.0001 
% ≥5mm PD 0.6451 0.4906 to 0.7602 < 0.0001 
% ≥6mm PD 0.5948 0.4261 to 0.7236 < 0.0001 
Gingival Bleeding Index 0.2883 0.0666 to 0.4828 0.0095 
Bleeding on Probing 0.3432 0.1271 to 0.5283 0.0018 
Plaque Index 0.2452 0.0203 to 0.4464 0.0284 
Table 3-3 listing Spearman’s Rho values for the measured clinical parameters and 
H2S detected from the GCF samples of all participants recruited to this study (n=80 
in all these comparisons). 
All clinical parameters used to measure disease were found to correlate positively with 
the concentration of H2S detected in the GCF of individuals; with the strongest being 
the percentage of periodontal pockets ≥5mm (Table 3-3). The GCF samples were 
collected from one tooth with the deepest periodontal pocket in each individual, unlike 
the more generalized sampling by Persson et al (1992), and these results suggest that the 
amount of H2S found in the individual site is correlated with periodontal disease 
prevalence in the oral cavity. With the use of more sensitive GCF sampling devices, this 
could be a useful indicator for monitoring active periodontal disease in multiple sites 
within the oral cavity. 
3.4 Periodontopathogens and Oral malodour 
 A small number of studies investigating the relationship between specific 
bacterial species and malodour have found those bacterial species associated with 
periodontal disease to be more abundant in the oral cavity of individuals with malodour 
compared to those without malodour (Kurata et al. 2008; Tanaka et al. 2004; Kuroshita 
et al. 2010b). While the classic red complex species namely P. gingivalis, T. forsythia 
and T. denticola have all been demonstrated to degrade free cysteine, methionine and 
serum peptides to VSCs (Persson et al. 1990; Persson et al. 1989), fewer bacterial 
species are known to degrade methionine, and most of these species currently known to 
degrade methionine to methanethiol are suggested to be periodontopathic (see section 
4.5). Therefore in this study, qPCR was employed to detect six species namely P. 
gingivalis, T. forsythia, A. actinomycetemcomitans, F. nucleatum, V. parvula and S. 
moorei in five different oral niches namely, saliva, tongue biofilm, subgingival plaque, 
supragingival plaque (facial surfaces) and interdental plaque of individuals to study 
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their association with VSCs. All six species are capable of producing H2S in serum and 
also from free cysteine substrate, whilst only P. gingivalis and F. nucleatum are known 
to produce CH3SH from methionine, with P. gingivalis producing methanethiol at a 
higher rate compared to F. nucleatum from a serum substrate as opposed to free 
methionine and vice versa (Persson et al. 1990). Some strains of A. 
actinomycetemcomitans have also been reported to produce CH3SH in broth cultures 
(Kuroshita et al. 2010a). 
3.4.1 Periodontopathogens in the different niches in health and disease 
Among the species detected, P. gingivalis, T. forsythia and A. actinomycetemcomitans 
displayed the most dynamic changes in the different niches between the cohorts. These 
are low prevalence, low abundance species, and were found to be significantly more 
abundant in the periodontitis cohort in the different niches studied. P. gingivalis was 
found to be significantly elevated in saliva, subgingival, supragingival and interdental 
plaque of periodontitis patients compared to health (Figure 3-21). Interestingly, healthy 
individuals with higher plaque coverage showed lower prevalence of P. gingivalis in all 
the niches compared to healthy individuals with low plaque coverage. This could be 
related to the ‘evenness’ of the microbial community where numbers of P. gingivalis 
remain similar in healthy individuals with high plaque score vs lower scores, but 
individuals with high plaque have greater abundance of other species involved in 
secondary colonization leading to lower proportions of P. gingivalis in individuals with 
higher plaque coverage, which also implies increase in biofilm thickness. However, 
normalizing these data using total bacterial load as determined using universal primers 
revealed a similar distribution of data with similar results, except for a significant 
increase in the proportions of P. gingivalis being observed with the supragingival 
plaque of the periodontitis cohort compared to healthy individuals with low plaque 
coverage. While P. gingivalis is thought to prefer the subgingival environment, these 
data indicate that this species is equally prevalent in the supragingival (buccal and 
lingual/palatal facial surfaces), and interdental plaque. 
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Niches 
 
Saliva Tongue Subgingival Supragingival Interdental 
BOP 0.276 0.321 0.347 0.304 - 
GBI - 0.253 0.354 0.322 - 
% ≥4mm PD 0.462 0.270 0.359 0.396 0.322 
% ≥5mm PD 0.392 - 0.263 0.266 0.223 
% ≥6mm PD 0.334 - 0.344 0.294 0.216 
Table 3-4 listing significant (p<0.05) Spearman’s Rho values computed for the 
number of P. gingivalis cells detected in the different niches and the clinical 
parameters. 
  
Figure 3-21 showing scatter dot plots of numbers of P. gingivalis CFU ml-1 detected in 
the niches that showed significant differences. Comparisons that showed statistical 
difference, median and interquartile ranges are indicated. HPH=High plaque health; 
LPH=Low plaque health; G=Gingivitis; P=Chronic periodontitis. 
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Positive correlations were also observed with the abundance of P. gingivalis in at least 
one niche and clinical parameters of disease such as BOP, GBI and percentage of 
probing depths greater than or equal to 4mm (Table 3-4). No correlations were observed 
with increasing plaque index scores, and these relationships hold true for the 
proportions of P. gingivalis present in these niches. Despite no significant differences 
being observed with the different cohorts of P. gingivalis abundance on the tongue, the 
positive association observed with increasing BOP, GBI and percentage of periodontal 
pockets ≥4mm suggests that although the tongue is the least dynamic niche studied, 
periodontal disease has an effect on the tongue ecology and this could partly explain the 
elevated methanethiol concentrations observed in the breath of the periodontitis cohort, 
and the increase in CH3SH: H2S ratio in association with the clinical parameters such as 
GBI and PD (Table 3-2). Similarly, only a non-significant increase of T. forsythia was 
observed on the tongue of the chronic periodontitis cohort, compared to health in the 
subgingival and supragingival niches (Figure 3-22). However, T. forsythia on the 
tongue was positively correlated with an increase in percentage of probing depths 
≥4mm and ≥5mm (Table 3-5). A. actinomycetemcomitans in different niches was found 
to be more closely associated with an increase in plaque scores and % of probing depths 
≥6mm (Table 3-5). Additionally, due to its association with plaque coverage, A. 
actinomycetemcomitans prevalence was also elevated in the healthy individuals with 
plaque coverage ≥30%, and this was reflected in the comparisons between healthy 
individuals with low plaque coverage and the gingivitis, chronic periodontitis cohorts in 
all the niches (Figure 3-23). These results further support the hypothesis that the tongue 
ecology changes in association with disease and this could result in a change in VSC 
profile observed in the breath of individuals.  
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Tannerella forsythia 
 
Saliva Tongue Subgingival Supragingival Interdental 
BOP - - 0.279 0.393 0.262 
GBI - - - 0.256 - 
% ≥4mm 0.299 0.298 0.315 0.407 - 
% ≥5mm 0.402 0.335 0.345 0.387 - 
% ≥6mm - - 0.315 0.348 - 
 
Aggregatibacter actinomycetemcomitans 
PI 0.256 - 0.244 0.264 0.272 
% ≥4mm 0.239 - - - - 
% ≥6mm 0.234 - 0.251 0.227 - 
Table 3-5 listing significant (p<0.05) Spearman’s rho values computed for the 
relationship between T. forsythia and A. actinomycetemcomitans CFUs detected in 
the different niches and the clinical parameters in all individuals. 
Figure 3-22 showing scatter dot plots of T. forsythia CFU ml-1 detected in niches that 
showed statistically significant differences between cohorts (indicated). No 
distinctions were observed between healthy individuals with low or high plaque 
coverage, H=Healthy including high plaque individuals; G=Gingivitis, P=Chronic 
periodontitis. Median and interquartile ranges are indicated. 
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F. nucleatum is one of the most prevalent species in the oral cavity and is an important 
VSC producer which is also associated with periodontal disease. Sub species exist 
within this microbial species that may be health or disease associated, but to date no 
qPCR method exists to determine the subspecies composition based on 16S primers and 
the data pertaining to this organism in the current study includes all subspecies (Kistler 
et al. 2013). More importantly, all subspecies of F. nucleatum have the homologs 
necessary to produce both H2S and CH3SH. However, while prevalence was high 
(>98%) in all niches, and differences could be observed between cohorts, these were not 
statistically significant (Figure 3-24). Increasing amounts of F. nucleatum could be 
observed in the saliva of individuals from health to periodontitis, and the abundance of 
F. nucleatum in terms of number of CFUs detected and in proportions, was higher in the 
interdental plaque of healthy individuals with low plaque coverage compared to all 
other cohorts. No significant correlations were observed with proportions of F. 
nucleatum in the oral niches and clinical parameters. Higher resolution in determining 
the different subspecies and indeed, other species such as F. periodonticum should yield 
a greater level of insight in to the ecological dynamics of this group of species in the 
different niches in health and disease (see section 4.5). 
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Figure 3-23 showing the prevalence of A. actinomycetemcomitans in the different 
niches among the cohorts. Data includes individuals in the healthy cohort with 
≤30% PI (n=21) and ≥30% PI (n=18), gingivitis (n=25) and periodontitis (n=23). 
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V. parvula and S. moorei are important species in relation to oral malodour and while 
Veillonella spp are some of the most prevalent species in the oral cavity, and have been 
associated with malodour and periodontal disease, S. moorei was reported to be 
selectively prevalent on the tongue of individuals with halitosis (Belda-Ferre et al. 2012; 
Haraszthy et al. 2008; Washio et al. 2005). QPCR assays were developed to detect both 
V. parvula and S. moorei in clinical samples in the present study, based on the RNA 
Polymerase B and 16S genes respectively. Since the start of this project, another study 
has reported qPCR detection of S. moorei in clinical samples, but the V. parvula assay 
remains the only optimised qPCR assay detecting this species in clinical samples 
(Vancauwenberghe et al. 2013). Among the veillonellae, the species V. parvula was 
chosen due to its membership in the classical ‘purple’ complex, its high abundance on 
the tongue in particular and also its reported high rate of H2S production in serum and 
free cysteine substrate (Persson et al. 1990; Socransky et al. 1998; Socransky & 
Haffajee 2005). Although no statistically significant changes in absolute numbers or 
proportions of V. parvula were detected among the niches, the most marked shifts 
among the different cohorts occurred on the tongue, supragingival plaque and saliva in 
terms of proportions (Figure 3-25). Negative relationships were observed with the 
proportions of this species in the subgingival plaque with the percentage of probing 
depths ≥4mm, ≥5mm and ≥6mm, while a positive correlation was observed with plaque 
score and proportions of V. parvula on the tongue (Table 3-6). These data suggest that 
Figure 3-24 showing scatter dot plots of F. nucleatum proportions in the different niches 
among the cohorts. Median and interquartile ranges indicated. 
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V. parvula could be an important source of hydrogen sulfide in individuals with high 
plaque coverage owing to the association of this clinical parameter to the proportions of 
V. parvula in the tongue. This observation is particularly significant in light of the 
ecological stability of the tongue as observed in metagenomic studies, which implies 
that smaller changes in the ecology of the tongue would likely have a greater effect 
owing to the high surface area of the tongue compared to the other niches studied 
(Caporaso et al. 2011; Yang et al. 2013).    
S. moorei prevalence in all the individuals was similar in the tongue and interdental 
niches (92%), whereas its prevalence in the subgingival and supragingival niches were 
lower (78% and 85%), and a 100% prevalence was observed in saliva. Increase in the 
proportions of S. moorei were observed with the saliva, tongue, subgingival and 
supragingival niches from health to disease, with a statistically significant shift 
observed in the supragingival plaque (Figure 3-26). Significant positive correlations 
were also observed with the increase in proportions of S. moorei in the subgingival, 
supragingival and salivary niches in association with the clinical parameters (Table 3-6). 
It is notable that this species appears to increase in niches where it is normally less 
prevalent, in association with disease. This is possibly a hallmark of an opportunist and 
the available literature on S. moorei supports this view (Detry et al. 2006; Zheng et al. 
2010; Schirrmeister et al. 2009).  
 
 
Figure 3-25 showing scatter dot plots of V. parvula proportions in the different niches 
among the cohorts. Median and interquartile ranges indicated. 
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Veillonella parvula 
 
Saliva Tongue Subgingival Supragingival 
PI - 0.256 - - 
≥4mm PD - - -0.245 - 
≥5mm PD 0.239 - -0.332 - 
≥6mm PD - - -0.243 - 
 
Solobacterium moorei 
BOP - - 0.258 - 
GBI 0.340 - 0.289 0.292 
PI 0.341 - - 0.303 
≥4mm PD - - - 0.257 
≥6mm PD - - 0.314 0.261 
Table 3-6 listing Spearman’s Rho values for comparisons that showed significant 
relationships (two tailed p<0.05) between proportions of V. parvula and S. moorei 
detected in the different niches and the clinical parameters. 
  
Figure 3-26 showing scatter dot plots of S. moorei proportions in the different niches 
among the cohorts. Comparison that showed statistical significance, median and 
interquartile ranges are indicated. 
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3.4.2 VSCs and Periodontopathogens 
The bacterial species detected in the different oral niches in individuals are all known 
VSC producers and given their associations with specific niches in disease, correlational 
analyses were conducted on the breath VSCs, sulcular H2S and associated parameters. 
Greater numbers of correlations were observed between the bacterial species detected in 
the different niches and the concentration of hydrogen sulfide measured subgingivally 
than any other VSC parameter (Table 3-7; Table 3-8). In terms of breath VSCs, 
significant correlations were observed between breath methanethiol concentrations, 
CH3SH: H2S ratio and the periodontal niches. These observations support the 
hypothesis that subgingival VSCs and indeed, breath methanethiol concentration and 
the associated parameter namely, CH3SH: H2S ratio are related to disease activity.  
While it is believed that tongue biofilm is responsible for the presence of breath VSCs, 
if tongue biofilm alone is responsible for the change in VSC profile, one would expect 
these correlational analyses to identify prevalence and/or abundance of bacterial species 
in tongue rather than the periodontal niches as those that are associated breath VSCs 
(Amou et al. 2014; Calil et al. 2009). Instead, due to breath methanethiol and CH3SH: 
H2S ratio being more associated with VSC producers and periodontopathogens 
increasing in numbers and proportions in periodontal niches such as interdental, 
subgingival and supragingival plaque, it is likely that these breath parameters identify a 
general periodontal inflammation or disease activity as in the case of H2S in the sulci. 
However in the present study, sampling of the tongue biofilm was not carried out on the 
dorsal area posterior to circumvallate papillae of the tongue which is thought to harbour 
a more diverse microbiota and it is possible that periodontal ecological changes affect 
the composition of this aspect of the tongue and thus bring about changes in the VSC 
concentration in the breath (Allaker et al. 2008). However, there is evidence that 
periodontal treatment is more effective at reducing malodour and indeed breath VSC 
concentration in individuals with gingivitis or chronic periodontitis than tongue 
cleaning combined with periodontal treatment, and this is consistent with the findings of 
this study (Pham et al. 2012). 
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Tannerella forsythia 
 
Saliva Tongue Subgingival Supragingival Interdental 
GCF H2S 0.377 0.288 0.430 0.309 - 
 
Porphyromonas gingivalis 
CH3SH (ppb) 0.294 - 0.224 0.277 0.223 
CH3SH: H2S 0.285 - - 0.286 0.254 
GCF H2S 0.277 - 0.236 0.311 0.269 
 
Aggregatibacter actinomycetemcomitans 
CH3SH: H2S - - 0.204 - 0.206 
GCF H2S 0.291 0.251 0.213 0.321 0.287 
 
Veillonella parvula 
GCF H2S - - -0.271 - - 
 
Fusobacterium nucleatum 
GCF H2S 0.206 - - - - 
 
Solobacterium moorei 
CH3SH (ppb) - - - - -0.241 
CH3SH: H2S - - - 
 
-0.248 
Table 3-7 listing Spearman’s Rho values that showed significant (two tailed p<0.05) 
relationships between the proportions of bacterial species detected in the different 
niches and the VSCs measured in the breath and periodontal pocket. 
 
Porphyromonas gingivalis 
 
Saliva Tongue Subgingival Supragingival Interdental 
CH3SH 0.289 - 0.289 0.304 0.237 
CH3SH: H2S 0.275 - 0.259 0.305 0.261 
GCF H2S - - 0.229 0.279 - 
 
Aggregatibacter actinomycetemcomitans 
Malodour Score 0.216 - 0.213 - - 
CH3SH: H2S - - 0.237 - 0.248 
GCF H2S 0.293 0.255 0.251 0.330 0.299 
Table 3-8 listing Spearman’s Rho values for significant comparisons (two tailed 
p<0.05) between CFUs of P. gingivalis or A. actinomycetemcomitans detected in the 
different niches and VSCs measured in the breath and periodontal pocket. 
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3.4.3 Latent VSC producing capability in oral sites 
To investigate if the different plaque samples from the individuals with gingivitis or 
chronic periodontitis are inherently more capable of producing VSCs than health, a 
small subset of samples collected from this study were incubated aerobically with 
cysteine or methionine substrate and the headspace analysed for VSCs. Only about 6% 
of the total samples analysed did not have any detectable H2S in the headspace and 
these were mostly samples from healthy individuals. In contrast, methanethiol was 
observed in a very limited number of samples across the different cohorts, with the 
frequency of methanethiol detection being higher in the samples from the gingivitis and 
chronic periodontitis cohorts than health (Figure 3-27). Interestingly, methanethiol was 
not detected in the headspace of any tongue biofilm samples when incubated with 
methionine. While it is possible that an anaerobic environment is favourable for 
methionine degradation in the tongue, methanethiol detected in other samples suggest 
that it is not a necessary condition for all niches. However, a higher percentage of 
samples might have displayed methanethiol production under anaerobic conditions than 
observed in this experiment.  
 
 
 
 
 
Figure 3-27 showing stacked bars of the number of samples from the different niches 
in health, gingivitis and chronic periodontitis cohorts that showed the presence of 
methanethiol in the headspace. 
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Figure 3-28 plotting mean (±SD) protein concentrations determined in the different oral 
samples in individuals with gingivitis, chronic periodontitis and oral health. Statistically 
significant comparisons indicated. 
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Figure 3-29 showing box plots of the H2S generated in the headspace of clinical samples 
incubated with cysteine as a function of the protein concentration of the samples. Midline 
is median, boxes extend from 25th to 75th percentile and the whiskers and outliers plotted 
by the Tukey method. Comparisons that showed statistical significance are indicated. 
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Determining the protein concentrations of the different samples revealed that except for 
saliva, the tongue biofilm and plaque samples from the gingivitis and chronic 
periodontitis cohorts had significantly higher concentration of protein than those from 
healthy individuals (Figure 3-28). Normalizing the observed H2S concentrations using 
the protein measured in each sample revealed significant differences between the health 
and disease cohorts in the periodontal niches which reflected the observed protein 
concentration in the samples (Figure 3-29). These data suggested that despite the higher 
protein concentration observed in the periodontal niches, the healthy samples from the 
same niches produced similar or higher amounts of H2S in the headspace, with the 
subgingival plaque and tongue biofilm showing the highest amounts of H2S produced. 
However, taking in to account the amount of protein measured in saliva of the different 
cohorts being similar, higher amounts of VSC production from saliva of the 
periodontitis patients was observed compared to health or gingivitis (Figure 3-28; 
Figure 3-29). The total bacterial load determined by the universal primers was also used 
to normalize these data, revealing further relationships (Figure 3-30). These data 
indicated that the interdental plaque displayed a significantly elevated rate of H2S 
production in individuals with chronic periodontitis compared to health or gingivitis, 
with the supragingival plaque also showing a similar non-significant increase. These 
results further support the hypothesis that the periodontal niches display the most 
dynamic shifts in VSC production in association with disease.  
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Figure 3-30 scatter dot plots showing H2S generated in the headspace of clinical 
samples incubated with cysteine as a function of the total bacterial load in samples. 
Median, interquartile range and comparisons that showed statistical significance are 
indicated. 
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3.5 Inflammation in the oral cavity and oral malodour 
The destructive sequelae arising from periodontal disease are primarily mediated by the 
host’s immune system and as such, the cytokine profile present in the healthy gingiva 
and the changes associated with gingivitis and chronic periodontitis are of particular 
interest. As found in the present study, the concentration of VSCs present in the breath 
was associated with periodontal disease, and it is possible that malodour as it relates to 
disease might identify particular cytokine markers of periodontal disease to which it 
might be closely related to in terms of disease progression. No previous investigations 
have attempted to relate malodour with inflammation as defined by the concentration of 
cytokines in the fluids of the oral cavity, and available evidence for the possible role of 
VSCs in the pathogenesis of periodontitis as it relates to inflammation and 
inflammatory markers secreted by the gingival tissue has been entirely in vitro to date. 
Therefore, in the present study, the relationship between malodour as defined by the 
VSC concentration in the breath and the cytokine profile present in the gingival 
crevicular fluid and saliva in the oral cavity of individuals with good oral health, 
gingivitis and chronic periodontitis was investigated. 
3.5.1 Crevicular cytokine profile in health and disease 
Analysis of the measured concentrations of the different cytokines with a Partial Least 
Squares regression based model yielded distinct cytokine profiles for the healthy 
individuals and chronic periodontitis patients, with an overlap of the gingivitis patients 
between these two groups (Figure 3-31). Cytokines that showed increased 
concentrations in the GCF of healthy individuals were IL1 alpha, TNF alpha, IL12p70, 
IL4, IL10, the chemokines CXCL10 and CCL2; and the adhesion molecules E-selectin 
and Intercellular Adhesion Molecule-1 (ICAM-1). Cytokines that showed more of an 
association with the periodontitis cohort were Granulocyte-Colony Stimulating Factor 
(G-CSF), IL6, IL13, IL1 beta, IL-17a, Interferon alpha (IFNa), Latency Associated 
Peptide (LAP), and the chemokines CXCL8 (IL8), CCL3 and CCL4 (Figure 3-32). 
Samples from individuals with gingivitis showed profiles that were either health or 
disease associated, clustering closely with either of the aforementioned cytokine 
profiles—no trends based on clinically measured plaque score, bleeding on probing or 
gingival bleeding index could be observed with regards to the more health associated or 
disease associated samples from this cohort. 
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Figure 3-31 showing a score plot of the cytokine profiles in the GCF samples 
from healthy, gingivitis and chronic periodontitis cohorts. The associated 
loading plot is shown in Figure 3-32. 
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Data for the healthy and gingivitis cohort in the present study appears to suggest that the 
traditionally identified osteoclastogenic cytokines such as IL1 alpha and TNF alpha are 
more abundant in the GCF of individuals with clinically healthy gums or gingivitis than 
periodontitis (Figure 3-31; Figure 3-32). IL1 alpha is thought to be constitutively 
secreted by normal oral keratinocytes and upregulated in response to TNF-alpha 
stimulation and while it is possible that these cytokines drive pro-inflammatory 
processes evident in healthy gingiva or gingivitis, the association observed with the 
anti-inflammatory T-reg cytokine, IL10 points to a homeostasis that exists in the 
gingival crevice of these individuals (Ng et al. 2013; Perrier et al. 2002; Lappin et al. 
2001). A key cytokine associated with the healthy and gingivitis cohort is IL4 which is 
thought to help differentiate naïve T-cells into a Th2 lineage and inhibit development of 
a Th1 response, as the latter is thought to play a role in the development of persistent 
inflammation whereas Th2 cell differentiation and the associated immune cell 
recruitment is thought to help in microbial clearance and maintaining homeostasis. 
Indeed, IL4 is thought to selectively increase expression of IL1 alpha in oral 
Figure 3-32 showing the loading plot for the measured cytokines in the GCF, 
associated with the score plot shown in Figure 3-31. 
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keratinocytes and reported data in the literature from GCF measurements suggest a role 
for IL4 in gingival health and in remission of periodontal disease (Pradeep et al. 2008). 
The association of IL4 with the healthy and gingivitis cohorts also supports the role for 
IL1 alpha and TNF alpha in the healthy gingiva (Perrier et al. 2002). However, 
IL12p70, the active heterodimeric form of IL12p40 and IL12p35 is thought to 
encourage T-cell differentiation towards a Th1 lineage and it may well be that health is 
characterized by the dynamic equilibrium between IL12 and IL4 mediated responses as 
suggested by these data (Hölscher 2004). 
The association of IL1 beta, IL6, IL17a, G-CSF and IFN alpha and the chemokines 
CXCL8, CCL3 and CCL4 with the chronic periodontitis cohort in the present study is in 
broad agreement with another study that used multiplexed bead-based immunoassay to 
detect cytokines and chemokines in the GCF collected from periodontitis patients before 
and after therapy (Thunell et al. 2010). The authors report elevated concentrations of 
IL1 alpha, IL1 beta, IL6 and the chemokines CCL2, CCL3 and CXCL8 in diseased sites 
vs healthy sites of generalized severe chronic periodontitis patients. Given that both 
localized and generalized, and also moderate and severe chronic periodontitis patients 
were included in the present study, the previously reported data correlate well with what 
is observed in the present study with regards to the health associated and disease 
associated cytokine profiles. Thunell et al. (2010) also reported an increase in CXCL10 
in the GCF after periodontal therapy in healthy sites and this is consistent with data 
from the present study finding this chemokine to be more health associated, with a role 
in wound healing being postulated. 
The glycoprotein G-CSF had the largest loading associated with the chronic 
periodontitis cohort in the present study and this cytokine is known to be involved in 
stimulating neutrophil proliferation and persistence in the gingiva by inhibiting its 
apoptotic mechanisms, while also suppressing osteoblast activity (Greenbaum & Link 
2011). This highlights the role of neutrophils in chronic inflammation as much as it is 
thought to be an important component of the initial immune response to microbial 
antigens. A study that measured CCL3 (MIP-1a) and CCL4 (MIP-1b) in health, 
gingivitis, chronic and aggressive periodontitis and found similar concentrations among 
the different groups, and consistent with this study more GCF samples in chronic 
periodontitis patients had elevated concentrations of these macrophage chemoattractants 
than health (Emingil et al. 2005). The role of the IL17 family of cytokines in 
periodontitis is a subject of ongoing investigations, and current knowledge suggests 
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IL17A to be the most pro-inflammatory of the IL17 family and is thought to be a 
signature cytokine of the Th17 response, which in itself is thought to have both 
protective and destructive roles in periodontitis depending on other co-stimulatory 
cytokine signals and the findings of the present study on the association of IL17A to 
chronic periodontitis is consistent with these observations (Awang et al. 2014; Gaffen & 
Hajishengallis 2008). 
Comparison between the different cohorts for the individual cytokines revealed that IL6 
and LAP were significantly elevated while IL4 was significantly reduced (at p<0.05) in 
the chronic periodontitis cohort when compared to health but not gingivitis (Figure 
3-33). Elevated concentrations of IL17A and IL13 were also observed in chronic 
periodontitis compared to gingivitis but not health (Figure 3-34). These observations are 
consistent with the PLS analysis and highlight the inflammatory mechanisms active in 
the different cohorts, in particular in chronic periodontitis. For example, elevated levels 
of IL6 in the periodontitis cohort suggests that a T-reg inhibitory and Th17 stimulatory 
environment prevails subgingivally in this cohort and blocking IL6 signaling is reported 
to lead to positive outcomes in treating various chronic inflammatory diseases in 
experimental models (Neurath & Finotto 2011). In regards to IL4, two sub groups with 
similar numbers of individuals were observed in the CP cohort: one with IL4 below 
detection limits and the other with values similar to the gingivitis cohort (Figure 3-33). 
Interestingly, individuals with detectable IL4 had higher mean levels of IL13 and IL10 
than those with no IL4 in the CP cohort suggesting two separate mechanisms are in play 
in these individuals. IL4 and IL13 signaling is characteristic of M2 type macrophage 
activation, and the higher presence of IL10 also in the same individuals is possibly 
indicative of a better prognostic outcome owing to the M2 macrophage phenotype 
involved in ligament repair and fibrosis leading to a regenerative response (Martinez & 
Gordon 2014; Chamberlain et al. 2011). LAP is a surrogate marker for active 
Transforming Growth Factor-beta, and increased levels of LAP in the CP cohort 
reinforces the observation that regenerative mechanisms are more active in chronic 
periodontitis compared to health or gingivitis (Steinsvoll et al. 1999). 
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Figure 3-33 showing scatter dot plots of concentrations of cytokines that 
showed statistically significant differences only between health and chronic 
periodontitis cohorts (p<0.05). Median and interquartile ranges indicated. 
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3.5.1.1 Correlations with clinical parameters 
Given the different inflammatory cytokine profiles found in the different cohorts, 
correlations between the measured clinical parameters (Gingival Bleeding Index, Plaque 
Index and Bleeding on Probing) and the cytokine concentrations within the healthy, 
gingivitis and chronic periodontitis cohorts were explored and a number of relationships 
were found (Table 3-9; Table 3-10; Table 3-11). Probing depths were not included in 
these analyses as GCF samples from multiple sites were pooled in all individuals to get 
the volume required for the cytokine analysis. More numbers of cytokines were found 
Figure 3-34 showing dot plots of the concentrations of the cytokines IL13 and IL17A 
that showed statistically significant differences only between the gingivitis and 
chronic periodontitis cohorts (p<0.05). Median and interquartile ranges indicated.  
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to be correlated with the percentage of sites bleeding on probing (BOP) in individuals in 
health, gingivitis and chronic periodontitis cohorts compared to the other clinical 
measures (Table 3-9). This is likely due to the fact that this is the first clinical 
measurement carried out along with probing depths in the oral health assessments. GBI 
and PDI are carried out later than BOP in the clinical protocol sequence and this may 
obscure some relationships with regards to the inflammatory status of the gingiva in 
general.  
Cytokine Rho 95% CI p-value 
E-selectin 0.5588 0.07133 to 0.8308 0.0244 
G-CSF -0.196 -0.6401 to 0.3461 <0.0001 
IL17A 0.6112 0.1020 to 0.8666 0.0202 
G-CSF 0.6094 0.09929 to 0.8659 0.0207 
ICAM1 0.5604 0.02505 to 0.8460 0.0371 
IL4 0.6529 0.1952 to 0.8770 0.0103 
Interferon-Ɣ -0.4171 -0.7726 to 0.1375 0.0067 
Table 3-9 listing cytokines measured in GCF of individuals in health (green), 
gingivitis (yellow) and chronic periodontitis (red) cohorts that showed significant 
Spearman’s correlations against their BOP values.  
Cytokine Rho 95% CI p-value 
CCL2 0.5214 0.01853 to 0.8137 0.0403 
E-selectin 0.5199 0.01651 to 0.8130 0.041 
Interferon-Ɣ 0.7598 0.3691 to 0.9223 0.0016 
Interferon-α 0.7112 0.2739 to 0.9048 0.0043 
G-CSF 0.5626 0.02815 to 0.8469 0.0362 
IL4 -0.5629 -0.8470 to -0.02867 0.0361 
E-selectin 0.5157 -0.01210 to 0.8187 0.0491 
Table 3-10 listing cytokines measured in GCF of individuals in the health (green), 
gingivitis (yellow) and chronic periodontitis (red) cohorts that showed significant 
Spearman’s correlations against their Gingival Bleeding Index values. 
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Cytokine Rho 95% CI p-value 
IL17a 0.5775 0.09872 to 0.8392 0.0191 
CCL3 0.5319 0.03306 to 0.8185 0.034 
E-selectin 0.5129 0.0069 to 0.8098 0.0422 
IL1α -0.641 -0.8783 to -0.1502 0.0135 
Table 3-11 listing cytokines measured in GCF of individuals in the health (green) 
and gingivitis (yellow) cohorts that showed significant Spearman’s correlations 
against their Plaque Index values. No significant correlations were observed in the 
chronic periodontitis cohort. 
 BOP scores in the healthy group were positively correlated with E-selectin and 
IFN-g (p=0.058), and negatively correlated with IL10 (p=0.057) indicating that gingival 
bleeding is related to lower levels of the anti-inflammatory cytokine IL10 in the GCF 
even in the healthy cohort where the cut-off is at <20% of the total sites with bleeding 
upon probing, while increased concentrations of E-selectin and IFN-g are certainly 
considered to be pro-inflammatory (Table 3-9). Interestingly, increased BOP in 
individuals who were classified as having gingivitis is more associated with increased 
concentrations of IL17A, G-CSF and ICAM1 pointing to possibility that the dominant 
mechanism prevalent in the cohort being the activation of Th17 response and neutrophil 
proliferation and anti-apoptosis. While a significant reduction in the levels of IL4 was 
detected in the GCF of the chronic periodontitis patients, bleeding on probing was 
found to be more positively correlated with IL4 levels in contrast to the healthy cohort. 
Given the involvement of IL4 and IL10 regenerative mechanisms, this suggests that 
higher levels of bleeding on probing in chronic periodontitis patients may indicate a 
more favourable outcome as bleeding in this context relates to the same mechanism as 
observed in the healthy cohort but in an inverse manner. Also, a decrease in IFN-g in 
the CP cohort in association with BOP scores suggests that higher bleeding as it relates 
to increased IL10 is likely to result in inhibition of IFN-g production and the converse 
of this as observed in the healthy cohort further corroborates the relationship between 
BOP and GCF cytokines in the healthy and chronic periodontitis cohorts (Cope et al. 
2011). 
As discussed above, GBI and PI were carried out much later in the clinical protocol 
sequence, and though the number of cytokines related to GBI is much lower than BOP 
scores, the findings are consistent with this, and forming a smaller subset of the 
relationships observed with the cytokines and BOP scores (Table 3-10). With regards to 
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the plaque scores, when individuals with plaque coverage >30% but with <20% BOP 
and % sites with <4mm PD were included in the Spearman’s correlation analysis, the 
Th17 cytokine IL17a and macrophage chemokine CCL3 were positively associated with 
an increase in plaque coverage (Table 3-11).  
3.5.2 Salivary cytokine profile in health and disease 
The salivary cytokine profile is thought to reflect the inflammatory condition of the oral 
cavity and it is suggested that GCF contributes substantially toward the cytokine 
concentrations in the saliva, in addition to a systemic influence (Ruhl et al. 2004; 
Wozniak et al. 2002). Whilst there are a few studies associating a number of pro-
inflammatory cytokines in saliva with periodontitis, a clear consensus with regards to 
the salivary cytokine profile as observed with GCF in health and periodontitis is not 
found in the literature (Teles et al. 2010). In the present study, a small subset of the total 
number of saliva samples collected from healthy, gingivitis and chronic periodontitis 
patients were analysed to ascertain if differences between health and disease could be 
observed, in addition to associations with malodour.  
  
  
Figure 3-35 showing the different cytokine profile in GCF and Saliva in this study 
(median value of each cytokine concentration across all cohorts plotted as bars). 
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Paired samples when analysed by the Wilcoxon’s signed rank test for differences in the 
concentrations of the cytokines between saliva and GCF across all cohorts showed IL1a 
and LAP to be significantly elevated in GCF, whereas higher concentrations of TNFa, 
IFNa, IFNg, G-CSF, CCL2, CCL3, CCL4, CXCL10, IL17A, IL10, IL12p70 and IL4 
were observed in saliva compared to GCF in the same individuals (Figure 3-35). Teles 
et al. (2010) investigated salivary cytokines in healthy individuals and chronic 
periodontitis patients and did not find any differences between the cohorts and 
attributed the results to dilution of GCF contributing to the overall cytokine profile in 
saliva. Interestingly, Wozniak et al. (2002) investigating potential biomarkers and their 
inhibition in saliva reported that concentration of the eight cytokines they measured 
were much lower in whole saliva than parotid saliva, and attributed these results to the 
sequestering effect of salivary mucins on the cytokines. Of the cytokines tested, the 
authors found only IL1a levels not affected when added exogenously to parotid or 
whole saliva and this was also the only cytokine found to be significantly elevated in 
saliva of chronic periodontitis patients compared to health (p<0.05) in the present study. 
The observation that this cytokine was also more elevated in GCF than saliva in all 
individuals in the present study possibly suggests that GCF contributes to salivary IL1a 
levels. However, while GCF concentrations of IL1a were elevated in the chronic 
periodontitis patients compared to health, this was not statistically significant. This 
could be due to only a limited number of sites sampled for GCF in this study (2 per 
quadrant), and though these generally are the deepest gingival pockets in each quadrant, 
the more generalized chronic periodontitis patients had more sites with equally deep 
pockets in each quadrant that were not sampled—and GCF flow from these sites could 
further enhance salivary IL1a levels. 
 Unlike GCF, PLS analysis revealed that saliva samples in the gingivitis and 
chronic periodontitis patients clustered more closely and had greater separation from 
health, with five variables namely IL1a, IL1b, CXCL8, CXCL10 and CCL2 showing 
the largest loadings associated with the gingivitis and chronic periodontitis samples 
(Figure 3-36; Figure 3-37). However, receiver operating characteristic (ROC) analysis 
of the sum of all cytokines positively associated with the second principal component 
revealed an Area under Curve (AUC) value of 0.68 (p=0.08) for distinguishing health 
from gingivitis and chronic periodontitis, indicating that these salivary cytokines are 
only a marginally useful model for diagnostics or monitoring cytokines relating to 
periodontal disease. 
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Figure 3-36 score plot from Partial Least Squares analysis of the measured 
cytokines in saliva samples of individuals showing distinct clustering between 
health and disease cohorts. Loading plot shown in Figure 3-37. 
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3.5.2.1 Correlations with clinical parameters 
Given that the clinical parameters such as PI, BOP, GBI and PD were used as diagnostic 
criteria, associations between salivary cytokines and these parameters in all individuals 
not split into cohorts were explored. More cytokines correlated significantly with plaque 
scores than any other clinical parameter, unlike those cytokines from GCF. These 
included positive associations with E-selectin, Interferon-α, CCL3, IL12p70 and IL17A 
(Table 3-12). Also, due to saliva being collected before any of the clinical assessments 
(BOP/GBI/PI) in the clinical protocol sequence, in principle should lead to less 
ambiguous relationships with these measurements provided that salivary cytokines are 
sufficiently influenced by periodontal disease to overcome the inhibitory nature of 
whole saliva to the cytokines measured. Whilst no statistically significant relationships 
were observed with salivary cytokines and BOP, the closest was the classic pro-
inflammatory cytokine IL1b with a fair correlation (r=0.35, p=0.056), whereas GBI was 
Figure 3-37 loading plot showing cytokines responsible for the clustering 
pattern shown in Figure 3-36. 
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positively associated with IL6, IL13 and IFN-a (Table 3-12). The strongest correlations 
observed were IL6 with GBI and E-selectin with PI. As discussed for GCF, the 
association with GBI and IL6 indicates that GBI as a clinical measurement to grade 
periodontal disease is valid, and while plaque coverage is thought to be more variable, 
its correlation with the more periodontitis-associated cytokines as observed with the 
GCF samples suggests that the overall plaque present in the mouth has an effect on 
salivary cytokines and a combination of these clinical measurements will allow one to 
make a good assessment of the periodontal condition. 
Gingival Bleeding Index 
Cytokine Rho 95% CI P (two-tailed) 
IL6 0.4872 0.1431 to 0.7262 0.0063 
IL13 0.4627 0.1119 to 0.7110 0.01 
Interferon-α 0.4189 0.0579 to 0.6830 0.0212 
Interferon-Ɣ 0.3598 -0.0116 to 0.644 0.0508 
Plaque Index 
E-selectin 0.506 0.1673 to 0.7378 0.0043 
Interferon-α 0.4546 0.1018 to 0.7059 0.0116 
CCL3 0.4183 0.05723 to 0.6826 0.0214 
IL12p70 0.374 0.0048 to 0.6535 0.0417 
IL17A 0.3675 -0.0028 to 0.6492 0.0457 
Interferon-Ɣ 0.3607 -0.0106 to 0.6446 0.0502 
Table 3-12 listing Spearman’s correlation coefficients for salivary cytokines that 
showed an association with GBI and PI with the samples not divided into cohorts 
(n=30; only cytokines yielding relationships with p<0.06 are listed). 
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3.5.3 Relationship between VSCs and cytokines in saliva and GCF  
The association between breath VSCs and cytokines in saliva and GCF were explored, 
following from the observation that there was an overall increase in the breath 
methanethiol concentrations, the CH3SH:H2S ratio and Malodour Score in the chronic 
periodontitis cohort compared to health in the present study. Whilst the clinical 
parameters such as GBI, PI and BOP measure different characteristics of periodontal 
disease, they were found to be associated with different cytokines in GCF and saliva, 
perhaps identifying the mechanisms of the disease that they are more closely related 
with. For example, increase in plaque coverage was positively associated with an 
increase in the measured E-selectin levels in the saliva of individuals. It is well known 
that E-selectin plays an important role in neutrophil recruitment and leukocyte 
extravasation as an adhesion molecule and these data are consistent with the explanation 
that the greater coverage of plaque around the teeth would lead to higher stimulation of 
E-selectin production and this would be reflected in salivary levels of E-selectin. 
Similarly, IL6 is known to be a Th17 differentiating, Treg inhibiting cytokine and the 
method by which a clinician assesses GBI would more easily associate with underlying 
inflammatory processes that cause swelling or edema, and IL6 is thought to be a key 
cytokine that drives the inflammatory processes towards a more chronic inflammatory 
condition if unregulated. Finally, BOP is more related to depth of the periodontal pocket 
in addition to inflammation, and the association with the classic osteoclastogenic 
cytokine IL1b further illustrates this point, as a deeper pocket indicates greater alveolar 
bone resorption. It was hypothesized that because malodour as defined by the VSC 
concentrations measured showed a significant difference with health and chronic 
periodontitis, it might also be positively associated with inflammatory processes that 
lead to and are active in periodontitis, in a similar manner to GBI, PI and BOP. 
3.5.3.1 VSCs and GCF cytokines 
The cytokines TNFa and IL12p70 were negatively correlated with Malodour Scores 
while weak positive associations were observed with IFNa and IL6 in GCF (Table 
3-13). Given that different immune mechanisms are more dominant in health, gingivitis 
and chronic periodontitis, the malodour scores in the different cohorts were analysed 
separately, yielding only one significant correlation, namely an inverse relationship with 
IL12p70 in the chronic periodontitis cohort. The association with IL12p70, IFNa and 
IL6 is consistent with the hypothesis that malodorous VSC concentration in the breath is 
associated with inflammation in the periodontium. While TNFa negatively correlating 
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with malodour scores is not compatible with this view, higher TNFa levels was 
associated with the healthy cohort in the present study and in this sense, these data are 
just internally-consistent with the findings of the health and disease associated cytokine 
profiles in GCF (Figure 3-31; Figure 3-32). There is evidence that suggests that a 
sustained release of H2S can inhibit formation of TNFa from LPS stimulated 
macrophages in a concentration dependent manner, and another study reports that H2S 
delivered in gaseous form to stimulate macrophages at concentrations much lower than 
usually found in the mouth air is sufficient to induce osteoclast differentiation and TNFa 
production (Whiteman et al. 2010; Ii et al. 2010). In reality, endogenous H2S production 
could also play a part and it is possible that these opposing mechanisms could exist in a 
dynamic equilibrium in the oral cavity. The lack of association between sulcular H2S 
measured in this study and GCF TNFa points to this possibility, with a weak positive 
relationship between sulcular H2S and TNFa in the healthy cohort (r=0.33) and a weak 
negative relationship observed with chronic periodontitis cohort (r=-0.3) indicating that 
opposing mechanisms are at play in the different cohorts. 
When the individual disease cohorts were not separated, the correlational analysis 
revealed that methanethiol and the methanethiol: hydrogen sulfide ratio yielded the 
strongest relationships even though H2S and malodour scores were also found to be 
associated with the same cytokines (Table 3-13). Therefore methanethiol concentrations 
and the VSC ratios were further analysed in the gingivitis and chronic periodontitis 
groups; the healthy cohort was not analysed in this instance due to low detection 
frequency of methanethiol in this cohort leading to less meaningful statistical analyses. 
These analyses yielded negative associations with IL17A in the gingivitis cohort and the 
cytokines IL12p70, TNFa and IL1b in the chronic periodontitis cohort (Table 3-14). 
While some of these relationships are consistent with breath VSCs being associated 
with periodontal inflammation, the negative correlations with cytokines such as IL17A 
and IL1b were less compatible with this hypothesis. This could be partly due to GCF 
being sampled from limited sites in the mouth and one would expect breath VSCs to be 
more consistent with the overall inflammatory status of the oral cavity and by extension, 
salivary cytokines. Indeed, associations with sulcular VSCs gave a more consistent 
picture of the positive relationship between VSCs and the localized inflammation 
detected by the GCF cytokine profile (Table 3-15). 
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Malodour Score 
Cytokine Rho 95% CI p-value 
IL12p70 -0.382 -0.6154 to -0.08699 0.0105 
TNFa -0.3874 -0.6193 to -0.09337 0.0094 
Hydrogen sulfide (ppb) 
IL12p70 -0.3356 -0.5812 to -0.03392 0.026 
TNFa -0.3698 -0.6065 to -0.07297 0.0135 
Methanethiol (ppb) 
IFNa 0.3767 0.08084 to 0.6115 0.0117 
IL6 0.3053 0.0001691 to 0.5584 0.0439 
IL4 -0.3638 -0.6021 to -0.06607 0.0152 
IL12p70 -0.4016 -0.6296 to -0.1099 0.0069 
TNFa -0.4101 -0.6357 to -0.1200 0.0057 
Methanethiol: hydrogen sulfide 
IFNa 0.3516 0.05212 to 0.5931 0.0193 
IL4 -0.3183 -0.5682 to -0.01461 0.0352 
TNFa -0.4038 -0.6311 to -0.1125 0.0066 
IL12p70 -0.4404 -0.6572 to -0.1563 0.0028 
Table 3-13 listing Spearman’s correlation coefficients for GCF cytokines that showed 
an association with sulcular H2S, breath H2S and CH3SH, ratio of CH3SH to H2S and 
malodour score with the samples not divided into disease cohorts (n=44). 
 
Methanethiol (ppb) 
Cytokine Rho 95% CI P (two-tailed) 
IL12p70 -0.418 -0.7832 to 0.1617 0.0131 
Methanethiol: hydrogen sulfide ratio  
IL17a -0.3013 -0.7256 to 0.2890 0.0251 
IL12p70 -0.542 -0.8383 to 0.001493 0.0009 
TNFa -0.5654 -0.8481 to -0.03232 0.035 
IFNg -0.318 -0.7342 to 0.2720 0.043 
Table 3-14 listing Spearman’s rho values for GCF cytokines that showed an 
association with CH3SH: H2S ratio and methanethiol concentrations in the breath of 
gingivitis (yellow) and chronic periodontitis cohorts (red). 
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Cytokine Rho 95% CI P (two-tailed) 
IL17a -0.3625 -0.7566 to 0.2248 0.005 
G-CSF -0.4204 -0.7844 to 0.1589 < 0.0001 
LAP -0.5048 -0.8224 to 0.05270 0.0315 
CCL3 -0.5305 -0.8334 to 0.01754 0.0024 
IFNg -0.6418 -0.8786 to -0.1517 < 0.0001 
IFNa -0.7587 -0.9219 to -0.3668 0.001 
G-CSF 0.6044 0.1169 to 0.8572 0.017 
Table 3-15 listing Spearman’s rho values for GCF cytokines that showed an 
association with sulcular H2S concentrations in the healthy (green), gingivitis 
(yellow) and chronic periodontitis cohorts (red). 
Associations that were found with sulcular H2S and GCF cytokines may not always be 
due to a simple stimulation of a proinflammatory response due to bacterial VSC 
production. It is well known that VSCs and in this case hydrogen sulfide can influence 
cytokine levels by sulfhydrylation of key cysteine residues in the peptide chains of the 
cytokines, in addition to other mechanisms such as transcriptional modulation and also 
helping in the invasion of periodontopathic bacteria and proteolytic breakdown of 
cytokines (Li et al. 2011). All of these mechanisms could influence cytokine levels in 
GCF and these are not always synergistic, while endogenous hydrogen sulfide 
production further complicates interpretation, as it is not possible to distinguish the 
relative contribution towards the sulcular VSCs detected in this study having a bacterial 
or potentially dysregulated host sulfur metabolism in the gingiva as a source. For 
example, endogenous H2S is thought to activate the transcription factor NF-κB by way 
of sulfhydration leading to an anti-inflammatory state, in addition to encouraging 
GAPDH mediated apoptotic mechanisms by direct sulfhydration of GAPDH (Mir et al. 
2014; Sen et al. 2012). It is quite possible that bacterial H2S production also contributes 
to these mechanisms, and it may well be that bacterial VSC production in the gingival 
milieu could be one of the main mechanisms of the commensal interaction between the 
oral microbiota and host immune pathways.  
A biphasic effect of H2S signalling is observed in studies that use NaHS as a H2S donor, 
where an inhibitory effect is observed at lower concentrations (100-200μM) and a 
stimulatory effect at higher concentrations (>500μM) is reported. This cannot explain 
the observed pattern as clearly, the amounts of H2S detected in the gingivitis cohort is 
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similar to the chronic periodontitis cohort (Whiteman et al. 2010; Figure 3-18). It could 
be that other VSCs such as methanethiol and in particular carbon disulfide detected in 
higher frequency in the chronic periodontitis cohort could have a role to play in these 
signalling events, resulting in a markedly different relationship. While the VSC profile 
in the subgingival microenvironment is difficult to interpret in conjunction with its 
relationship with the cytokine profile, VSCs in the breath have a more direct 
relationship with the oral microbiota. Therefore, the presence or absence of 
methanethiol in the breath could reveal important relationships with regards to the 
immune processes in the subgingival environment. Given the markedly different 
immune mechanisms prevalent subgingivally in chronic periodontitis, only the healthy 
and gingivitis cohorts were included in this analysis. This is also a more valid 
comparison as the VSC concentrations present in the breath of the gingivitis cohort did 
not differ significantly with health (Section 3.2). It was found that individuals with the 
presence of methanethiol in their breath had reduced levels of TNFa and IL12p70, and 
significantly higher levels of interferon-alpha in GCF (Figure 3-38). Furthermore, the 
CH3SH: H2S ratio in this data set yielded fair correlations with IFNa and IL12p70 
confirming the previous findings (Table 3-16). However, individuals with clinically 
classified gingivitis were overrepresented in the methanethiol positive group (64%) 
compared to the negative group (31%). For the cytokines interferon-alpha and IL12p70 
distinct groupings were observed but no clinical difference with regards to individuals 
belonging to health or gingivitis cohorts could be ascertained (Figure 3-38). 
  
Figure 3-38 showing scatter dot plots of cytokines that showed differences between 
methanethiol positive (P) or negative (A) individuals. Only IFN-a showed statistical 
significance at p=0.043. 
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Methanethiol: hydrogen sulfide ratio 
Cytokine rho 95% CI P (two-tailed) 
Interferon α 0.3884 0.02160 to 0.6631 0.0339 
IL12p70 -0.3595 -0.6438 to 0.01200 0.051 
Table 3-16 listing Spearman’s rho values for the cytokines that showed the strongest 
associations with the CH3SH: H2S ratio in healthy and gingivitis cohort GCF.  
3.5.3.2 VSCs and Salivary cytokines 
The cytokines present in saliva were hypothesized to be more closely associated with 
breath VSCs and potential correlations were explored. As discussed in section 3.5.2, 
any relationships observed will be despite the inhibitory effect of whole saliva on the 
detection of these cytokines, although IL1a is one cytokine for which no inhibitory 
effect is known. Accordingly, moderately positive correlations were observed for the 
chemokine CCL2 and IL1a in association with malodour score, hydrogen sulfide and 
methanethiol concentrations in the breath (Table 3-17). A stronger relationship was also 
observed between these cytokines, in addition to the chemokine IL8 (CXCL8) with 
increasing CH3SH: H2S ratio in the breath of individuals. These cytokines were more 
associated with gingivitis and periodontitis cohorts as found in the multivariate analysis 
of these salivary cytokines  and these observations support the hypothesis that VSCs in 
the breath as it relates to health and chronic periodontitis, are associated with a pro-
inflammatory state in the oral cavity (Figure 3-36; Figure 3-37). Further, the VSC 
methanethiol was found to be largely responsible for these observations. For example, 
when all samples were split into methanethiol positive or negative groups, the 
methanethiol positive samples showed significantly elevated IL8, IL1a and CCL2 
concentrations than the methanethiol negative samples (Figure 3-39). To minimize the 
contribution of the saliva samples from the chronic periodontitis cohort towards these 
results, samples from just the healthy and gingivitis cohorts were analysed and saliva 
from methanethiol positive individuals still showed significantly elevated IL1a, and 
though IL8 and CCL2 levels were not statistically different at p<0.05, elevated 
concentrations were still observed (Figure 3-39). Although, individuals with clinically 
classified gingivitis were over represented in the methanethiol positive group (55%) 
compared to the methanethiol negative group (25%), elevated levels of IL1a, CCL2 and 
IL17A could still be observed in the saliva samples of individuals in the healthy cohort 
whose breath samples were positive for methanethiol (Figure 3-39).  
The observation that methanethiol concentrations and CH3SH: H2S in the breath were 
largely associated with pro-inflammatory cytokines in saliva and to some extent in GCF 
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supports the hypothesis that methanethiol is the VSC that identifies increased disease 
activity. This is because unlike hydrogen sulfide, methanethiol production in the oral 
cavity is entirely bacterial and increased concentration of methanethiol suggests that 
bacteria that can produce this VSC are more active in the oral biofilm relative to other 
species. Indeed, as discussed in the next chapter, bacteria that have the capability to 
produce methanethiol are almost exclusively putative periodontopathogens and the 
observed increase of the classic neutrophil chemokine IL8 and macrophage chemo 
attractant CCL2 (MCP-1) in saliva in the methanethiol positive individuals suggests 
wholesale activation of immune mechanisms taking place in the oral cavity in response 
to the activity of the few methanethiol producing bacteria. Furthermore, a striking 
difference between GCF and salivary cytokine profiles was the low prevalence of the 
Latency associated Peptide (LAP) in saliva of healthy individuals, and the positive 
association of LAP in saliva with breath methanethiol and the CH3SH: H2S ratio 
indicates that immune regulatory mechanisms are much more active when higher 
methanethiol concentrations or CH3SH: H2S was observed in the breath of individuals. 
Malodour Score 
Cytokine rho 95% CI P (two-tailed) 
CCL2 0.3971 0.02450 to 0.6729 0.0329 
IL1a 0.3657 -0.01226 to 0.6523 0.0511 
Methanethiol 
CCL2 0.4062 0.03528 to 0.6787 0.0288 
Methanethiol: hydrogen sulfide ratio 
CCL2 0.4903 0.1398 to 0.7316 0.0069 
IL1a 0.4046 0.03341 to 0.6777 0.0295 
LAP 0.3906 0.01671 to 0.6686 0.0362 
IL8 0.3821 0.006828 to 0.6631 0.0408 
Table 3-17 listing Spearman’s correlation coefficients for salivary cytokines that 
showed significant associations (p>0.05) with breath H2S and CH3SH, ratio of CH3SH 
to H2S and malodour score with the samples not divided into disease cohorts (n=29). 
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Figure 3-39 showing salivary cytokines that differed between individuals whose breath 
samples were positive or negative for methanethiol. Cytokines that showed statistically 
significant differences are indicated. Top row: individuals from all cohorts split into 
methanethiol positive and negative groups. Median and interquartile ranges indicated. 
Middle row: individuals from only healthy and gingivitis cohorts were included. 
Median and interquartile ranges indicated. Bottom row: Mean (±SD) levels of cytokines 
that showed differences in methanethiol positive (n=5) and negative (n=9) individuals 
within the healthy cohort.  
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3.6 Summary 
The microbial and inflammatory aspects of the association between VSCs in the breath 
and periodontal disease were investigated by employing a number of different 
techniques. Breath analysis confirmed the different VSC profile in the breath of 
periodontitis patients with an increased presence of methanethiol in the breath. 
Methanethiol concentration and methanethiol to hydrogen sulfide ratio in the breath 
were found to correlate positively with clinical parameters of periodontal disease. A gas 
chromatographic method was developed to detect VSCs in the periodontal pocket, 
leading to finding significantly elevated concentrations of hydrogen sulfide in the 
periodontal pockets of individuals with gingivitis and periodontitis. The microbial 
aspect of periodontitis was studied using a qPCR methodology with specific samples 
from the periodontal niches, tongue and saliva to find a number of positive associations 
between the prevalence and abundance of putative periodontopathogens which are 
known VSC producers in the niches studied. The observed changes of 
periodontopathogens were also found to correlate positively with breath methanethiol 
and subgingival hydrogen sulfide concentrations. qPCR assays were developed to detect 
specific microbial species that were associated with malodour and periodontal disease, 
helping elucidate the ecological shifts observed with these species in health and disease. 
The VSC producing capability of the samples from different oral niches were studied to 
reveal periodontal niches as the most dynamic in VSC production in free cysteine 
substrate in health and disease, suggesting the importance of VSC production in these 
niches. The inflammatory cytokine profile in health and disease was determined by 
analysis of saliva and gingival crevicular fluid samples of individuals, finding that a 
more disease associated inflammatory profile correlated with breath and subgingival 
VSCs.   
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4 THE VOLATILE SULFUR COMPOUND 
PRODUCING MICROBIOME 
Advances in DNA sequencing technologies have accelerated the characterisation of the 
oral microbiome in health and disease in recent years. Familiar concepts of the 
microbial role in health and disease have been refined and extended in the search for a 
unified pathogenetic theory of oral diseases involving microbial plaque (Rosier et al. 
2014). Ecological dynamics involving different bacterial taxa have been known to play 
a part in the aetiopathogenesis of gingivitis and chronic periodontitis and efforts have 
been focused on identifying the microbial taxa most responsible for altering the overall 
microbiota of the oral soft and hard tissue niches in the different disease states, in 
addition to characterising individual differences (Kistler et al. 2013; Lourenço et al. 
2014; Abusleme et al. 2013; Liu et al. 2012).  
Intra-oral halitosis and its relation to chronic periodontitis, depends on the sulfur 
metabolism of the oral microbiome, and an accelerated sulfur metabolic cycle in the oral 
microbiome confers selective advantages in the face of the mounting host inflammatory 
challenge (Yaegaki 2008). Mechanisms by which this could help create a dynamic shift 
in the ecology of the oral microbiota are still being investigated with many being 
proposed. Although, the majority of the gram-positive and gram-negative bacterial 
species have orthologs of the enzyme family responsible for cysteine and/or methionine 
degradation, it was found that fewer species are efficient at degrading free cysteine and 
methionine in the fluids surrounding the oral mucosa such as the saliva and gingival 
crevicular fluid (Persson et al. 1990; Persson et al. 1989). Fewer still, are able to 
produce the volatile sulfur compounds from peptides in the niches relevant to 
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periodontal diseases such as the subgingival and interdental niches. Indeed, if sulfur 
metabolism of the microbiota is an important contributor to periodontal diseases, one 
would expect to find bacterial taxa that are known to be particularly efficient VSC 
producers to be causing the ecological shift in the niches relevant to disease at the 
various stages of disease progression. The aims of this investigation were therefore to 
characterise the native bacterial taxa at the niches relevant to periodontitis and oral 
malodour namely subgingival plaque, interdental plaque and tongue, in healthy 
individuals. Then, to compare this to individuals with clinically identified gingivitis and 
chronic periodontitis in terms of the bacterial taxa causing the ecological shift and hence 
to determine the proportions of VSC producing taxa that are involved in the changes to 
the microbial community. 
4.1 Samples & sequencing summary 
 A total of 113 samples from 53 participants overall passed DNA quality control 
and were sequenced, with the number of samples in each niche per cohort listed in 
Table 4-1. An aggregate of 11,473,531 sequences were assembled after initial quality 
control, yielding a total of 3,483,725 unique sequences with 407bp mean length. The 
mean (±SD) number of sequences from the different samples overall were: interdental 
plaque 82,136(±28,704); subgingival plaque 106,516(±38,363); tongue 
117,732(±35,209). HOMINGS analysis resolved on average 87% of the total sequences 
from each sample to human oral species and genus listed in the curated HOMD (Human 
Oral Microbiome Database), whilst the VAMPS based RDP-classifier also reached a 
similar sequencing depth with classification, except resolving only up to genus level 
(Table 4-2). Rarefaction curves plotted against alpha-diversity measures such as 
Phylogenetic Diversity, Chao I, Shannon and Simpson indices based on Operational 
Taxonomic Units (OTU) clustering in QIIME, suggested a sub-sampling depth of 8000 
sequences per sample would give sufficient coverage of the observed diversity in all the 
niches (Figure 4-1). 
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Cohort Interdental Subgingival Tongue 
No. of sample 
triads 
Health 18 12 17 9 
Gingivitis 12 8 13 7 
Chronic 
Periodontitis 
12 10 8 6 
Table 4-1 listing the number of samples analysed from each cohort and the number 
of individuals who contributed all three niche samples that passed quality control. 
Identification 
level 
Percentage of total sequences (Mean±SD %) 
HOMINGS VAMPS 
Interdental Subgingival Tongue Interdental Subgingival Tongue 
Genus 31.5±9.5 32.9±18.3 29.3±12.2 79.3±10.3 89.1±3.9 87.7±7.1 
Species 54.4±11.4 54.8±20.0 57.6±14.7 n/a n/a n/a 
Unmatched  14.1±7.4 12.4±8.7 13.2±12.7 6.8±2.9 5.1±1.6 4.8±1.0 
Table 4-2 comparing the percentage of sequences assigned by HOMINGS and 
VAMPS to their respective maximum identification level. 
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Figure 4-1 showing rarefaction curves for all samples plotted against Phylogenetic 
Diversity, Chao I, Shannon and Simpson diversity indices at a sub-sampling depth 
of 8000 sequences. 
4.2 Species diversity, chronic periodontitis and oral malodour 
 An increase in ecological diversity and species richness in the oral cavity is 
often reported in association with periodontal disease, for example in gingivitis and 
chronic periodontitis (Kistler et al. 2013; Ge et al. 2013; Griffen et al. 2012; Liu et al. 
2012). However, owing to much methodological heterogeneity in sequence processing 
pipelines and indeed, participant selection criteria and sampling strategies at the more 
basic level, this observation has not been consistently supported in the literature 
(Galimanas et al. 2014; Jünemann et al. 2012).  
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4.2.1 Microbial diversity between niches and cohorts 
 In the present study, a triad of oral samples collected from the same 
participants in healthy, gingivitis and chronic periodontitis cohorts were analysed with 
alpha-diversity measures such as Chao 1, Shannon-Weaver and Simpson Diversity 
indices with the RDP classified data at the genus-level. Comparing these metrics 
between the niches and cohorts yielded useful relationships (Table 4-3). For example, 
the interdental plaque was consistently richer than the subgingival plaque in healthy 
individuals but not in gingivitis and chronic periodontitis. Whilst, the richness between 
the niches were not significantly different in gingivitis and chronic periodontitis, the 
diversity metrics were able to distinguish between the subgingival and interdental 
niches in both health and gingivitis but not in chronic periodontitis. This indicates that 
while the richness of the subgingival plaque increases in gingivitis, the overall diversity 
remains the same in comparison to the interdental plaque, even at the genus-taxonomic 
level.  
Further, comparing these measures in the same niche between the cohorts did not reveal 
any significant differences, though non-significant differences were found, such as 
increase in the interdental plaque diversity in gingivitis compared to health and CP, and 
increase in subgingival diversity in CP compared to health or gingivitis. Determining 
the richness and diversity of microbial plaque in the interdental and subgingival niches 
of individuals may be a useful marker to distinguish gingivitis from periodontitis and 
health as it accounts for individual variation. Additionally, whilst the richness 
estimators were able to distinguish the interdental niche from the tongue in the healthy 
and gingivitis cohorts, the diversity as measured by the Shannon, Simpson and Inverse 
Simpson indices failed to do so. However, in the CP cohort, no differences were 
observed with any of these measures when the different niches were compared. 
Together these data suggest that in the gingivitis stage, the subgingival niche 
experiences an increase in richness, as more genera colonise the niche relative to the 
interdental plaque, which culminates in the changes observed in the subgingival plaque 
of chronic periodontitis patients where the diversity matches the interdental plaque 
indicating a dysbiotic state, given that the interdental niche is the least disturbed in 
terms of prevalent oral hygiene practices and possibly represents a ‘proto-dysbiotic’ 
microbial reservoir in the healthy individuals. 
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Indices 
Interdental vs 
Subgingival  
Interdental vs 
Tongue 
Subgingival vs 
Tongue 
H G CP H G CP H G CP 
Observed Richness + ns ns ++ ++ ns ns ns ns 
Abundance 
Coverage Estimator 
+ ns ns ++ ++ ns ns + ns 
Chao I ns ns ns + ns ns ns ns ns 
Shannon Diversity ++ ++ ns ns + ns ns ns ns 
Simpson Diversity + ++ ns ns ns ns ns ns ns 
Inverse Simpson + ++ ns ns ns ns ns ns ns 
Table 4-3 showing differences in the diversity and richness estimates of plaque 
collected from the different niches within the same individual (Friedman’s test with 
Dunn’s multiple comparison; significance indicated as +; H=Health, G=Gingivitis, 
CP=Chronic periodontitis). 
4.2.2 Microbial diversity and oral malodour 
 A metagenomic study that investigated the tongue microbiota in relation to oral 
malodour did not find an association with microbial diversity (Yang et al. 2013). 
However, this study did not use an organoleptic assessment of the breath of subjects to 
determine malodour, but rather relied on an arbitrary H2S concentration in 100 ppb 
steps for absence of malodour and moderate/severe malodour. In the present study, the 
malodour score used to distinguish individuals with or without malodour employed both 
VSCs measured in conjunction with the recognition threshold for the VSCs and enabled 
a more realistic classification criterion. Within the healthy cohort, a non-significant 
increase in diversity of the tongue samples of individuals with malodour was observed, 
compared to individuals without malodour at the genus-level (Figure 4-2). In addition, a 
non-significant decrease in the diversity of the interdental plaque was also observed 
with regards to individuals who had malodorous breath compared to those that did not 
have malodour. Although limited in the number of observations, healthy individuals 
with severe malodour also displayed a clearer difference with regards to diversity and 
richness in the tongue compared to healthy individuals without malodour.  
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Figure 4-2 plotting Shannon diversity index for healthy individuals with or without 
malodour in the tongue and interdental plaque (Median and interquartile range is 
shown). 
 Exploring possible associations between oral malodour as measured by the 
malodour score in the participants in the different cohorts revealed that interdental and 
subgingival niches too have a relationship with malodorous breath (Table 4-4). The 
strongest associations between malodour and alpha-diversity were observed for the 
subgingival niche in chronic periodontitis and interdental plaque in the gingivitis cohort. 
Whilst malodour in the healthy cohort was associated an increase in diversity and 
richness in the tongue, a negative relationship was observed with the interdental plaque. 
The latter association was observed to be stronger in the gingivitis cohort in relation to 
the diversity measures, with the richness and diversity of subgingival plaque showing a 
stronger positive association with malodour, than in health. As established in the 
previous section (4.2.1), a general equalisation of the richness and diversity is observed 
in chronic periodontitis between the different niches. However, unexpectedly, higher 
malodour scores within this cohort were still associated with an increase in richness and 
diversity of all three niches—the strongest association being with the subgingival 
plaque (Table 4-4).     
 Previous studies have established the association between oral malodour, 
volatile sulfur compounds in the breath and plaque-induced periodontal diseases 
(Takeuchi et al. 2010; Quirynen et al. 2009), and available ecological surveys of the 
human oral cavity have tended to focus on the tongue or saliva in relation to oral 
malodour, as those two niches are thought to play important roles in halitosis (Yang et 
al. 2013; Takeshita et al. 2012). The present study is the first to consider the ecology of 
the periodontal niches in relation to oral malodour and has found important associations 
between microbial diversity in the periodontal environment and malodour exhibited in 
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individuals with gingivitis, chronic periodontitis and periodontal health. Whilst changes 
occurring in the tongue ecology may be important in the malodour present in 
individuals with good oral health, periodontal habitats such as the subgingival and 
interdental niches proved to be more associated with malodour found in individuals 
with gingivitis or chronic periodontitis. Although, the tongue may be the dominant 
niche responsible for malodour in the gingivitis and chronic periodontitis cohorts due to 
its surface area, the associations found in this analysis suggests that subgingival 
microbiota may have a role to play in influencing the composition of the tongue 
microbiota and hence, oral malodour. These data highlight the interconnected nature of 
the different oral niches and the importance of niches other than the tongue to inform 
the relationship of the oral microbiota with malodour in health and disease. 
 
Indices 
Health Gingivitis 
Chronic 
Periodontitis 
T S I T S I T S I 
Observed Richness 0.38 0.03 -0.10 0.01 0.24 -0.08 0.40 0.81 0.40 
Abundance 
Coverage Estimator 
0.29 0.15 -0.11 0.03 0.17 -0.06 0.40 0.72 0.38 
Chao I -0.06 0.28 0.01 0.05 0.29 0.02 0.62 0.55 0.24 
Shannon Diversity 0.39 -0.13 -0.40 0.08 0.33 -0.66 0.31 0.72 0.07 
Simpson Diversity 0.22 -0.20 -0.51 0.03 0.30 -0.45 0.22 0.66 0.01 
Table 4-4 listing Spearman’s rho values computed for the malodour scores linked 
with the alpha-diversity metrics for the different niches from the RDP-classifier 
(T=tongue; S=Subgingival; I=Interdental) within each cohort. 
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4.3 General bacterial ecology in health and disease 
 The human oral microbiota is one of the most extensively characterised human 
microbiome in terms of health and disease, and studies have emphasized the unique 
nature of each niche within the oral cavity (Belda-Ferre et al. 2012; Abusleme et al. 
2013; Zaura et al. 2009). Attempts to describe the inter-individual variation present in 
the microbiota of oral niches have suggested that while a particular strain or species in a 
niche may be shared by different individuals, and even among different niches in the 
same individual, variation is observed in the relative abundances of the species or strain, 
and this is due to the functional adaptations required to colonise a specific niche (Huse 
et al. 2012; Caporaso et al. 2011; The Human Microbiome Project Consortium 2012). 
Thus, the higher resolution afforded by the HOMINGS methodology in identifying 
particular species and strains enables better identification of species within a genus that 
may be health or disease associated. 
4.3.1 Health 
Analysis of the tongue, subgingival plaque and interdental plaque in the healthy cohort 
enabled extraction of three principal components that accounted for 75.9% of the total 
variation observed (Figure 4-3). The score plots revealed that the three niches in health 
are distinct in their community structure with the greatest distance between the 
interdental and tongue microbiota (Figure 4-4). With little or no overlap between the 
communities in these two niches, 46% variation (PC1) observed between the samples 
accounted for this difference.  
The major difference of interdental plaque from tongue and subgingival plaque can be 
explained by a significant decrease in the Rothia mucilaginosa (p<0.0001), and an 
increase of Fusobacterium spp. (p<0.0001; Figure 4-5). Further associations that 
differentiate interdental plaque from the other niches include Streptococcus intermedius, 
TM7 genus and Parvimonas micra. The community structure of interdental plaque also 
exhibited the least variation among samples. These observations are in line with 
previous studies that have explored the interdental and tongue microbiota with regards 
to the most abundant taxa identified in the interdental plaque and tongue being 
Fusobacterium sp and the nitrate-reducing R. mucilaginosa, respectively; and TM7 
genus also being particularly abundant in the interdental plaque (Zaura et al. 2009; 
Takeshita et al. 2012; Kazor et al. 2003) 
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Figure 4-3 PCA score plot showing interdental niche from the healthy cohort lying 
furthest away from tongue and subgingival plaque, correlating negatively with 1st, 
2nd and 3rd principal components with variance explained 46%, 21% and 9% 
respectively. 
Greater heterogeneity of the subgingival microbiota was observed in health—a few 
samples were more similar to the tongue microbiota (Figure 4-4), whilst a third of the 
samples were more similar to the interdental microbiota in the taxa that exhibited the 
largest loadings in that axis, for example Fusobacterium sp. A few others varied along 
the third principal component with an associated increase of Rothia dentocariosa 
(PC3=0.69). This heterogeneity may be partly due to the sampling strategy of buccal 
and lingual subgingival samples being pooled, and the resultant community structure 
perhaps reflecting the interface of the tongue and interdental niches in that individual. 
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Figure 4-4 showing variance of the subgingival niche from tongue and interdental 
niches in health, along the PC1 and PC2 axes. 
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Figure 4-5 showing median values (plotted as stacked bars) of the three taxa that 
showed the largest loadings with the different niches within the healthy cohort. R. 
mucilaginosa and Fusobacterium sp showed statistically significant differences. 
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 Whilst the tongue and interdental plaque have distinctive microbial 
communities in the healthy cohort, subgingival plaque showed a general 
conglomeration of species, possibly reflecting the dynamic nature of this niche in 
health. However, a few species could still be identified as being particularly associated 
with this niche in comparison to the other niches in this cohort. These relate to a 
preponderance of streptococci including S. sanguinis, S. gordonii, Neisseria elongata 
and Lautropia mirabilis. Species such as S. sanguinis and S. gordonii have been 
previously reported to be associated with subgingival plaque accumulating in the sites 
with shallow probing depth in chronic periodontitis patients (Ge et al. 2013), and the 
present study indicates that these species may just be associated with the subgingival 
niche in health regardless of other affected teeth as these bacteria may have adaptations 
to a shallow subgingival niche. The species L. mirabilis has also been previously 
associated with health in the subgingival niche (Kistler et al. 2013). 
4.3.2 Gingivitis 
In gingivitis, the interdental plaque community was still as distinct from the other 
niches as in health (Figure 4-6), with a similar community structure, especially with 
Fusobacterium spp. being the most dominant taxon compared to subgingival and tongue 
niches which in turn had Streptococcus spp. and R. mucilaginosa as being their most 
dominant taxons, respectively. However additional species not associated with the 
studied niches in health were also found to distinguish the different niches from each 
other within the gingivitis cohort. For example, Atopobium rimae displayed significant 
shifts with regards to the interdental plaque compared to the subgingival and tongue 
niches (Figure 4-7). Whilst A. rimae has been associated with chronic periodontitis in 
previous studies in relation to the subgingival microbiota and with periradicular lesions 
(Paster et al. 2001; Kumar et al. 2003; Schirrmeister et al. 2009), it may well be that this 
species first proliferates in the interdental plaque at the gingivitis stage before gaining 
access to the subgingival environment as inflammation persists, particularly as its 
general prevalence and relative abundance in the tongue is also comparatively higher. 
A large overlap of the subgingival and tongue microbiota was observed in gingivitis, in 
particular, due to the subgingival microbiota exhibiting an increase in abundance of 
Granulicatella adiacens and Granulicatella paradiacens compared to the interdental 
niche (Figure 4-8). As with A. rimae, a direct route of transmission from the tongue is 
indicated, as this genus is highly prevalent and abundant in the tongue and it is possible 
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that with an increase in inflammatory load, Granulicatella spp. find colonisation of the 
subgingival niche more favourable.   
 
 Figure 4-6 showing PCA sample score plots of interdental, subgingival and tongue 
communities in gingivitis. The variances explained are: PC1=32%, PC2=23%, 
PC3=17%. 
As observed with the subgingival and interdental niches, the inherent variation present 
in tongue samples in the gingivitis cohort could be explained by shifts in taxa associated 
with the tongue in health in comparison to the subgingival and interdental niches, in 
addition to a few taxa not observed in the healthy cohort. These gingivitis-associated 
taxa include a phylotype identified as Streptococcus salivarius/vestibularis (p<0.0001), 
Gemella sanguinis (p<0.0001) and Prevotella melaninogenica (p=0.0003; Figure 4-9). 
S. salivarius has been associated with the tongue in studies that have explored the 
different oral niches, with cloning-sequencing and Next Generation Sequencing 
approaches (Aas et al. 2005; Eren et al. 2014), both in terms of prevalence and 
abundance. Whilst this phylotype has generally been associated with a ‘healthy’ 
subgingival plaque in comparison to chronic periodontitis (Lourenço et al. 2014), 
studies have also associated S. salivarius with the subgingival niche, particularly in the 
deep sites of moderate/high carious lesions (Ge et al. 2013). It is possible that the 
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associations observed in other studies with the subgingival plaque could simply due to 
an opportunistic response to the inflammatory stress in the subgingival environment 
leading to ‘overspill’ of this species from tongue and colonisation of the subgingival 
plaque. 
Figure 4-7 showing relative abundance of A. rimae in the different niches within the 
gingivitis cohort. Significant differences between niches are indicated; boxes 
represent 25th to 75th percentile; whiskers and outliers are plotted per the Tukey 
method. 
Figure 4-8 showing relative abundance of the phylotype identified as G. adiacens/ 
paradiacens in the subgingival, tongue and interdental niches. Significant 
differences between the niches are indicated; boxes represent 25th to 75th percentile; 
whiskers and outliers. 
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Figure 4-9 showing taxa that differentiate the tongue from the subgingival and 
interdental plaque in the gingivitis cohort (median values plotted as stacked bars). 
Statistically significant differences (p<0.001) were observed with all three taxa when 
compared with subgingival or interdental niches 
The genera Gemella and Prevotella are some of the most prevalent taxa in the oral 
cavity and in particular on the tongue dorsum (Huse et al. 2012), so it is not unexpected 
that this study found the G. sanguinis and P. melaninogenica to selectively increase in 
the tongue compared to the other niches in the gingivitis cohort. However, these species 
are also known to be opportunistic (Ruoff 2002), and these data suggest that an increase 
in inflammation observed in the periodontal environment in the gingivitis cohort also 
perhaps has an effect on the tongue microbiota resulting in proliferation of G. sanguinis 
and P. melaninogenica. Interestingly, the abundance of P. melaninogenica in 
subgingival plaque was found to have a fairly negative correlation with the chronic 
periodontitis patients whose periodontal pocket depths improved in response to 
treatment (Schwarzberg et al. 2014). This is consistent with the findings of the present 
study, associating this species as a ‘native’ of the tongue microbiota and as a possible 
opportunist in the periodontal environment as inflammation persists subgingivally. 
   121 
4.3.3 Chronic periodontitis 
A much larger overlap and heterogeneity of the microbial communities across the oral 
niches was observed in chronic periodontitis (CP), with the interdental niche in the 
different individuals clustering more similarly to the subgingival niches (Figure 4-10). 
However, the loading plots for the variables accounting for this clustering pattern 
suggest that the ‘core’ taxa underpinning the interdental niche such as Fusobacterium 
sp, has not changed significantly from health, through to disease—with additional taxa 
such as Porphyromonas endodontalis and Tanerella forsythia exhibiting an association 
with this niche in the CP cohort (Figure 4-11). 
Figure 4-10 showing clustering of microbiota in the interdental, subgingival and 
tongue niches with respect to the 1st (44%), 2nd (20%) and 3rd principal components 
in chronic periodontitis patients 
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Figure 4-11 showing median values (plotted as stacked bars) of the top taxa that 
showed the largest loadings with respect to the interdental niche within the chronic 
periodontitis cohort. 
Similarities between subgingival and interdental microbiota were observed in chronic 
periodontitis, with regards to the taxa that showed largest loadings with the interdental 
niche, highlighting the overlap between the two niches, in particular with the species T. 
denticola and T. forsythia (Figure 4-11). The role of these species in the pathogenesis of 
chronic periodontitis is well documented and in this case, their presence in the 
interdental niche could be due in part to transmission from the subgingival niche as 
clearly, they are more abundant subgingivally in the CP cohort (Sharma 2010; Frederick 
et al. 2011; Figure 4-11). The genera Rothia, Granulicatella and Streptococcus showed 
the largest shifts in relation to the subgingival niche compared to the interdental or the 
tongue niches in the CP cohort—not unlike the gingivitis cohort (Figure 4-12). 
Additionally however, species such as Leptotrichia honkongensis, P. melaninogenica 
and Corynebacterium durum were found to decrease in the subgingival niche in CP 
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compared to the other niches, in particular the interdental niche. The species R. 
dentocariosa has been associated with healthy subgingival plaque and the present study 
suggests that owing to the high relative abundance of this species in the periodontal 
environment (Figure 4-12), a larger shift in its abundance from health to disease is 
necessary for it to be considered a health-associated species (Kistler et al. 2013). Indeed, 
this has been recognised in a study by (Abusleme et al. 2013) who suggest that R. 
dentocariosa be considered part of the ‘core’ microbiota in the subgingival niche due to 
its high relative abundance in health and disease. 
Figure 4-12 showing median values (plotted as stacked bars) of the taxa that showed 
the largest loadings with respect to the subgingival niche within the CP cohort. 
The tongue microbiota in the CP cohort exhibited variation similar to that of the 
gingivitis cohort with species such as R. mucilaginosa, Streptococcus spp, G. sanguinis 
and P. melaninogenica forming the ‘core’ taxa whose relative abundances differentiated 
this niche from the subgingival and interdental niches. In addition, taxa such as 
Haemophilus parainfluenzae, Leptotrichia sp HOT417, Actinomyces odontolyticus, 
Actinomyces sp HOT172 and HOT449 showed large loadings for individual tongue 
samples. 
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4.4 Ecological variation in specific niches 
Comparing the different niches within the healthy, gingivitis and chronic periodontitis 
cohorts in this study has revealed that each niche has a few ‘core’ species that dominate 
or account for a large percentage of the bacterial biomass observed, and this largely 
remained the same from health through to disease. This fundamental stability of the oral 
niches has been observed in a much larger scale in other investigations that have studied 
the temporal variation in selected oral niches (Yang et al. 2013; Xu et al. 2015). 
However, it is also understood that the microbial diversity found within a human niche 
could account for its temporal stability, such that the more diverse a niche, the more 
temporal stability was observed in a cross-sectional study (Flores et al. 2014). This 
feature of the human oral microbiome allows one to compare the same niche among 
different cohorts separated by the degree of inflammation in the mouth such as 
gingivitis and chronic periodontitis, to look for patterns of microbial composition that 
influence or is affected by the inflammation observed.  
4.4.1 Interdental plaque 
A dimension reduction technique using Partial Least Squares regression enabled 
identification of phylotypes that displayed differences in relative abundance amongst 
the three cohorts. This analysis is biased toward the more prevalent and abundant taxa, 
so larger fluctuations in relative abundance of a particular taxon would result in higher 
loadings assigned to it. As discussed in the previous section in relation to the chronic 
periodontitis cohort (Figure 4-12), microaerophiles such as R. dentocariosa and R. 
mucilaginosa exhibited large loadings associated with the interdental niche in the CP 
cohort (Figure 4-13; Figure 4-14). Whilst R. dentocariosa is more abundant in the 
subgingival niche, the accumulation of R. mucilaginosa in the interdental plaque of 
chronic periodontitis patients is unusual. As described in the previous sections, R. 
mucilaginosa is the most dominant phylotype in the tongue and this finding suggests 
that the tongue microbiota may have a major role to play in chronic periodontitis, by 
acting as a reservoir for organisms that can colonise the subgingival and interdental 
niches. Additionally, this finding follows the clinical observation that the interdental 
spaces in affected teeth of CP patients are typically larger than healthy individuals, 
leading to the interdental niche in the CP patients being much less anaerobic than the 
healthy (Imai et al. 2012). 
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Figure 4-13 showing score plots of the interdental plaque communities in health, 
gingivitis and chronic periodontitis showing deviation of the different cohorts. 
Figure 4-14 showing taxons that had large loadings with respect to the principal 
components shown in Fig. 4-13. 
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Figure 4-15 bar plot showing median values of taxa that showed an association with 
the shift of the interdental samples in the gingivitis and chronic periodontitis cohort 
as shown in Fig. 4-13 and 4-14 (1% cut-off for dominant taxa and 0.1% cut-off for rare 
taxa are indicated in the plot). 
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Forty targets in total were identified as influencing the community shift from health to 
gingivitis and periodontitis in the interdental plaque with the most relevant plotted in 
Figure 4-15. The majority of these targets are measured as ‘rare’ taxa (<0.1% relative 
abundance), and a few species such as Mycoplasma faucium, Bacteroidetes [G-3] 
HOT280, Bacteroidaceae [G-1] HOT272 were found to be exclusively associated with 
CP. The classical periodontopathogens such as P. gingivalis and T. forsythia also most 
commonly occur as rare phylotypes and all detected targets were searched for a shift in 
the median values from nil in the healthy and gingivitis cohorts to >nil in the CP cohort 
revealing statistically significant shifts in abundances of Aggregatibacter 
paraphrophilus, Eubacterium saphenum, Peptostreptococcaceae HOT383, M. faucium 
and P. gingivalis (Figure 4-16).  
Receiver operating characteristic (ROC) curves generated for the taxa identified as 
linked with the shift of the gingivitis cohort from health in Figure 4-13 and Figure 4-14 
yielded two targets with Area under Curve (AUC) values of 0.72 at p<0.05, namely 
Filifactor alocis and Fretibacterium HOT359/HOT452 (Figure 4-17). In addition, the 
sum of taxa that showed statistical significance as plotted in the heat map in the 
individual participants (Figure 4-16), gave an AUC value of 0.8 at p<0.005 in 
distinguishing health from chronic periodontitis, but the comparisons between health-
gingivitis and gingivitis-chronic periodontitis pairs were not significant (Figure 4-17).  
Species such as F. alocis and E. saphenum are relatively newer associations with 
periodontitis, but at the subgingival niche (Kumar et al. 2003; Bruce J Paster et al. 2001; 
Griffen et al. 2012). M. faucium, Fretibacterium HOT359 and the Bacteroidetes 
phylotypes HOT272 and HOT280 have been associated with periodontitis recently by 
studies that have used NGS technologies to survey the subgingival ecology in relation to 
periodontitis (Abusleme et al. 2013; You et al. 2013; Griffen et al. 2012). A. 
paraphrophilus and Peptostreptococcaceae HOT383 are novel associations with 
periodontitis, and most of the discussed taxa are novel associations with gingivitis or 
chronic periodontitis in the interdental niche. In particular, species such as F. alocis and 
E. saphenum are considered to be putative periodontopathogens in the subgingival niche 
not unlike P. gingivalis or T. forsythia and the present study has identified a significant 
increase of F. alocis abundance in the interdental niche of the gingivitis cohort 
compared to health, suggesting that this species is involved at an earlier stage of the 
etiopathogenesis of periodontitis than previously recognised. Although the 
pathogenicity of M. faucium and A. paraphrophilus is largely unexplored in relation to 
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periodontitis, studies of these organisms on other contexts indicate that these species 
have latent virulence factors that may enable a pathobiont-like role in the development 
of chronic periodontitis (Kwon et al. 2004; Sen Yew et al. 2014). 
Figure 4-16 showing a heat map of rare taxa that showed strong associations with the 
CP cohort. Asterisk before taxon name indicates statistical significance between 
health and CP; darkest red in each row indicates >90th percentile; white denotes 
absence of detection. 
Figure 4-17 showing significant ROC curves in distinguishing gingivitis from health 
(F. alocis and Fretibacterium sp), and periodontitis from health (sum of P. gingivalis, 
E. saphenum, A. paraphrophilus, M. faucium and Peptostreptococcaceae HOT383) in 
the interdental plaque. 
4.4.2 Subgingival Plaque 
The subgingival plaque is the most widely studied niche in relation to gingivitis and 
chronic periodontitis, including using the next sequencing approaches, and in the 
present study a variation of less than 5% of the total relative abundances of 52 taxa 
measured in the subgingival plaque were identified as influencing the shift from health 
to gingivitis or chronic periodontitis with only about 2.4% variation in 43 taxa between 
gingivitis and chronic periodontitis (Figure 4-18). The species that were found in higher 
abundance in the healthy subgingival plaque compared to that of gingivitis or chronic 
periodontitis were Rothia mucilaginosa, Rothia aeria, Streptococcus sp and 
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Leptotrichia wadei (Figure 4-19). Interestingly, R. dentocariosa was found in higher 
average abundances in the gingivitis cohort compared to health. This could be due to the 
dynamic relationship between the most abundant taxa observed in the subgingival 
plaque of individuals in this study namely Streptococcus sp, R. mucilaginosa, R. 
dentocariosa, Neisseria sp and H. parainfluenzae, whereby only one of those species 
dominate by occupying the largest biomass, especially between Rothia sp and 
Streptococcus sp. The taxa Neisseria sp and H. parainfluenzae were only present in 
comparable relative abundances in a minority of individuals and so cannot be used to 
infer relationships with health or disease (Figure 4-20). However, a more even 
community could be observed in the CP cohort with regards to Rothia sp, 
Streptoccoccus sp and Granulicatella sp compared to health or gingivitis where a larger 
variance in the abundance of the different taxa that dominate the ecological landscape is 
observed (Figure 4-20). 
Figure 4-18 showing subgingival communities from health, gingivitis and chronic 
periodontitis against the extracted principal components. 
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Figure 4-19 showing taxa that had the largest loadings associated with the score plot 
shown in Fig. 4-18. 
Figure 4-20 showing the taxa that collectively occupied the largest biomass in the 
individual subgingival niches in health and disease (h=health; g=gingivitis; 
p=chronic periodontitis). 
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Figure 4-21 bar plot showing median values of rare taxa (<0.1% relative abundance) 
that showed an association with the shift of the subgingival samples in the 
gingivitis and chronic periodontitis cohort as shown in Fig. 4-18 and 4-19 (taxa with 
statistically significant differences are indicated with an asterisk). 
  
0 .0 0 0 1 0 .0 0 1 0 .0 1 0 .1 1
A g g re g a tib a c te r  a p h ro p h ilu s /H O T 4 5 8
A g g re g a tib a c te r  H O T 5 1 3
B a c te ro id a le s [G -2 ] H O T 2 7 4
G ra n u lic a te lla  e le g a n s
J o h n s o n e lla  ig n a v a
P o rp h y ro m o n a s  e n d o d o n ta lis
P o rp h y ro m o n a s  H O T 3 9 5
T re p o n e m a  H O T 2 4 7
V e illo n e lla  p a rv u la
* * B a c te ro id a c e a e [G -1 ] H O T 2 7 2
C a m p y lo b a c te r  re c tu s /s h o w a e
C lo s tr id ia le s [F -2 ][G -2 ] H O T 0 8 5
* * D e s u lfo b u lb u s  H O T 0 4 1
E u b a c te r iu m [1 1 ][G -1 ] in f irm u m
* F re tib a c te r iu m  fa s tid io s u m
* F re tib a c te r iu m  s p
* F re tib a c te r iu m  H O T 3 5 9 /H O T 4 5 2
L e p to tr ic h ia _ b u c c a lis /H O T 2 2 5
* L e p to tr ic h ia c e a e [G -1 ] H O T 2 1 0
L e p to tr ic h ia c e a e  s p
* M y c o p la s m a  fa u c iu m
* P a rv im o n a s  s p
P a rv im o n a s  m ic ra
P e p to s tre p to c o c c u s  s to m a tis
S tre p to c o c c u s  s a liv a r iu s /v e s tib u la r is
* * T a n n e re lla  fo rs y th ia
T M 7 [G -1 ] H O T 3 5 3
* T re p o n e m a  d e n tic o la
T re p o n e m a  s p  p ro b e 1
T re p o n e m a  s p  p ro b e 2
* T re p o n e m a  s p  p ro b e 4
T re p o n e m a  s p  p ro b e 5
* T re p o n e m a  m a lto p h ilu m
* T re p o n e m a  s o c ra n s k ii
T re p o n e m a  H O T 2 3 1 /H O T 2 3 7
T re p o n e m a  H O T 2 7 0
%  R e la tiv e  A b u n d a n c e
h ea lth
g in g iv it is
p e rio d o n tit is
   132 
In the subgingival plaque, a higher prevalence and abundance of phylotypes belonging 
to the family Synergistetes [F-2] and genus Treponema sp were observed in relation to 
gingivitis and chronic periodontitis and this has also been observed by other 
investigators (Figure 4-21; You et al. 2013; Abusleme et al. 2013). Treponema sp 
HOT247 and Aggregatibacter sp HOT513 were observed to be prevalent in just the 
gingivitis cohort, while Treponema sp HOT270, M. faucium, Leptotrichia sp 
HOT210/HOT220 and Bacteroidaceae[G-1] HOT272 were associated with an increased 
prevalence and abundance in the chronic periodontitis cohort.  
When all the measured taxa were screened for a shift in the median values from nil 
within the healthy or gingivitis cohort, to >0 in the CP cohort, M. faucium, P. gingivalis 
and Eubacterium minutum showed the largest changes  exclusively associated with the 
CP cohort (Figure 4-22). A separate cluster of taxa that showed incremental increase in 
the median values from nil in health through to >0 in gingivitis and CP were E. 
saphenum, Chloroflexi sp HOT439, Bacteroidetes sp HOT280 and Treponema parvum 
(Figure 4-22). The sum of all these taxa was able to distinguish between health and 
periodontitis and gingivitis from health, while the M. faucium, P. gingivalis and E. 
minutum cluster only differentiated between health and CP. However, the second cluster 
was able to distinguish more accurately between health, gingivitis and CP (Figure 4-23).   
 It is notable that E. saphenum, P. gingivalis. M. faucium and Bacteroidetes 
HOT280 exhibited similar shifts in abundance in both the interdental and subgingival 
niches across the cohorts and these may be due to these taxa playing the role of the 
tertiary colonisers in both the sites (Figure 4-16 and Figure 4-22). However, the 
prevalence of these species was higher in the interdental niche of the healthy cohort 
compared to the subgingival niche, suggesting that perhaps these putative 
periodontopathic strains are normally present at low levels in the interdental niche of 
healthy individuals and this follows the clinical observation that this niche is a critical 
area of the periodontium linked with the origin of carious lesions and periodontal bone 
loss due to microbial and host induced destruction (Berchier et al. 2008). While these 
taxa are normally prevalent at very low abundances in the subgingival niche, the 
classical periodontopathogens such as T. forsythia and T. denticola were much more 
abundant and exhibited changes from gingivitis to periodontitis to such an extent that 
both these taxa would be considered to be dominant in this niche in periodontitis (>1% 
relative abundance; Figure 4-21). Indeed, the diverse array of species from the genus 
Treponema implicated in the aetiopathogenesis of periodontitis would likely make this 
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group of species one of the most important in the overall ecology and pathogenicity of 
the microbiota found in the periodontal environment (Meng You et al. 2013). 
Figure 4-22 showing a heat map of rare taxa that showed strong associations with the 
CP cohort in the subgingival plaque. Asterisk before taxon name indicates statistical 
significance between health and CP; darkest red in each row indicates >90th 
percentile; white denotes absence of detection. 
Figure 4-23 showing ROC curves for Cluster II (E. saphenum/Chloroflexi 
HOT439/Bacteroidetes HOT280/T. parvum) and sum of taxa in Cluster II and I (M. 
faucium/P. gingivalis/E. minutum). Plots on the left are for health vs gingivitis and 
the right are for health vs chronic periodontitis. 
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4.4.3 Tongue 
Of the niches studied, limited data as regards the tongue ecology exists in association 
with periodontal disease (Galimanas et al. 2014), while another investigation had also 
used the NGS approach to study tongue ecology in relation to halitosis (Yang et al. 
2013). The present study has indicated that tongue has an important role to play in the 
ecology of the periodontal niches due to its nature of being a potential reservoir for 
periodontopathic microbiota and also its close proximity to the interdental and 
subgingival niches in the lingual aspect of the periodontal environment, leading to free 
transmission of microbiota that may colonise the subgingival and interdental niches. 
Conversely, the alpha diversity analyses of the different niches with respect to the 
breath VSCs in the participants of the present study has indicated that the changes 
occurring in the periodontal environment in relation to gingivitis and periodontitis 
influences the tongue microbiota and hence, may explain the changes observed in the 
concentrations of the different breath volatiles as the tongue is thought to be the largest 
contributor to the presence of malodorous volatiles in the breath of individuals with 
halitosis. Unlike the periodontal niches, however, the tongue ecology was less well 
defined across the different cohorts with the PLS analysis, finding larger variance in the 
tongue communities from the different cohorts and leading to an appearance of a more 
stable ecology with respect to the different disease states (Figure 4-24).  
Figure 4-24 showing score plot of tongue samples from the different cohorts against 
the first two principal components.  
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Figure 4-25 showing taxa that had substantial loadings on the tongue communities 
observed in Fig. 4-24. 
 
The principal components extracted by the analysis showed the tongue ecology of the 
gingivitis cohort to be more dissimilar to health than chronic periodontitis; however a 
small shift in the periodontitis samples could still be observed (Figure 4-24). Whilst the 
tongue was observed to be the least diverse of the niches considered in this study, 
smaller changes in relative abundances of the observed species present in the tongue 
will likely result in a much larger impact in overall ecology and indeed the composition 
and concentration of the breath volatiles, owing to the large surface area of the tongue. 
A small subset of targets were identified in the tongue samples that increased from 
health to gingivitis or chronic periodontitis and these include Prevotella 
melaninogenica, Alloprevotella tannerae, Atopobium rimae, Streptococcus 
salivarius/vestibularis, Actinomyces HOT172, Prevotella pallens, Prevotella veroralis 
and Fusobacterium sp from health to gingivitis (Figure 4-25 and Figure 4-26).  
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Figure 4-26 bar plot showing median values of relevant taxa that showed an 
association with the shift of the tongue samples in the gingivitis and chronic 
periodontitis cohort as shown in Fig. 4-24 and Fig. 4-25 (taxa with statistically 
significant differences are indicated with an asterisk) 
Due to the variation observed in the different taxa among the cohorts, all measured taxa 
were screened for the largest incremental shifts in the median values from health to 
gingivitis and chronic periodontitis, and 33 targets were found to increase in gingivitis 
and CP, while 45 targets were found to increase in gingivitis but decrease in CP. These 
include P. melaninogenica, Eubacterium sp, S. gordonii/sanguinis, Fusobacterium sp 
and Parvimonas sp (Figure 4-27). In addition, searching for taxa that displayed a 
considerable increase in prevalence in the tongue of gingivitis and chronic periodontitis 
patients compared to healthy individuals, revealed taxa such as Eubacterium brachy, 
Streptococcus constellatus, Peptostreptococcaceae HOT113 and Desulfobulbus 
HOT041 involved in the ecological shifts observed (Figure 4-28). 
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Figure 4-27 plot of the median values of taxa that showed largest increase in 
prevalence and abundance from health to gingivitis and periodontitis in the tongue 
samples (taxa with statistically significant differences are indicated with an 
asterisk). 
Figure 4-28 showing heat map of rare taxa present in the tongue that showed 
positive associations with gingivitis and chronic periodontitis cohorts. Asterisk 
before taxa name indicates statistical significance between cohorts; darkest red in 
each row indicates >90th percentile; white denotes absence of detection. 
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The tongue ecology was observed to differ in both the dominant and rare taxa from 
health to disease. The dominant genera that increased in abundance were Prevotella sp, 
Fusobacterium sp and Streptococcus sp, and species such as P. melaninogenica, F. 
periodonticum and S. salivarius/vestibularis in particular within these genera. 
Galimanas et al. (2014) studied tongue ecology in relation to periodontitis and reported 
a shift in composition in association with periodontitis with an increase in abundance of 
genera such as Synergistetes, Treponema and Clostridiales—largely agreeing with the 
findings of this study pertaining to the rare taxa. Whilst no data are available in the 
literature with regards to shift of the dominant taxa in association with disease, existing 
data confirm Prevotella sp, Fusobacterium sp and Streptococcus sp to be the most 
prevalent and dominant taxa on the tongue (Paster et al. 2006; Eren et al. 2014). Though 
an increase in the numbers of dominant and rare taxa detected in the tongue samples 
was observed from health to gingivitis and chronic periodontitis, the first indication that 
the tongue ecology changes in association with inflammation in the periodontium is 
suggested by the rare taxa that increase in abundance and prevalence in the gingivitis 
and CP cohorts (Figure 4-27 and Figure 4-28). For example, the streptococcal species S. 
gordonii, S. sanguinis and in particular S. constellatus are thought to be preferentially 
abundant and prevalent in the subgingival and supragingival niches (Paster et al. 2006; 
Eren et al. 2014). This is consistent with that observed in the subgingival and interdental 
samples of the healthy cohort in this study, and these species exhibited an increased 
prevalence and abundance in the tongue samples of the gingivitis and CP cohort 
individuals (Figure 4-27 and Figure 4-28). Further evidence that the tongue ecology 
changes with periodontal disease or indeed that free transmission occurs between the 
tongue and periodontal niches is suggested by the increase in the tongue of TM7 sp 
HOT437 that was particularly abundant and prevalent in the interdental niche in health 
or disease (Figure 4-27). In addition, periodontopathic species such as P. gingivalis, T. 
forsythia and Eubacterium sp also increase in prevalence and abundance on the tongue 
of individuals with gingivitis or chronic periodontitis. Taken together, these data 
suggest that while the tongue is a unique niche with specific periodontitis associated 
taxa different from the subgingival and interdental niches increasing in prevalence and 
abundance, a change in ecology of the tongue is also observed in relation to rare taxa 
that are not normally associated with the tongue but have been observed to increase in 
the subgingival and interdental niches. 
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4.5 Ecology of the VSC producers 
Volatile sulfur compound producing bacteria are some of the most prevalent in the oral 
cavity and anaerobic degradation of proteinaceous substrate in the oral cavity is thought 
to be linked with periodontitis and malodour in health and periodontitis (Kurata et al. 
2008; Zappacosta et al. 2007). As observed in the present study, an association is also 
reported with the prevalence and increased concentration of methanethiol in the breath 
of chronic periodontitis patients (Takeuchi et al. 2010). This is consistent with the 
observation that gram-negative anaerobic bacteria are generally the more active VSC 
producers in the oral cavity in disease, and these bacteria also tend to increase in 
abundance in the periodontal niches in association with oral inflammation (Torresyap et 
al. 2003). In this study, the association of oral malodour and periodontal disease was 
investigated in terms of the putative VSC producing species present in the oral cavity. 
The exponential growth in  understanding of the existing ecological diversity in the oral 
cavity through NGS approaches has limited one’s ability to generalise previous surveys 
of VSC producing bacteria in the oral cavity in elucidating the full diversity of VSC 
producing species present (Washio et al. 2005; Persson et al. 1990). However, a 
bioinformatic appraisal of the available genomes of the oral microbiota in the current 
study helped extend the diversity of the VSC producing potential in the oral cavity. Of 
the 573 species level targets detected by HOMINGS, 295 species had full genomic 
sequences available and were searched for the presence of homologs capable of 
degrading cysteine or methionine to produce VSCs. Only 24 species were determined to 
have a homolog of methionine gamma lyase capable of degrading methionine to 
CH3SH, in contrast to the majority of the available bacterial genomes containing 
cysteine desulfhydrases capable of producing H2S from cysteine (218 of 295; See 
Appendix for full list). The ecological changes observed in these species in association 
with disease in the different niches are discussed in the following sections. 
4.5.1 Health 
A consistent observation across the different niches in the PLS analysis was that, the 
majority of taxa that were observed to increase in the different niches associated with 
gingivitis or chronic periodontitis were VSC producing organisms. A further 
observation is that the 24 species having the potential to produce methanethiol from 
methionine are often disease associated species and these include Fusobacterium sp, 
Porphyromonas sp Treponema sp and Megasphaera micronuciformis. Correlation 
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analysis of all the targets detected in relation to the Malodour Score as measured from 
the VSCs present in the breath samples of individuals in the healthy cohort revealed 
potential associations with malodour in the different niches. More taxonomic groups in 
the tongue were associated with the malodour scores compared to the interdental or 
subgingival niches, suggesting that tongue ecology is more relevant to malodour in 
healthy individuals (Table 4-5). Periodontopathic species such as A. 
actinomycetemcomitans and T. lecithinolyticum were observed to show a positive 
association in the interdental and subgingival niches respectively and the species 
Johnsonella ignava showed a positive association with malodour in both the niches. J. 
ignava, a likely H2S producer,  has been associated with oral squamous cell carcinoma 
(Pushalkar et al. 2012), however, due to the lower prevalence of this species (<40% of 
the total samples), its associations with the periodontal niches and malodour is primarily 
due to an increase in prevalence rather than abundance. 
Interdental plaque Tongue 
Taxon rho Taxon rho 
Johnsonella ignava 0.567 Parvimonas sp 0.710 
Streptococcus 
salivarius/vestibularis 
0.557 Tannerella HOT808 0.686 
Aggregatibacter 
actinomycetemcomitans 
0.521 Streptococcus sp 0.624 
TM7 HOT352 0.495 Gemella sp 0.573 
Veillonellaceae HOT155 -0.491 Bergeyella HOT322 0.573 
Selenomonas sputigena -0.526 Stomatobaculum HOT097 0.559 
Prevotella veroralis -0.566 Peptococcus HOT167 0.557 
Subgingival plaque Gemella haemolysans 0.545 
Taxon rho TM7 sp 0.503 
Mollicutes HOT504 0.670 Peptostreptococcus stomatis 0.493 
Treponema lecithinolyticum 0.664 Neisseria elongata -0.525 
Johnsonella ignava 0.616 
Aggregatibacter 
aphrophilus/HOT458 
-0.544 
Prevotella pallens 0.606 Rothia mucilaginosa -0.546 
Porphyromonas HOT279 -0.624 Selenomonas noxia -0.589 
 
Actinomyces massiliensis -0.629 
Rothia sp -0.645 
Table 4-5 listing taxa that showed the strongest correlations (Spearman’s rho) with 
particular niches as malodour scores increased in the healthy cohort.  
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An increase in Parvimonas sp and Streptococcus sp, in addition to a decrease in Rothia 
sp abundance on the tongue in association with oral malodour as measured by VSCs in 
the breath is consistent with the ecological changes observed on the tongue from health 
to chronic periodontitis in the present study, suggesting that the tongue ecology of 
healthy individuals with malodour is possibly more biased towards a disease associated 
ecology. However, no consistent clustering pattern could be established with regards to 
disease associated ecology in the niches studied—the healthy cohort samples from 
individuals with malodour clustered both closer to the gingivitis/periodontitis cohort(s) 
and further away from disease towards a more health associated ecology (Figure 4-29). 
This finding also held true with non-euclidean clustering of the samples using Bray-
Curtis, Jaccard and Kulczynski distances determined by OTU-based analysis in QIIME. 
 
Figure 4-29 PCA score plot of tongue samples from healthy individuals with and 
without malodour as determined by the Malodour Score along with gingivitis and 
chronic periodontitis samples. 
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Different streptococcal species increasing in the tongue, subgingival and interdental 
niches in the disease cohorts in comparison to health and in association with malodour 
scores underlines the role of these species in both disease and malodour. Whilst 
streptococci are not the most prolific producers of VSCs from proteinaceous substrate, it 
has been demonstrated that S. salivarius can encourage degradation of mucin to produce 
malodorous volatiles including VSCs by other gram-negative bacteria by the activity of 
β-galactosidases inherent to streptococci and S. salivarius is present even in the most 
anaerobic areas of the tongue such as the dorsal posterior to circumvallate papillae, co-
existing with gram-negative anaerobic bacteria (Sterer & Rosenberg 2006; Sterer et al. 
2009; Allaker et al. 2008). Further, given the association of VSCs with periodontal 
disease, increase of streptococci in the tongue and other niches in association with 
increase of VSCs in the healthy cohort could be taken to mean that increase of these 
streptococci could facilitate ecological succession for more periodontopathic bacteria, 
and the increased presence of VSCs in the breath could be a consequence of increase in 
prevalence and abundance of periodontopathic bacteria in the tongue of individuals with 
malodour. This hypothesis is supported by data from this study pertaining to the classic 
red complex bacteria—it was found that these bacteria collectively are more abundant 
and prevalent in the different niches of healthy individuals with malodour as opposed to 
no malodour ( ). Whilst no statistical differences could be demonstrated owing to less 
sample numbers, increase in prevalence and abundance of T. forsythia and A. 
actinomycetemcomitans was observed in all three niches in individuals with malodour 
scores >1 compared to <1. All of these organisms have the enzyme homologs to 
produce H2S while only T. denticola and P. gingivalis can produce CH3SH.  
 Of the 24 species identified as methanethiol producers only 14 species were 
observed in all of the niches in the healthy cohort, with the interdental niche showing 
the highest prevalence of methanethiol producing species (mean=11±2), compared to 
the subgingival niche (mean=9±2) or the tongue (mean=6±2). These observations also 
hold true for the observed richness of the H2S producing species in the different niches. 
The species T. denticola, F. naviforme/nucleatum ssp fusiforme were the most abundant 
in the interdental niche whereas F. periodonticum and M. micronuciformis were the 
most prevalent and abundant in the tongue of the healthy cohort (Figure 4-31). These 
data suggest that the interdental niche in the healthy individuals is a potential reservoir 
for VSC producers and F. periodonticum and M. micronuciformis are likely involved in 
the production of methanethiol in the breath of the healthy cohort in this study, given 
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that the tongue ecology is the most important in malodour present in healthy 
individuals. A weak positive association was found with abundance of F. periodonticum 
in the tongue and methanethiol concentration in the breath (r=0.33). It is notable that 
species such as T. denticola, P. endodontalis and F. nucleatum are more abundant and 
prevalent in the periodontal niches whereas F. periodonticum and M. micronuciformis 
are more abundant in the tongue, particularly as the former species have been shown to 
be more prolific in degrading serum substrate to VSCs, whereas the tongue associated 
F. periodonticum is more efficient at producing methanethiol from free methionine and 
less so at degrading serum proteins (Persson et al. 1990). This further illustrates the 
nature of adaptations inherent in these species toward the different habitats they occupy, 
as the periodontal niches are more likely to provide serum proteins in the form of 
gingival-crevicular fluid, whereas free methionine or cysteine is more likely to be 
available in the tongue, by degradation of proteinaceous material from saliva and 
mucosal debris from tongue biofilm. 
Figure 4-30 showing relative abundances of the red complex bacteria and A. 
actinomycetemcomitans in the different niches between healthy individuals with 
and without malodour as determined by the malodour score. Boxes represent Min-
Max range and the mid line is the median. 
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Figure 4-31 showing median values (plotted as stacked bars) of the methanethiol 
producing taxa in the tongue, interdental and subgingival niches of the healthy 
cohort 
4.5.2 Gingivitis 
Metagenomic studies have so far explored the association of oral malodour with the 
ecology of saliva and tongue in healthy individuals (Yang et al. 2013; Takeshita et al. 
2012), and the present study is the first to explore oral malodour with periodontal 
disease. Findings from this study pertaining to the VSCs present in the breath of the 
health and disease cohorts are consistent with findings reported in the literature, 
particularly of the association of malodour as defined by the concentration of the VSCs 
in the breath increasing in the disease cohort, and the role of methanethiol as the more 
dominant VSC in the breath of individuals with gingivitis and chronic periodontitis, 
further supported by the increase of the ratio of CH3SH to H2S in these cohorts 
compared to health.  
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Interdental plaque Subgingival plaque 
Taxon rho Taxon rho 
Porphyromonas HOT275 0.741 Atopobium sp 0.881 
Olsenella HOT809 0.631 TM7[G-1] HOT347 0.873 
Enterococcus faecalis 0.588 Granulicatella elegans 0.762 
Solobacterium moorei 0.580 Clostridiales HOT075 0.762 
Leptotrichia hofstadii/HOT909 -0.592 Neisseria pharyngis -0.577 
Leptotrichia goodfellowii -0.608 
Catonella morbi/HOT164 -0.629 Eubacterium yurii -0.592 
Selenomonas noxia -0.634 Veillonella atypica/dispar -0.655 
Oribacterium HOT078/HOT372 -0.650 Enterococcus faecalis -0.655 
Porphyromonas endodontalis -0.676 
Prevotella 
nanceiensis/HOT299 
-0.764 
Leptotrichia spp probe2 -0.748 Oribacterium HOT108 -0.764 
Tongue 
Taxon rho Taxon rho 
Leptotrichia HOT215 0.714 Streptococcus constellatus 0.617 
Stomatobaculum HOT097 0.703 Corynebacterium spp 0.604 
Neisseria elongata 0.674 Eubacterium infirmum 0.587 
Actinomyces spp probe1 0.659 Prevotella micans 0.577 
Rothia aeria 0.654 Actinomyces odontolyticus -0.613 
Table 4-6 listing taxons that showed the strongest correlations with the three niches 
in the gingivitis cohort. Only variables with 95% confidence intervals in line with 
the spearman’s correlation coefficient values are listed. 
 The relationship between malodour and the periodontal niches were not similar 
in the gingivitis and chronic periodontitis cohort to that of health as shown in previous 
section discussing the association between overall richness and diversity and malodour 
(4.2.2). For example, species richness and diversity in the tongue had the least positive 
relationship with malodour scores in the gingivitis cohort, compared to the health and 
chronic periodontitis groups, whilst a more dynamic relationship was observed with 
regards to the subgingival and interdental niches in the gingivitis and chronic 
periodontitis cohorts in comparison to health. This supports the contention that 
malodour as it relates to VSCs in the breath of individuals has a deeper relationship with 
inflammation in the oral cavity and in particular, the microbial role in inflammation of 
the periodontium. This suggests that the associations observed with malodour in the 
gingivitis and chronic periodontitis cohorts include changes in microbial ecology due to 
the disease and/or a more direct relationship with VSC production.  
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In the gingivitis cohort, malodour scores were associated with an increase of 
Porphyromonas HOT275, Olsenella HOT809 and E. faecalis in the interdental plaque; 
Atopobium sp, TM7 HOT347 and G. elegans in the subgingival plaque; Leptotrichia 
HOT215, Stomatobaculum HOT097 and N. elongata in the tongue. All of these species 
that have full genome sequences available have enzyme homologues that can produce 
H2S. It is interesting to note that the strongest correlation observed with malodour and 
the subgingival plaque in the gingivitis cohort was for the genus probe detecting a 
collection of species namely A. fossor, A. minutum, A. parvulum, A. rimae and 
Atopobium HOT199 (Spearman’s rho=0.881; Table 4-6). These species are less 
abundant in the subgingival plaque than the tongue or the interdental plaque and as 
observed in the comparison between the niches in this cohort (4.3.2), they increased in 
the interdental plaque, and it was suggested that this species is likely an opportunist in 
the subgingival plaque in response to inflammation. Another example of a non-native 
species that proliferates in a different niche in the gingivitis cohort compared to health 
and that being associated with malodour is S. constellatus in the tongue (Figure 4-28; 
Table 4-6). These observations indicate the potential relationship between VSCs and 
inflammation in gingivitis, as clearly if VSC concentration in the breath has a 
mechanistic link with inflammation, one would expect to find these associations with 
ecological changes occurring as part of the aetiopathogenesis of the disease and this 
may not always relate to VSC production. This is further illustrated by the negative 
correlation observed between abundance of P. endodontalis, a prolific H2S and CH3SH 
producer in the interdental plaque of the gingivitis cohort, suggesting that the change of 
ecology occurring in the interdental niche in relation to gingivitis is related to malodour, 
but in an inverse manner, given that in the healthy cohort P. endodontalis is more 
abundant in the interdental niche than any other niches studied. However, a negative 
relationship was still observed with respect to this species and malodour score in the 
subgingival plaque of this cohort, whilst a non-significant increase in prevalence and 
abundance was observed in comparison to health. 
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Figure 4-32 showing stacked median values of putative methanethiol producing species 
in the oral niches in health and disease 
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 The ecology of methanethiol producing bacteria in the periodontal niches could 
be a microcosm of disease progression from health to chronic periodontitis, and these 
niches were observed to be the most dynamic, with the interdental niche found to be 
most active in gingivitis (Figure 4-34). Species such as T. denticola, F. alocis, T. 
putidum, P. endodontalis and Centipeda periodontii displayed an increase in abundance 
in this niche (in that order), with a representative increase of abundance observed in the 
subgingival plaque in T. denticola, P. endodontalis and F. alocis.  It is notable that T. 
denticola and F. alocis appear to play a strong role in the changes observed in this niche 
in gingivitis, and T. denticola is shown to be very active in producing copious amounts 
of methanethiol and hydrogen sulfide from serum proteins (Persson et al. 1990). In 
addition, the methionine gamma lyase present in T. denticola responsible for producing 
methanethiol has been shown to be so efficient that its rate of methanethiol production 
from degrading free methionine is almost 100-fold higher at physiological 
concentrations than P. gingivalis (Fukamachi et al. 2005). T. denticola is likely to be 
more important in methanethiol production in the periodontal niches.  
An increase in abundance of F. periodonticum, M. micronuciformis and F. nucleatum 
ssp animalis was observed on the tongue, however no change in richness was observed. 
M. micronuciformis and F. periodonticum levels in saliva were positively associated 
with high methanethiol and hydrogen sulfide content in the breath of healthy 
individuals, respectively, whereas P. endodontalis only displayed a weak correlation to 
VSCs in a metagenomic study by Takeshita et al. (2012) with a sample size of 43. 
Observations in the present study suggest that the associations observed by Takeshita et 
al (2012) are predominantly due to microbial shedding from the tongue and whilst 
saliva is not as specialised as the niches considered in the present study, a positive 
correlation would still be expected with respect to the subgingival or interdental niches 
and P. endodontalis. However, with the overall diversity estimates in connection with 
malodour scores only displaying a fair positive association with subgingival niche and a 
moderate negative correlation with the interdental niche (Table 4-4), any real 
relationships will be due to species that display more dramatic shifts in abundances or 
prevalence in association with VSCs.  
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4.5.3 Chronic periodontitis 
The total number of significant correlations found between malodour scores and the 
different niches were the highest in the chronic periodontitis cohort compared to health 
or gingivitis. Stronger relationships were found too with the subgingival and tongue 
niches showing predominantly positive associations whilst the interdental niche 
showing more negative associations with microbial species (Table 4-7). The group of 
species detected by the Rothia spp probe and R. dentocariosa in the subgingival and 
interdental niches were found to correlate negatively with malodour scores. Whilst 
greater abundance of Rothia spp in general and R. dentocariosa in particular in the 
periodontal niches is considered to be more health associated, this correlation suggests 
that the periodontal ecology of periodontitis patients with malodour is likely to be more 
disease associated than patients without malodour (Kistler et al. 2013; Abusleme et al. 
2013). Indeed, the positive associations observed with putative periodontopathic species 
and phylotypes such as Fretibacterium HOT360, Bacteroidetes HOT280, T. denticola, 
F. alocis and E. saphenum in the subgingival plaque supports this hypothesis.   
The strongest correlations with malodour scores in this cohort was observed with TM7 
phylotypes and tongue, with a collection of species detected by the TM7 spp probe 
showing a strong positive correlation with regards to the tongue of the chronic 
periodontitis patients (rho=0.976). The phylotype most responsible for this is likely to 
be TM7 HOT352, as that displayed the next strongest relationship with the tongue 
(rho=0.952). This is unlikely to be a spurious relationship as TM7 phylotypes feature 
heavily in the periodontal niches as being positively associated with increasing 
malodour scores, and due to the high prevalence of these phylotypes, this relationship is 
not due to increase in prevalence but due to abundance in the different niches as part of 
disease progression (Table 4-7). Positive associations were also found between 
malodour scores and TM7 prevalence in the tongue, interdental and subgingival niches 
in the healthy and gingivitis cohorts (Table 4-5; Table 4-6). TM7 are a major phylum of 
uncultivated microorganisms, until recently when a species named TM7x was cultivated 
as a strict epibiont of a particular A. odontolyticus strain (He et al. 2015). This species 
was found to have a reduced genome devoid of amino acid synthesising capability and a 
parasitic symbiosis with the host bacterial strain. Assuming that this finding is an 
archetype of the phylum TM7, it is possible that the TM7 phylotypes that show 
correlations with malodour score and consequently with VSC concentration in the 
breath are linked with microbial strains that are key VSC producers themselves and/or 
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are disease associated and thus stimulate VSC production by way of their epibiotic 
associations.  
Subgingival plaque Tongue 
Taxon rho Taxon rho 
Fretibacterium HOT360 0.833 TM7 spp 0.976 
Bacteroidetes HOT280 0.772 TM7 HOT352 0.952 
Treponema denticola 0.768 Gemella morbillorum 0.91 
Stomatobaculum HOT097 0.76 Porphyromonas HOT279 0.874 
Chloroflexi HOT439 0.759 Gemella spp 0.857 
Filifactor alocis 0.754 Lachnoanaerobaculum umeaense 0.833 
Treponema sp probe5 0.746 Oribacterium HOT108 0.833 
Capnocytophaga granulosa 0.746 Clostridiales HOT085 0.814 
Treponema sp probe4 0.736 Clostridiales HOT075 0.802 
Eubacterium saphenum 0.733 Parvimonas spp 0.786 
Prevotella nigrescens 0.717 Peptococcus HOT167 0.779 
Alloprevotella tannerae 0.717 Eubacterium sulci 0.762 
TM7 HOT353 0.709 Solobacterium moorei 0.762 
Peptostreptococcaceae HOT369 0.697 Campylobacter rectus/showae 0.738 
TM7 HOT437 0.687 Stomatobaculum HOT097 0.738 
Rothia spp -0.746 Actinomyces odontolyticus -0.709 
Interdental plaque 
Taxon rho Taxon rho 
TM7 HOT353 0.832 Veillonella atypica/dispar -0.648 
TM7 HOT349 0.743 Gemella haemolysans -0.65 
Clostridiales HOT075 0.669 Rothia sp -0.657 
TM7 sp 0.587 Leptotrichia hongkongensis -0.69 
Veillonella parvula -0.559 Actinomyces sp probe1 -0.741 
Actinobaculum HOT183 -0.585 Rothia dentocariosa -0.811 
Campylobacter concisus -0.626 
  
Table 4-7 listing taxons that showed the strongest correlations with the three niches 
and malodour scores in the chronic periodontitis cohort. Only the strongest 
correlations found in species with ≥75% prevalence in this cohort is reported. 
 
Whilst TM7 has been detected in tongue and saliva in previous metagenomic malodour 
studies that were carried out in healthy individuals, no associations were reported (Yang 
et al. 2013; Takeshita et al. 2012). Though associations were observed in the present 
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study with the tongue in the healthy cohort, they were of moderate strength compared to 
the disease cohorts and the associations were more due to increase in prevalence than 
abundance. This suggests that the ecological shift observed with regards to TM7 is more 
disease associated with VSCs being a marker of disease that identifies this relationship, 
as TM7 was more prevalent in the interdental niche in the healthy cohort and was found 
to increase in prevalence in the other niches in gingivitis and chronic periodontitis. 
Methanethiol producing species were more abundant in the subgingival niche of the 
chronic periodontitis cohort compared to all the other niches, suggesting a potential 
pathogenetic role for methanethiol production in active periodontal disease. T. denticola 
was found to be the most abundant of the CH3SH producing species in this niche with 
P. endodontalis and P. gingivalis also showing an increase in abundance (Figure 4-34). 
The prevalence of P. gingivalis was observed to increase in both the interdental and 
subgingival plaque in this cohort. An increase in prevalence of T. denticola and F. 
alocis was observed in the tongue of the chronic periodontitis patients compared to 
health, and the ‘core’ species of F. periodonticum remained similar in abundance, with 
an increase in abundance of M. micronuciformis also observed. It is notable that with all 
of the methanethiol producing species diversity is conserved in the interdental plaque of 
periodontitis patients with the periodontopathic P. gingivalis being carried by this niche, 
suggesting that active disease could be precipitated by transmission of the latent 
virulence from the interdental to the subgingival niche, possibly explaining the episodic 
nature of periodontal disease.  
4.5.3.1 Ecology of the sulphate reducers 
Perhaps the most direct evidence of VSC production in the periodontal niches is 
provided by a class of bacteria called Sulphate reducing bacteria (SRB) known to use 
sulphate as an electron acceptor in anaerobic respiration forming a number of 
malodorous VSCs including hydrogen sulfide, carbon disulfide, and trace amounts of 
methane-, ethane- and propanethiol (Le et al. 2005). The major genera of oral SRBs 
belong to class deltaproteobacteria and epsilonproteobacteria and are some of the least 
studied group of bacteria in relation to oral malodour, but consistently show an 
association with periodontal disease (Vianna et al. 2008; Figure 4-15; Figure 4-21; 
Figure 4-27; Figure 4-28). Limited numbers of these species are detected by 
HOMINGS, namely Desulfomicrobium orale, Desulfovibrio fairfieldensis, 
Desulfovibrio HOT040, Desulfobulbus HOT041 and a group of species belonging to the 
genus Desulfobulbus namely D. elongatus, D. mediterraneus, D. propionicus and D. 
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rhabdoformis. Prevalence of these species were high in the interdental niche in general, 
but also showed a significant increase in prevalence and abundance in the subgingival 
niche of chronic periodontitis patients (Figure 4-35). Only Desulfobulbus spp was 
detected in the tongue, which also showed a significant increase in prevalence in 
chronic periodontitis patients compared to health but not gingivitis. 
 
The RDP-classifier displayed a higher resolution than HOMINGS, detecting eight 
different genera of sulphate reducing bacteria in all the niches, with the tongue showing 
the most diversity amongst the niches. The genus Desulfobulbus spp was found to be 
the most prevalent in the tongue of periodontitis patients confirming the results of the 
HOMINGS analysis whilst the genus Sulfospirillum spp was more prevalent in the 
Figure 4-35 showing abundances of the sum of all sulfate-reducing taxa detected 
in the three niches of the different cohorts as individual bars. Statistical 
differences found using one-way ANOVA between the cohorts are indicated. 
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tongue of healthy individuals (Figure 4-36). Interestingly, though a high prevalence of 
Desulfobulbus spp was observed in the subgingival and interdental samples from the 
three cohorts, the species richness of the sulphate-reducers increased in both the niches 
in periodontitis suggesting that the available sulphate levels in the periodontal niches 
must also increase to sustain this diversity. Indeed, this hypothesis is supported by the 
gas chromatographic analysis of subgingival paper point samples for the presence of 
VSCs, showing a significant increase of H2S from health to gingivitis and periodontitis 
(Figure 3-19). 
 
  
Figure 4-36 showing the diverse genera of SRBs detected in selected tongue 
samples from the different cohorts. Only samples with detected SRBs are shown 
(h=health; g=gingivitis; p=periodontitis). 
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The role of VSC production in chronic periodontitis is well illustrated by the ecological 
changes observed with the sulphate reducing bacteria present in the oral cavity. Unlike 
other bacterial species, a direct functional relationship can be inferred with an increase 
in prevalence and abundance of this group of bacteria in the different niches. Given the 
association of tongue with malodour and VSC concentration in the breath, the observed 
diversity of SRBs in the tongue in all the cohorts suggests that available suphate is high 
in the tongue regardless of disease state. A change in SRB ecology in the interdental 
and subgingival niches in association with periodontitis indicates that VSC production 
in these niches is high and that it plays a functional role in the anaerobiosis of the 
periodontal environment. The observed abundance of SRBs in the subgingival and 
interdental niches of periodontitis patients suggests that this class of bacteria may even 
be the most important VSC producer in the subgingival environment in association with 
inflammation, as sulphate is most likely generated as a by-product of the prevailing 
oxidative stress in response to microbial challenge and these group of bacteria that can 
readily metabolise such compounds to lower the redox potential may have functional 
advantages for the wider bacterial community.  
4.6 Summary 
To conclude, the study of general ecology in health, gingivitis and chronic periodontitis 
of three different niches namely tongue, subgingival and interdental plaque using Next 
Generation Sequencing revealed that the interdental niche was the most diverse in 
health, with the tongue being the least diverse. Consistent with the available literature, it 
was found that in chronic periodontitis, there is a general normalisation of diversity and 
richness among the three niches and this included proliferation of species in niches not 
normally found in health. The interdental and subgingival niches were found to be the 
most dynamic in gingivitis and chronic periodontitis in this regard, with changes also 
observed in the tongue ecology in gingivitis and chronic periodontitis, particularly with 
the prevalence and abundance of periodontopathic bacterial species. Malodour as 
defined by the VSC concentration of the breath was found to correlate positively with 
diversity and richness in the tongue in health, whereas this association was weaker in 
disease. However, the periodontal niches were found to be more associated with VSC 
concentration in the breath of the gingivitis and periodontitis cohorts. Observed 
variation in the microbial ecology of the tongue, subgingival and interdental niches 
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within and between cohorts were elucidated to find that both classical and novel 
periodontopathogens involved in changes associated with disease.  
Diversity of VSC producing bacteria was described for each niche in the different 
cohorts, and numerous relationships were found with VSC concentrations in the breath. 
Periodontopathic species were found to be VSC producers and positive correlations 
were found with these species in each cohort within the three niches studied, such that 
increasing VSC concentrations within each cohort was found to correlate more strongly 
with disease associated ecology. Finally, the ecology of sulphate reducing bacteria in 
the periodontal and tongue niches is described and important relationships with 
periodontal disease were elucidated.  
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5 THE ROLE OF METHIONINE GAMMA 
LYASE IN INFLAMMATION AND 
MICROBIAL ECOLOGY  
Porphyromonas gingivalis is one of the most widely studied bacterium in relation to 
plaque-induced inflammatory diseases of the mouth. Classically part of a trio of 
microbial species (‘red complex’) including Tanerella forsythia and Treponema 
denticola that were strongly linked to the etiopathogenesis of periodontitis, P. gingivalis 
has now been proposed as a ‘keystone’ pathogen in the new paradigm of periodontitis 
(Hajishengallis et al. 2012). This model recognizes that some bacterial species though in 
low abundance are able to drive the ecology of the biofilm community in response to 
environmental cues or adaptations by influencing the diversity and evenness of such 
communities. Studies have elaborated the mechanisms by which P. gingivalis could 
bring about changes in the community structure by manipulating the host response. 
These include interfering with neutrophil recruitment by deactivating IL-8 production, 
down regulation of E-selectin production by gingival epithelia, impeding the 
complement cascade by effecting C5aR/TLR2 crosstalk and gingipain induced 
degradation of important complement proteins such as C3 and C5 (Bostanci et al. 
2007a; Hajishengallis et al. 2011; Takeuchi et al. 2013; Wang et al. 2010). Whilst these 
mechanisms could elicit a sustained, if ineffective immune response from the host, the 
adaptation of P. gingivalis to the subgingival habitat is thought to be realized in the 
episodic nature of these mechanisms.  
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 P. gingivalis is known to be a prolific producer of volatile sulfur compounds 
(VSCs) in serum and also from free sulfur containing amino acids such as cysteine and 
methionine, however it is reported to be more efficient at producing VSCs from a serum 
substrate than cysteine and methionine (Persson et al. 1990; Stephen et al. 2014). These 
VSCs such as hydrogen sulfide, methanethiol and dimethyl disulfide are thought to be 
useful in lowering the redox potential of the subgingival microenvironment and aid in 
the invasiveness of the organism and indeed the biofilm, by increasing the permeability 
of the mucosal cell membrane (Ng & Tonzetich 1984). Given that one of the described 
mechanisms of IL-8 deactivation by serB protease requires cell invasion for it to occur 
(Takeuchi et al. 2013), one would expect VSC production to be an important adaptive 
mechanism for P. gingivalis and indeed for other potential keystone pathogens.  
 Of the genetic complement that can produce VSCs in P. gingivalis, a previous 
study has characterized the methionine Ɣ lyase (mgl) that produces methanethiol by 
catabolic degradation of methionine, and this enzyme has been reported to confer 
resistance to an antimicrobial agent 3-chloro-DL-alanine by exhibiting deaminating 
activity towards it as with methionine, in both P. gingivalis and F. nucleatum 
(Yoshimura et al. 2000; Yoshimura et al. 2002a). Virulence studies in a murine abscess 
model has demonstrated that P. gingivalis W83 wild type was markedly more invasive 
than the mgl-deficient mutant, whilst a drug trifluoromethionine that depends on the 
activity of mgl to release its active form showed considerable increase in the survival of 
mice when injected along with the wild type P. gingivalis (Yoshimura et al. 2000; 
Yoshimura et al. 2002b). These observations are consistent with the hypothesis that 
VSC production or indeed mgl-activity could aid invasiveness. However, it is well 
known that planktonic forms of bacteria often exhibit a different phenotype to biofilms 
and these studies did not involve biofilms and it is possible biofilm dwelling P. 
gingivalis downregulates VSC producing genes to exhibit a less invasive phenotype. 
The present study aimed to replicate the knockout of the methionine Ɣ lyase in the 
strain W50 (as opposed to W83). The mutant and wild type P. gingivalis were then 
grown in a 10-species oral biofilm model and used to stimulate transformed oral 
keratinocytes in vitro. Biofilm composition was determined to study the effect of the 
mgl gene knockout in influencing the ecology of the biofilm, and if the possible altered 
ecology in any way affects the cytokine response of the oral keratinocytes. 
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5.1 Characteristics of the mutant and biofilms 
The methionine gamma lyase in P. gingivalis W50 was confirmed to be identical to the 
strain W83 used by Yoshimura et al. (2000) and the mutant W50 (named PG343 
henceforth) produced less than 1% of the total methanethiol in the headspace compared 
to the wild type W50, when incubated with L-methionine suggesting successful 
knockout of mgl (Figure 5-1). However, it is possible that P. gingivalis W50 has other 
as yet undiscovered gene(s) still capable of producing methanethiol, as the previous 
study on strain W83 only observed complete absence of methanethiol in the headspace 
of bacterial cells incubated with L-methionine after mutagenesis but not in the culture 
supernatants.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 5-1 top: restriction sites and expected amplicons sizes on the ORF identified to 
code for mgl in P. gingivalis W50; bottom right: an agarose gel showing DNA bands for 
the actual amplicons within the ORF chosen to ligate the ermF-ermAM cassette in P. 
gingivalis strains W50 and W83; bottom left: agarose gel showing intense 3kb DNA 
bands (0.5/1/5µl loads shown) corresponding to the amplified F1-R2 fragment after 
restriction digest and before electroporation. 
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Morphologically, PG343 colonies resembled W50, with a distinction being, the mutant 
strain took longer to attain black pigmentation when cells frozen at -80°C were revived 
on blood agar, but subsequently subcultured generations did not show this difference 
with the wild type W50. The growth rates of both strains were also similar in BHI broth 
supplemented with haemin. Colorimetric assays showed similar activities for both arg-
gingipain (Rgp) and lys-gingipain (Kgp) in PG343 and W50 broth cultures and 
supernatants, with only the slopes of Rgp activity measured in the cultures of PG343 
Figure 5-2 showing arg-gingipain and lys-gingipain activities in BHI haemin broth 
cultures and their respective cell-free culture supernatants of P. gingivalis W50 and 
PG343. Data points are mean values from duplicates with linear regression lines and 
95% confidence bands plotted. Only the slopes of PG343 and W50 cultures for the arg-
gingipain assay differed significantly (p=0.001). 
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differing significantly (Figure 5-2). As reported in the literature, the culture supernatants 
showed marked reduction in measured enzyme activity for both the gingipains, but this 
was particularly evident for Kgp (Aduse-Opoku et al. 2000). This is consistent with the 
observations of the agar colonies, as lys-gingipains are thought to play a key role in the 
release of heme from haemoglobin and subsequently to black pigmentation. The 
differences observed of the Rgp activities between PG343 and W50 cultures may only 
result in a negligible reduction of the Rgp-Kgp complex’s function. There is also 
evidence that methanethiol can compromise the erythrocyte cell membrane, causing it to 
rupture, in addition to having particular preference for inhibiting erythrocyte associated 
cytochrome c oxidase, catalases and pyruvate kinases (Ahmed et al. 1984; Valentine et 
al. 1987; Finkelstein & Benevenga 1986). While lys-gingipains are ultimately 
responsible for black-pigmentation by providing access to haemoglobin, methanethiol 
production may accelerate the availability and access to haemoglobin, and therefore to 
iron uptake and black pigmentation. 
5.1.1 Biofilm composition 
Growth of biofilms with PG343 and W50 resulted in markedly different biofilm 
compositions. Firstly, measurement of the total CFU ml
-1
 equivalents in the biofilms by 
using P. gingivalis cultures as standards indicated that the PG343 biofilms had, on 
average an order of magnitude more cells than the W50 biofilms. Secondly, the 
proportions of the individual species in the PG343 biofilms were congruent, resulting in 
a more even community compared to W50 biofilms. Differences were observed in the 
overall composition of biofilms grown with the W50 or PG343 strains (Figure 5-3). 
Streptococcus spp (p=0.02) and A. naeslundii (p=0.004) proportions decreased 
significantly in the mutant biofilms compared to wild type, whilst V. dispar proportions 
increased significantly (p=0.0008). The cumulative distributions of A. 
actinomycetemcomitans, V. dispar, A. naeslundii and Streptococcus spp proportions in 
the mutant biofilms also differed significantly from the wild type (WT) biofilms. No 
statistical differences in the proportions of other species were detected. However, when 
the amounts of DNA extracted from each sample is taken into account (a truer reflection 
of biomass) without normalizing to the universal primer set, F. nucleatum, P. 
intermedia, V. dispar and P. gingivalis increased significantly in the PG343 biofilm 
compared to W50 both in numbers and cumulative distributions (Figure 5-4). Although 
not statistically significant, elevated CFU ml
-1
 equivalents of A. actinomycetemcomitans 
were also observed in the PG343 biofilms compared to W50. 
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Figure 5-3 showing the proportion of the different species in the PG343 and W50 
biofilms (n=9 for both) relative to total CFU ml-1 equivalents as measured by the 
universal primers ineach biofilm. Boxes extend from 25th to 75th percentile, mid line 
being median; whiskers and outliers plotted by the Tukey method. Asterisk before 
species indicate statistical significance. 
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It is well known that P. gingivalis is one of the most efficient degrader of free L-
methionine and in serum (Persson et al, 1990). It is possible that methionine degradation 
by P. gingivalis prevents other species, in particular, F. nucleatum from proliferating by 
using it as an energy source (Bakken et al. 1989; Gharbia et al. 1989). It may well be 
that in the PG343 biofilms, more availability of L-methionine encourages growth of F. 
nucleatum, which can further support the proliferation of all the other species as F. 
nucleatum is well known as a bridging-species in the oral biofilm (Bradshaw et al. 
1998; Merritt et al. 2009). This could explain the increased overall CFEs as measured in 
the PG343 biofilms. This hypothesis would suggest that mgl of P. gingivalis could have 
a role to play in the overall ecology and community structure of the oral biofilm, as a 
‘keystone’ virulence factor. A possible mechanism by which this could occur is via 
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Figure 5-4 showing the composition of the W50 and PG343 biofilms (n=9 for 
both) as a function of the amounts of DNA extracted from each biofilms. 
Asterisk before species name indicates statistical significance at p<0.01 for 
both Mann-Whitney U and Kolmogorov-Smirnov tests. Boxes extend from 25th 
to 75th percentile, mid line being median. Whiskers and outliers plotted by the 
Tukey method. 
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control of the activated methionine cycle which in turn regulates luxS mediated 
production of autoinducer-2 like quorum sensing molecules that have been extensively 
studied in relation to bacterial biofilm formation (Figure 5-5). Given the importance of 
the methionine cycle in the quorum sensing phenomena, the catabolism of available 
methionine may play a role in co-aggregation behaviour among bacterial species, and 
indeed this could be one mechanism by which the periodontopathic bacteria which form 
a small subset of the oral microbiota that are capable of catabolic degradation of 
methionine may exert community-wide effects (Geske et al. 2008; Sun et al. 2004). 
Interestingly, disabling luxS in P. gingivalis W50 is reported to have a reduction in 
haemagglutination and cysteine protease (gingipain) activity of the strain but did not 
affect the overall virulence (Burgess et al. 2002).  
If the increased proportions of Streptococcus spp and particularly A. naeslundii in the 
W50 biofilms may be thought of as beneficial, owing to their prior associations to 
healthy plaque, the presence of P. gingivalis in low levels in the oral biofilm may help 
regulate the community structure towards a more health associated ecology (Abusleme 
et al. 2013; Ge et al. 2013). However, the metagenomic study in this thesis and other 
such studies have detected disease associated streptococci and one particular strain used 
in growing the biofilms namely S. intermedius is thought to be a more opportunistic 
pathogen in diseases that involve oral transmission and also periodontitis (Socransky et 
Figure 5-5 showing a schematic of the activated methionine cycle and its role in 
producing autoinducer-2, with the potential role for methionine gamma lyase in 
controlling this cycle. Adapted from (Redanz et al. 2012). 
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al. 2013; Whiley et al. 1992). This species is also shown to co-aggregate synergistically 
with disease associated species and is also a more efficient H2S producer than the other 
streptococcal strains used in this model (Young et al. 1996; Takahashi et al. 2011). The 
inability to delineate the relative proportions of these species among the streptococci by 
quantitative PCR in this biofilm model is a limitation, as while this study has found a 
reduction in the overall proportion of the streptococci in the PG343 biofilms compared 
to W50 (Figure 5-3), the total number of cells (measured as CFU ml
-1
 equivalents) were 
higher in the PG343 biofilms (Figure 5-4).  
The species that displayed the most substantial change in proportions and CFU 
equivalents (increase of ~10
3
 CFUe) in the PG343 biofilms was V. dispar. This species 
lacks methionine gamma lyase and it is possible that V. dispar benefits the most from 
the F. nucleatum vs P. gingivalis dichotomy in the ability to degrade methionine within 
the present invitro model. The proportions of P. gingivalis measured in both the PG343 
and W50 biofilms did not show a difference, suggesting that methionine degradation is 
not critical to the general metabolism of P. gingivalis, however judging by the PG343 
biofilm composition in terms of CFU equivalents, a considerable increase was observed 
(a difference of 2 orders of magnitude). This may also be due to the fact that the CFU 
equivalents measured of the overall biofilm community was also increased in the 
PG343 biofilms, possibly an effect of the increased presence of F. nucleatum being able 
to support more biomass (Hendrickson et al. 2014). In another invitro multi-species 
biofilm model, V. dispar, P. intermedia and F. nucleatum were seen in close proximity 
to each other and the effect observed of general proliferation of cells in the PG343 
biofilm supported by an increase in Fusobacterium spp suggests a possible explanation 
of these data (Guggenheim et al. 2009). Whilst three different F. nucleatum subspecies 
were used in constructing the present 10-species model the available qPCR primers 
based on the 16S rRNA gene are unable to distinguish between these species, so the 
dynamics between these species in the PG343 and W50 biofilms were not determined. 
A proteomic study on the effect of A. actinomycetemcomitans in an invitro 11-species 
biofilm containing P. gingivalis, described the antagonistic nature of interactions 
between these two species (Bao et al. 2015). The authors observed that whilst no change 
in the overall species proportions were observed in terms of numbers when A. 
actinomycetemcomitans was incorporated into an existing biofilm, a wide array of 
protein expression profiles among the different species were found with most of the 
virulence factors in P. gingivalis being down regulated. However, it has also been 
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reported that while P. gingivalis can aggregate and develop mutualistic biofilms with A. 
actinomycetemcomitans, in simple in vitro models P. gingivalis tended to dominate and 
overwhelm A. actinomycetemcomitans and this was a function of the proteolytic ability 
of the P. gingivalis strain used (Takasaki et al. 2013; Periasamy & P. E. Kolenbrander 
2009). In the present study A. actinomycetemcomitans is the only species observed to be 
less in CFU equivalents and relative proportions in the PG343 biofilms compared to all 
the other species in the W50 biofilms (Figure 5-3; Figure 5-4). This suggests that the 
mutant PG343 is more dominant than W50, possibly due to more available methionine 
for autoinducer-2 mediated signalling and interactions with other species in the biofilm. 
5.2 Cytokine response of the cells to biofilms 
Analysis of the cell culture supernatants revealed that compared to the W50 biofilm 
stimulations, the supernatants from the PG343 biofilm stimulations contained 
significantly lower IL-8 in both the 4h (p=0.03) and 24h (p=0.005) conditions, whilst 
the same was observed for IL-6 in just the 4h stimulations (p=0.0002). Statistical 
differences with a similar pattern were found between the PG343 and W50 biofilm 
stimulations in the following cytokines (Figure 5-6): IL-1α at 4h (p=0.048); ICAM-1 at 
4h (p=0.02) and 24h (p=0.004); TGF-β at 24h (p=0.03). Although no statistically 
significant differences were observed with the concentrations of interferon-gamma, IL-
13 or E-selectin between the PG343 and W50 biofilm stimulations, different patterns of 
stimulation were observed at 4h and 24h (Figure 5-7). For example, the W50 biofilms 
appear to stimulate more IL-13 production at 4h than the PG343 biofilms, but this 
pattern was not observed at 24h where all conditions including controls produced a 
similar concentration of IL-13. A similar pattern at 24h was observed for E-selectin, but 
in this instance, the PG343 stimulated more E-selectin production at 4h. Except for IL8 
and IL6, amounts of other cytokines tended to increase at 24h vs 4h. Differences were 
also observed within this, for instance IL1 alpha was found consistently across all 
samples whereas IL1 beta and IL6 were found to be present only at the 24h and 4h 
stimulations respectively. As regards interferon-gamma and interferon-alpha, more 
PG343 biofilms stimulated production of the former than the latter compared to the 
W50 biofilms at 4h. At 24h however, more W50 biofilms stimulated production of 
interferon-gamma, whereas the interferon-alpha levels were similar for both the biofilm 
types, but more reduced than controls. 
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Figure 5-6 showing scatter dot plots of the concentrations of IL8, IL6, IL1 alpha, IL1 
beta, ICAM1 and TGF beta measured in the cell culture supernatants after a 4h or 
24h stimulation with the PG343 (Δ) or W50 (WT) biofilms (C= Controls). Only 
statistical significance between the PG343 and W50 biofilms are indicated. Red lines 
indicate median values. 
   167 
Figure 5-7 showing scatter dot plots of the concentrations of IL13, interferon-alpha, 
E-selectin and interferon-gamma detected in the cell culture supernatants after 4h 
and 24h stimulations with the PG343 (Δ) or W50 (WT) biofilms (C= Controls). 
A more comprehensive evaluation of the cytokines secreted by the immortalised OKF6 
human oral mucosal keratinocyte monolayer was carried out in this study, finding the 
presence of more than ten signalling molecules changing in response to stimulation with 
the bacterial biofilms. The cells used in this model are transformed and not from 
primary cultures, and there is likely to be differences to an in vivo response of the oral 
keratinocytes (Dickson et al. 2000). Indeed, the mRNA expression of the cell line used 
in this study is reported to resemble primary dysplasic cell lines (Dickman et al. 2014). 
However, without the methodological constraints of maintaining a primary cell line, the 
monolayer comprised of transformed oral keratinocytes is a valid model to explore 
epithelial cytokine response to microbial challenge given appropriate experimental 
controls. 
5.2.1 Interleukin-8 and Interleukin-6 
Detectable IL8 and IL6 levels were present at the 24h time point showing differences 
between the PG343 and W50 biofilms. Detection of IL6 in the control conditions at 4h 
and 24h were similar for IL6 but the control cells were observed to produce more IL8 at 
24h compared to 4h (Figure 5-6). These data suggest a possible dampening of immune 
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response by the PG343 biofilm compared to the W50 owing to the presence of lower 
amounts of the potent chemokine IL8 at 24h compared to 4h. However, the ability of P. 
gingivalis to degrade both IL8 and IL6 is extensively reported in the literature and these 
data are also consistent with P. gingivalis or indeed other organisms degrading IL8 and 
IL6 as the levels of these cytokines in the PG343 biofilm stimulations were lesser than 
the controls. While IL8 is a chemokine that is primarily concerned with attracting 
neutrophils to an insulted site, IL6 is thought to be a major regulator of the pro-
inflammatory response towards an infectious agent, particularly in linking the innate 
and adaptive immune responses (Neurath & Finotto 2011; Tanaka et al. 2014). So, by 
degrading IL6, the oral biofilm may prevent IL6 mediated signalling to recruit the Th2 
and Th17 responses to more effectively address the microbial challenge. The mRNA 
expression data as discussed in the next section sheds some light on the patterns 
observed of concentrations of cytokines such as IL8 and IL6 which showed 
inconsistency of mRNA expression in relation to actual concentration of cytokines 
detected, and the mRNA data indicates that a more consistent interpretation is provided 
by the cytokine degradation hypothesis and therefore the supposed greater virulence of 
the PG343 biofilm (see section 5.3). 
5.2.2 Interleukin-1α and Interleukin-1β 
The levels of IL1 alpha and IL1 beta were higher in the supernatants of W50 biofilm 
stimulations compared to the controls and PG343 stimulations at both 4h and 24h 
(Figure 5-6). Unlike IL8 and IL6, the amounts of IL1 alpha and IL1 beta detected in the 
PG343 biofilm stimulations were higher than controls suggesting a pro-inflammatory 
effect in both types of biofilms. Studies have reported that P. gingivalis can antagonise 
production of IL1 alpha and IL1 beta when used to co-stimulate with other species in 
planktonic phase, while a non-degradative hypothesis is advanced with stimulation of P. 
gingivalis on its own in particular its LPS being identified as the main component of 
IL1 stimulation (Bostanci et al. 2007a; Bostanci et al. 2007b; Hamedi et al. 2009). 
Peyyala et al. (2013) report that stimulation of oral keratinocytes with 3-species (S. 
gordonii/P. gingivalis/F. nucleatum) biofilms resulted in greater secreted IL1 alpha 
compared to biofilms that did not contain all three species at once, suggesting 
synergistic co-stimulation. In another study, secreted IL1 alpha levels are reported to be 
directly related to the amount of F. nucleatum cells present (Peyyala et al. 2012). The 
observed levels of IL1 alpha and IL1 beta may be a reflection of stimulation by F. 
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nucleatum and P. gingivalis and the mRNA data sheds further light on whether the 
PG343 or W50 biofilms exert a greater pro-inflammatory effect (See section 5.3). 
5.2.3 E-selectin 
Expression of E-selectin—an important leukocyte adhesion molecule was found to be 
elevated in the supernatants of cells stimulated with the PG343 biofilms compared to 
W50 and controls at 4h but not at 24h (Figure 5-7). E-selectin is primarily an 
extracellular molecule due to its function and is secreted in response to TNF-alpha, IL1 
and P. gingivalis lipopolysaccharide (LPS), and it is thought that it takes at least 2 hours 
after cytokine recognition for its expression on the cell surface with the levels returning 
to baseline by 24h after cessation of stimuli (Leeuwenberg et al. 1992). Furthermore, P. 
gingivalis LPS is thought to display heterogeneous structures that differentially 
modulate E-selectin expression and it is possible that the mgl
-
 P. gingivalis in the 
PG343 biofilms display more of the penta-acylated LPS structures that are thought to be 
more virulent and/or LPS from other species such as F. nucleatum also playing a role 
(Reife et al. 2006). The more acute response shown by the cells in expressing E-selectin 
to the PG343 biofilms at 4h suggests this biofilm to be more virulent compared to the 
W50 biofilms, and this is consistent with the increase in total number of bacterial cells 
and in turn the numbers of individual species in the PG343 biofilms as revealed by the 
qPCR data. 
5.2.4 Intercellular adhesion molecule-1  
In contrast to E-selectin expression, a reduction was observed in the amount of the 
intercellular adhesion molecule-1 (ICAM-1) detected in the supernatants of cells 
stimulated with the PG343 biofilms and it is reported that increasing ICAM-1 
expression facilitates P. gingivalis invasion in gingival epithelial cells in a single 
species model (Kato et al. 2014). Conflicting with this report is another study that found 
that the cysteine proteases of P. gingivalis (i.e. gingipains) degrade ICAM-1 secreted by 
human oral epithelia in a dose dependent manner and thereby prevent 
polymorphonuclear leukocyte attachment, so helping P. gingivalis in immune evasion 
(Tada et al. 2003). The data from the present study is more consistent with the findings 
of the latter study, however the former study was concerned with P. gingivalis invasion 
of epithelial cells while the latter with immune subversion, and even low levels of 
ICAM1 did not abolish invasion and it is not clear how these findings may relate to a 
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biofilm context where other species may influence the ability of the biofilm to stimulate 
and/or degrade ICAM1.  
5.2.5 Transforming growth factor-β, interferons and interleukin-13 
A greater prevalence of TGF-beta was observed in cells stimulated by the W50 biofilms 
compared to the PG343 and controls at both 4h and 24h, with the PG343 biofilm 
stimulations having similar levels as in controls (Figure 5-6). TGF-beta and IL6 are 
believed to act in concert to differentiate naïve T-cells into an IL17 secreting Th17 
lineage, and this data is consistent with the amount of IL6 detected in PG343 vs W50 
biofilm stimulations, as increased presence of IL6 is thought to also induce TGF-beta 
production (Bettelli et al. 2006; Mangan et al. 2006). 
Interferon-alpha (IFN-alpha) was detected more frequently across all samples than 
interferon-gamma (IFN-gamma) and no significant differences were found with regards 
to both the cytokines, while a difference in levels of IL13 between the experimental 
conditions was only observed at 4h (Figure 5-7). Elevated levels of IL13 were observed 
in stimulations with W50 biofilms compared to PG343 biofilms at 4h and this cytokine 
is thought to suppress inflammatory responses and has an important role in Th2 
response (Bao & Reinhardt 2015). 
The keystone pathogen hypothesis perhaps best explains the observed cytokine patterns, 
whereby biofilm dwelling P. gingivalis acts as a keystone species and is able to bring 
about community-wide effects via its immune subversive mechanisms. The cytokine 
expression patterns found in this study are consistent with P. gingivalis dominating the 
biofilm community in concert with other species in the biofilm, and the modulation of 
virulence from being covert to overt in the W50 and PG343 biofilms, respectively 
precipitated by deletion of methionine gamma lyase suggests that this enzyme has an 
important role to play in P. gingivalis being a keystone species, particularly in its 
interaction with other species of the biofilm.   
5.3 mRNA expression profile of the stimulated cells 
Array analysis of the RNA extracts from cells after stimulation showed that at 4h, 
relative to the unstimulated controls, the cells stimulated with the PG343 biofilms 
expressed a higher fold change of mRNA corresponding to the pro-inflammatory 
cytokines such as TNF alpha, IL8, IL6, CCL20 and CXCL10 compared to the W50 
biofilms, whereas macrophage inhibitory factor (MIF), IL-18 and IL-13 mRNA showed 
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greater spread of expression compared to controls in both the W50 and PG343 biofilm 
stimulations (Figure 5-8). Whilst the 24h stimulations yielded the highest relative fold 
changes in mRNA expression versus the 4h stimulations, there were differences in the 
cytokine expression profiles between the mutant and wild type stimulations at 24h 
(Figure 5-9). Compared to the wild type biofilm, the cells stimulated by the mutant 
biofilm expressed a greater fold change of mRNAs for IL18 and IL13 whereas IL1 
alpha, TNF alpha, IL8, CXCL10 and MIF were expressed to a greater level in the 
former. 
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Figure 5-8 mRNA expression at 4h of the different cytokines shown as box plots of ΔCt 
values against the housekeeping gene GAPDH. Whiskers and outliers determined by 
the Tukey method; Midline is median. C=Control; Δ=PG343 biofilms; WT=W50 
biofilms. Asterisk before cytokine name in the x-axis denotes statistical significance at 
p<0.05 between Δ and WT.  
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The mRNA expression data indicated a higher-fold upregulation of IL-8, IL-6 and IL1 
alpha transcripts in the cells stimulated with PG343 biofilms both at 4h and 24h. The 
ability of P. gingivalis to degrade IL-8, IL-6 and IL-1β has been documented in the 
literature and this may explain the decreased levels of these cytokines in the cell 
supernatants but higher mRNA expression in the cells stimulated with the PG343 
biofilm compared to W50 biofilms (Fletcher et al. 1998). This suggests that the PG343 
biofilm encourages greater mRNA transcription owing to degradation of these cytokines 
by P. gingivalis and possibly other species in the biofilm disturbing the dynamic 
equilibrium that is more evident with the W50 biofilm, where a negative feedback loop 
likely prevents a ‘runaway’ effect of continuous transcription, translation and 
degradation as is observed with the PG343 biofilm stimulations.  
Although little or no TNF-alpha was detected in the cell culture supernatants of both 
PG343 and W50 biofilms, mRNA expression for this potent cytokine suggested a more 
acute response by the cells toward the PG343 biofilms at 4h with both biofilm types 
showing equal stimulation of this cytokine transcription at 24h. P. gingivalis cysteine 
proteases are reported to degrade TNF-alpha rapidly (<10 mins), and the chosen time 
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Figure 5-9 mRNA expression at 24h of the different cytokines shown as box plots of 
ΔCt values against the housekeeping gene GAPDH. Whiskers and outliers 
determined by the Tukey method; Midline is median. C=Control; Δ=PG343 
biofilms; WT=W50 biofilms. 
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points for supernatant harvest of 4h and 24h is likely to be too late to observe the effect 
of the mRNA transcription as intact TNF alpha in the cell culture supernatants (Calkins 
et al. 1998).  
Transcription of IL18 and IL13 mRNA were upregulated by the PG343 biofilms at 24h 
compared to non-stimulated controls. IL18 is thought to be a regulatory protein that 
promotes IFN-gamma production while IL13 is thought to have anti-inflammatory 
properties. It is notable that IFN-gamma levels in most of the samples measured were 
below detection limits at both 4h and 24h, but the regulatory IL18 transcription suggests 
that more of the IFN-gamma production is stimulated by the cells in response to the 
PG343 biofilms than the W50 biofilms. Indeed, IFN-gamma is known to promote 
production of ICAM1 and the concentration of ICAM1 detected in both the biofilm 
stimulation and controls were comparable, suggesting a possible block in IFN-gamma 
production by the biofilms, possibly by post-translational modulation as IFN-gamma 
suppression is reported in T. denticola and P. gingivalis (Lee et al. 2009; Pulendran et 
al. 2001).  
P. gingivalis LPS is reported to stimulate a strong IL13 response in a mouse model and 
though the cells used in the present study are not immune cells per se, stimulation of 
IL13 mRNA transcription is still observed at both 4h and 24h with a greater effect 
shown by the PG343 biofilms (Pulendran et al. 2001). However, in terms of the actual 
cytokines detected, an opposite effect was observed between the PG343 and W50 
biofilms at 4h. It is possible that the biofilm degrades IL13, although no studies of this 
exist. P. gingivalis is also thought to inhibit production of the chemokine IP-10 
(CXCL10) which is believed to be important in eliciting a Th1 response promoting 
clearance of bacteria (Hajishengallis & Lamont 2014). Certainly, at 24h the mRNA 
expression of CXCL10 by cells in response to PG343 would be considered to be down 
regulated compared to the W50 biofilms, reinforcing the pathogenicity of the PG343 
biofilms. Cytokine data also indicated a reduction in the concentration of intact 
CXCL10 in both the stimulations compared to the unstimulated controls consistent with 
the literature. 
The expression of macrophage migration inhibitory factor (MIF) and CCL20 in the 
biofilm stimulations were elevated compared to controls but similar to each other. MIF 
was not measured by the immunoassay and it is also reported to be cleaved by the lys-
gingipains; the mRNA expression in this study reveals a marginally acute stimulation at 
4h by the PG343 biofilms compared to the W50 biofilms (Klarström Engström et al. 
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2015). A similar pattern for CCL20 was also observed except the transcription of this 
chemokine was considerably elevated in relation to the unstimulated controls at both 4h 
and 24h. The CCL20 observations are consistent with data reported in the literature with 
regards to human primary gingival fibroblasts and P. gingivalis in planktonic phase 
(Dommisch et al. 2012). 
5.4 Summary  
The finding that methanethiol producing species are also periodontopathic and the 
association of methanethiol in the breath with periodontitis suggests that methanethiol 
or the enzyme responsible for production of methanethiol may have a role to play in 
inflammation and ecology. As such, an in vitro 10-species biofilm coculture model was 
employed to test this hypothesis. Methionine gamma lyase deficient P. gingivalis was 
constructed in the strain W50 and incorporated into the biofilm co-culture model. 
Analysis of the biofilms grown with the wild type or mutant P. gingivalis (introduced as 
the last in the sequence during construction of the biofilms) revealed considerable 
changes in the composition and overall biomass of the biofilms, suggesting a more 
virulent phenotype in the mutant biofilm. Cytokines measured in the cell culture 
supernatants after stimulation with both the biofilm types suggested that the mutant 
biofilms may have a more immunogenic phenotype as the cytokine levels and mRNA 
expression revealed a more acute pro-inflammatory effect compared to the wild type 
biofilms. However, the response elicited by the W50 biofilms could in fact be more 
insidious, by way of the slower accumulation of the cytokines and a much more 
controlled inflammatory response at the 4h time point. The presence of elevated levels 
of intact cytokines such as IL-8, IL-6 and IL-1β may help activate inflammatory 
pathways that may be more desirable for the microbial fitness in the oral cavity, 
possibly modelling the low grade inflammation that exists in the normal healthy 
gingiva. Possible mechanisms by which methionine gamma lyase in P. gingivalis and 
indeed other methanethiol producers might help bring about the changes observed in the 
biofilm composition and hence, the cytokine response are proposed. 
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6 CONCLUSIONS 
The increased incidence of oral malodour in periodontitis patients is an oft reported 
observation in the literature, with the suggestion that a component of oral malodour that 
involves volatile sulfur compounds namely hydrogen sulfide and methanethiol being 
particularly associated with clinical parameters of disease. Investigations have also 
further reported that methanethiol concentrations in the breath of individuals with 
periodontitis is markedly elevated compared to health, with the associated parameter 
namely the ratio of methanethiol to hydrogen sulfide also correlating with clinical 
indices of disease such as periodontal pocket depth, bleeding on probing and plaque 
coverage. It has also been established that when there are no systemic confounders, the 
oral microbiota is largely responsible for producing these breath odours, with the sulfur 
metabolism of the oral microbiome implicated in VSC production. Whilst the tongue 
biofilm is thought to be mainly responsible for malodorous VSC concentrations present 
in the mouth in healthy individuals, the oral niches around the gingiva were thought to 
be linked to malodour and the observed VSC profile in individuals with chronic plaque-
induced periodontitis. It is also well known that the changes occurring in the periodontal 
niches in terms of the disease process, is more proteolytic and therefore more favourable 
for VSC production. However, gaps exist in the current understanding of the 
relationship between VSCs in the breath and plaque-associated periodontal disease. For 
example, while VSCs in the breath are associated with clinical measurements of 
periodontal disease, no studies exist of the association between inflammatory 
mechanisms observed in periodontal disease progression and VSCs, with regards 
inflammatory markers in the fluids of the oral cavity. Given the closer association of 
breath VSCs with oral microbiota, and the fact that periodontal tissue destruction is 
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largely caused by dysregulated host immune mechanisms, inflammation may not 
necessarily correlate with VSCs in the breath. In addition, the understanding of the oral 
microbial diversity in health and disease has been accelerated since the advent of high 
throughput DNA/RNA sequencing technologies, and currently there are no 
investigations that have studied the microbial ecology of the tongue in context of the 
periodontal niches in health and disease in association with VSCs in the breath. 
Therefore, in the investigations described in this thesis, it was endeavoured to study the 
microbial and inflammatory aspects of periodontal disease in view of the possible role 
of VSCs as a marker of disease and as a marker of the activity of dysbiotic microbiota. 
Consistent with the literature, it was confirmed that individuals with periodontal disease 
have significantly higher methanethiol concentration in the breath compared to healthy 
individuals. The methanethiol to hydrogen sulfide ratio in the breath of individuals was 
also found to correlate with clinical measures of periodontal disease such as periodontal 
pocket depth, bleeding on probing and plaque coverage. Breath samples collected from 
individuals was not assessed organoleptically, however a formula based on the human 
recognition threshold for VSCs was constructed and the resulting scale was used to 
grade breath samples in terms of malodour intensity, finding that the intensity of 
malodour was significantly higher in the breath of periodontitis patients compared to 
health based on the measured VSC concentrations. Malodour self-perception was also 
assessed, confirming the belief that individuals with poor gum health are more likely to 
have a true perception that they have malodour. Attempts to measure VSCs in the 
gingival crevicular fluid using ex vivo gas chromatographic methodology highlighted 
the variation inherent in the different filter paper types used to sample GCF, leading to a 
reduced sensitivity in detecting VSCs. However, significantly higher concentrations of 
H2S were observed in the samples obtained from individuals classified into the 
gingivitis and chronic periodontitis compared to health. A novel VSC namely carbon 
disulfide was also observed to be highly prevalent in the GCF of chronic periodontitis 
patients compared to health. These data suggested that presence of VSCs in the gingival 
sulcus indicated a more proteolytic and active inflammatory state than absence. Indeed, 
inflammatory markers determined in GCF samples of the same individuals suggested 
that H2S in the GCF was more closely associated with a pro-inflammatory state 
subgingivally in chronic periodontitis patients. 
A qPCR methodology was used to detect key bacterial species in saliva, tongue and 
three periodontal niches namely subgingival plaque, supragingival plaque and 
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interdental plaque. These bacteria were associated with periodontitis but also reported to 
be efficient VSC producers. The role of the putative periodontopathogens namely P. 
gingivalis, T. forsythia and A. actinomycetemcomitans in periodontal disease and 
association with malodour were confirmed as these organisms increased in the 
periodontal niches in association with disease and breath methanethiol concentrations. 
A stronger association was observed between the abundance of these periodontopathic 
species and the H2S concentrations measured in the GCF of individuals. When the 
different plaque samples were incubated with cysteine or methionine substrate, the 
periodontal niches proved to be more dynamic in VSC production from health to 
disease, suggesting a greater latent potential in the periodontal microbiota to produce 
VSCs than the tongue. However, it has to be recognised that due to the surface area of 
the tongue, the larger bacterial biomass in the tongue would eclipse the contribution of 
the periodontal microbiota toward breath VSCs, and these data suggested that VSC 
production in the periodontal niches could be an important virulence mechanism, either 
as a direct cause of disease or as a consequence of proteolytic activity due to disease. 
An ecological survey of the tongue, subgingival and interdental niches was conducted 
using a Next Generation Sequencing approach to further characterise putative VSC 
producing species present in the different niches in different disease states. While 
malodour intensity was positively correlated with an increase in microbial diversity on 
the tongue in health, the subgingival niches showed stronger associations with overall 
microbial diversity and richness at the genus level, in the gingivitis and chronic 
periodontitis cohorts. These observations suggested that while the tongue may be an 
important niche for oral malodour, the periodontal niches are more closely associated 
with malodour or breath VSCs in disease. These data are consistent with interventional 
studies that showed periodontal treatment to be more effective at reducing malodour 
than tongue cleaning in chronic periodontitis than health. The tongue ecology was also 
observed to change in association with disease, with the putative VSC producing 
periodontopathogens increasing in prevalence and abundance in the tongue in 
association with disease. A survey of the available bacterial genomes revealed that very 
few species are capable of producing methanethiol from methionine, and the majority of 
species identified to produce this VSC are infact, known periodontopathogens. These 
observations have possibly discovered the cause of the increasing methanethiol to 
hydrogen sulfide ratio in association with clinical parameters of periodontal disease. It 
is suggested that an increase in methanethiol concentration in the breath in association 
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with disease is observed, directly due to the activity of these putative 
periodontopathogens as this enzyme is exclusive to prokaryotes and not found in 
humans. 
An in vitro 10-species biofilm co-culture model was used study the potential role for the 
methanethiol producing enzyme methionine gamma lyase of P. gingivalis, in eliciting 
an inflammatory response and influencing biofilm composition, especially in light of P. 
gingivalis being a keystone species. Comparison of the composition of the biofilms 
grown with the wild type P. gingivalis or methionine gamma lyase deficient mutant 
revealed marked differences, with a larger biomass and a more even community 
observed with the mutant biofilms compared to wild type. The inflammatory response 
elicited by the biofilms from oral keratinocytes suggested that the wild type biofilms 
were more insidious compared to the mutant biofilm which displayed a more overtly 
pathogenic phenotype, the latter possibly due to an increase in biomass. These data 
illustrated the possible keystone phenotype of P. gingivalis with the VSC producing 
gene, methionine gamma lyase likely to be an important virulence factor, in helping P. 
gingivalis exert community wide effects.   
A recent metatranscriptomic study appears to confirm that sulfur metabolism of the oral 
microbiota, and methionine gamma lyase of P. gingivalis in particular are important 
phenotypes that are upregulated in periodontal disease compared to health (Yost et al. 
2015). Further work could focus on uncovering some of the mechanisms of host-
pathogen interactions of other methanethiol producing species, and indeed hydrogen 
sulfide production, in biofilm formation and inflammation. 
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8 APPENDICES 
8.1 List of species with H2S and CH3SH producing homologs 
HOT Organism Name H2S CH3SH 
389 Abiotrophia_defectiva y none 
  Achromobacter_Genus_probe y none 
554 Acinetobacter_baumannii y none 
  Acinetobacter_Genus_probe y none 
408 Acinetobacter_sp_oral_taxon_408 
 
na 
183 Actinobaculum_sp_oral_taxon_183 
 
na 
850 Actinomyces_cardiffensis 
 
na 
888_449 Actinomyces_dentalis_&_sp_oral_taxon_449 y n 
  Actinomyces_Genus_probe_1 
 
none 
  Actinomyces_Genus_probe_2 y none 
617 Actinomyces_georgiae y n 
618 Actinomyces_gerencseriae y n 
866 Actinomyces_graevenitzii y n 
866 Actinomyces_graevenitzii y n 
645 Actinomyces_israelii y n 
849 Actinomyces_johnsonii y n 
852 Actinomyces_massiliensis y n 
671 Actinomyces_meyeri n n 
176 Actinomyces_naeslundii y n 
176 Actinomyces_naeslundii y n 
701 Actinomyces_odontolyticus y n 
701 Actinomyces_odontolyticus y n 
701 Actinomyces_odontolyticus y n 
708 Actinomyces_oricola na na 
893_175 Actinomyces_oris_&_sp_oral_taxon_175 y n 
746 Actinomyces_radicidentis na na 
746 Actinomyces_radicidentis na na 
169 Actinomyces_sp_oral_taxon_169 na na 
   204 
170 Actinomyces_sp_oral_taxon_170 y n 
171 Actinomyces_sp_oral_taxon_171 y n 
172 Actinomyces_sp_oral_taxon_172 y n 
175 Actinomyces_sp_oral_taxon_175 y n 
178 Actinomyces_sp_oral_taxon_178 y n 
180 Actinomyces_sp_oral_taxon_180 y n 
181 Actinomyces_sp_oral_taxon_181 nm n 
414 Actinomyces_sp_oral_taxon_414 
 
na 
446 Actinomyces_sp_oral_taxon_446 na na 
448 Actinomyces_sp_oral_taxon_448 y n 
525 Actinomyces_sp_oral_taxon_525 na na 
525 Actinomyces_sp_oral_taxon_525 na na 
848 Actinomyces_sp_oral_taxon_848 y n 
877 Actinomyces_sp_oral_taxon_877 y n 
896 Actinomyces_sp_oral_taxon_896 na na 
897 Actinomyces_sp_oral_taxon_897 na na 
179 Actinomyces_timonensis y n 
179 Actinomyces_timonensis y n 
688 Actinomyces_viscosus y n 
531 Aggregatibacter_actinomycetemcomitans y n 
545_458 Aggregatibacter_aphrophilus_&_sp_oral_taxon_458 y n 
720 Aggregatibacter_paraphrophilus na na 
720 Aggregatibacter_paraphrophilus na na 
762_512 Aggregatibacter_segnis_&_sp_oral_taxon_512 y n 
458 Aggregatibacter_sp_oral_taxon_458 y n 
512 Aggregatibacter_sp_oral_taxon_512 na na 
513 Aggregatibacter_sp_oral_taxon_513 na na 
485 Agrobacterium_tumefaciens n n 
831 Alloiococcus_otitis nm n 
  Alloprevotella_Genus_probe a none 
302 Alloprevotella_rava y n 
308 Alloprevotella_sp_oral_taxon_308 na na 
473 Alloprevotella_sp_oral_taxon_473 y n 
474 Alloprevotella_sp_oral_taxon_474 na na 
912 Alloprevotella_sp_oral_taxon_912 na na 
913 Alloprevotella_sp_oral_taxon_913 na na 
914 Alloprevotella_sp_oral_taxon_914 na na 
914 Alloprevotella_sp_oral_taxon_914 na na 
466 Alloprevotella_tannerae n n 
198 Alloscardovia_omnicolens y n 
  Anaerococcus_Genus_probe y 
y; A. hydrogenalis; A. 
prevotii; A. vaginalis 
859 Anaerococcus_lactolyticus n n 
738_788 Anaerococcus_prevotii_&_tetradius n n 
121 Anaeroglobus_geminatus n n 
  Aquamicrobium_Genus_probe y none 
   205 
660 Aquamicrobium_lusatiense na na 
  Arcanobacterium_Genus_probe a none 
811 Arcanobacterium_haemolyticum nm n 
190 Arsenicicoccus_sp_oral_taxon_190 y n 
  Atopobium_Genus_probe y none 
674 Atopobium_minutum nm n 
723 Atopobium_parvulum nm n 
750 Atopobium_rimae nm n 
750 Atopobium_rimae nm n 
199 Atopobium_sp_oral_taxon_199 nm n 
416 Atopobium_sp_oral_taxon_416 na na 
810 Atopobium_sp_oral_taxon_810 nm n 
814 Atopobium_vaginae nm n 
45 Bacillus_clausii y y 
272 Bacteroidaceae[G-1]_sp_oral_taxon_272 nm n 
274 Bacteroidales[G-2]_sp_oral_taxon_274 nm n 
911 Bacteroidales[G-3]_sp_oral_taxon_911 na na 
  Bacteroides_Genus_probe y none 
630 Bacteroides_heparinolyticus na na 
787 Bacteroides_tectus na na 
465 Bacteroides_zoogleoformans na na 
  Bacteroidetes[G-3]_Genus_probe y none 
280 Bacteroidetes[G-3]_sp_oral_taxon_280 
 
na 
281 Bacteroidetes[G-3]_sp_oral_taxon_281 
 
na 
365 Bacteroidetes[G-3]_sp_oral_taxon_365 
 
na 
436 Bacteroidetes[G-3]_sp_oral_taxon_436 
 
na 
503 Bacteroidetes[G-3]_sp_oral_taxon_503 
 
na 
899 Bacteroidetes[G-3]_sp_oral_taxon_899 
 
na 
509 Bacteroidetes[G-4]_sp_oral_taxon_509 
 
na 
  Bacteroidetes[G-5]_Genus_probe y none 
505 Bacteroidetes[G-5]_sp_oral_taxon_505 
 
na 
507 Bacteroidetes[G-5]_sp_oral_taxon_507 
 
na 
511 Bacteroidetes[G-5]_sp_oral_taxon_511 
 
na 
511 Bacteroidetes[G-5]_sp_oral_taxon_511 
 
na 
516 Bacteroidetes[G-6]_sp_oral_taxon_516 
 
na 
  Bartonella_Genus_probe y none 
39 Bdellovibrio_sp_oral_taxon_039 
 
Closest 16S B. 
bacteriovorus does 
not have mgl; B. 
exovorus has MGL 
319 Bergeyella_sp_oral_taxon_319 
 
na 
322 Bergeyella_sp_oral_taxon_322 
 
na 
900 Bergeyella_sp_oral_taxon_900 
 
na 
907 Bergeyella_sp_oral_taxon_907 
 
na 
407 Bifidobacteriaceae[G-2]_sp_oral_taxon_407 
 
na 
895 Bifidobacterium_animalis_subsp_animalis y none 
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895 Bifidobacterium_animalis_subsp_lactis y n 
889 Bifidobacterium_breve y n 
588 Bifidobacterium_dentium y n 
  Bifidobacterium_Genus_probe_1 y none 
  Bifidobacterium_Genus_probe_2 y none 
862 Bifidobacterium_longum y n 
891 Bifidobacterium_scardovii na n 
  Bordetella_Genus_probe y none 
590 Brevundimonas_diminuta y n 
  Brevundimonas_Genus_probe y none 
603 Bulleidia_extructa nm n 
  Burkholderia_Genus_probe y 
none; present in 
undetected strains 
94 Butyrivibrio_sp_oral_taxon_094 
 
na 
575 Campylobacter_concisus y y? 
575 Campylobacter_concisus y y? 
580 Campylobacter_curvus y n 
  Campylobacter_Genus_probe y none 
623 Campylobacter_gracilis y n 
748_763 Campylobacter_rectus_&_showae n n 
44 Campylobacter_sp_oral_taxon_044 
 
na 
776 Campylobacter_sputorum y none 
842 Campylobacter_ureolyticus nm n 
  Capnocytophaga_Genus_probe_1 a none 
  Capnocytophaga_Genus_probe_2 a none 
337 Capnocytophaga_gingivalis y n 
325 Capnocytophaga_granulosa y n 
627 Capnocytophaga_haemolytica 
 
na 
*_326 Capnocytophaga_infantium_&_sp_oral_taxon_326 n none 
329 Capnocytophaga_leadbetteri 
 
na 
700 Capnocytophaga_ochracea y none 
323 Capnocytophaga_sp_oral_taxon_323 
 
na 
324 Capnocytophaga_sp_oral_taxon_324 y n 
332 Capnocytophaga_sp_oral_taxon_332 y n 
334 Capnocytophaga_sp_oral_taxon_334 
 
na 
335 Capnocytophaga_sp_oral_taxon_335 y n 
336 Capnocytophaga_sp_oral_taxon_336 y n 
338 Capnocytophaga_sp_oral_taxon_338 y n 
380 Capnocytophaga_sp_oral_taxon_380 n n 
412 Capnocytophaga_sp_oral_taxon_412 y n 
863 Capnocytophaga_sp_oral_taxon_863 y n 
864 Capnocytophaga_sp_oral_taxon_864 
 
na 
878 Capnocytophaga_sp_oral_taxon_878 
 
na 
901 Capnocytophaga_sp_oral_taxon_901 
 
na 
902 Capnocytophaga_sp_oral_taxon_902 
 
na 
903 Capnocytophaga_sp_oral_taxon_903 
 
na 
   207 
775 Capnocytophaga_sputigena y n 
  Cardiobacterium_Genus_probe a none 
633 Cardiobacterium_hominis nm n 
540 Cardiobacterium_valvarum nm n 
  Catonella_Genus_probe a none 
165_164 Catonella_morbi_&_sp_oral_taxon_164 y none 
451 Catonella_sp_oral_taxon_451 
 
na 
2 Caulobacter_sp_oral_taxon_002 
 
na; C. crescentus; C. 
vibrioides; C. segnis 
726 Centipeda_periodontii y y 
  Chlamydophila_Genus_probe a none 
733 Chlamydophila_pneumoniae na na 
439 Chloroflexi[G-1]_sp_oral_taxon_439 nm n 
439 Chloroflexi[G-1]_sp_oral_taxon_439 nm n 
93 Clostridiales[F-1][G-1]_sp_oral_taxon_093 
 
na 
402 Clostridiales[F-1][G-2]_sp_oral_taxon_402 
 
na 
75 Clostridiales[F-2][G-1]_sp_oral_taxon_075 
 
na 
75 Clostridiales[F-2][G-1]_sp_oral_taxon_075 
 
na 
85 Clostridiales[F-2][G-2]_sp_oral_taxon_085 
 
na 
366 Clostridiales[F-2][G-3]_sp_oral_taxon_366 
 
na 
381 Clostridiales[F-2][G-3]_sp_oral_taxon_381 
 
na 
876 Clostridiales[F-3][G-1]_sp_oral_taxon_876 y n 
591 Corynebacterium_diphtheriae y n 
591 Corynebacterium_diphtheriae y n 
591 Corynebacterium_diphtheriae y n 
595 Corynebacterium_durum y n 
  Corynebacterium_Genus_probe a none 
666 Corynebacterium_matruchotii y n 
835 Corynebacterium_mucifaciens 
 
na 
184 Corynebacterium_sp_oral_taxon_184 
 
na 
853 Corynebacterium_urealyticum n n 
579 Cryptobacterium_curtum nm na 
23 Delftia_acidovorans n n 
  Desulfobulbus_Genus_probe a none 
41 Desulfobulbus_sp_oral_taxon_041 nm nm 
703 Desulfomicrobium_orale 
 
na 
605 Desulfovibrio_fairfieldensis 
 
na 
40 Desulfovibrio_sp_oral_taxon_040 
 
na 
  Dialister_Genus_probe_1 a none 
  Dialister_Genus_probe_2 a none 
118 Dialister_invisus nm n 
843 Dialister_micraerophilus nm n 
736 Dialister_pneumosintes 
 
na 
119 Dialister_sp_oral_taxon_119 
 
na 
502 Dialister_sp_oral_taxon_502 
 
na 
502 Dialister_sp_oral_taxon_502 
 
na 
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502 Dialister_sp_oral_taxon_502 
 
na 
502 Dialister_sp_oral_taxon_502 
 
na 
  Dietzia_Genus_probe a none 
368 Dietzia_sp_oral_taxon_368 
 
na 
813 Dolosigranulum_pigrum y n 
  Eggerthella_Genus_probe a none 
654 Eggerthella_lenta y n 
569 Eggerthia_catenaformis y none 
577 Eikenella_corrodens y n 
11 Eikenella_sp_oral_taxon_011 
 
na 
880_* Enterococcus_durans_&_faecium y n 
604 Enterococcus_faecalis y n 
  Enterococcus_Genus_probe a y; E. malodoratus 
803_802 Enterococcus_italicus_&_saccharolyticus y n 
904 Erysipelothrichaceae[G-1]_sp_oral_taxon_904 
 
na 
905 Erysipelothrichaceae[G-1]_sp_oral_taxon_905 
 
na 
  Erysipelothrichaceae_Genus_probe a none 
  Erysipelothrix_Genus_probe aa none 
484 Erysipelothrix_tonsillarum y n 
747 Erythromicrobium_ramosum 
 
na 
  Escherichia_Genus_probe a y; E. coli; E. fergusonii 
105 Eubacterium[11][G-1]_infirmum y n 
467 Eubacterium[11][G-1]_sulci y 
none; E. 
acidaminophilum 
557 Eubacterium[11][G-3]_brachy y none 
759 Eubacterium[11][G-5]_saphenum y n 
673 Eubacterium[11][G-6]_minutum y none 
694 Eubacterium[11][G-6]_nodatum y none 
694 Eubacterium[11][G-6]_nodatum y none 
377 Eubacterium[11][G-7]_yurii y n 
377 Eubacterium[11][G-7]_yurii y n 
  Eubacterium_Genus_probe_1 a 
none; present in E. 
acidaminophilum 
  Eubacterium_Genus_probe_2 a none 
655 Eubacterium_limosum y n 
655 Eubacterium_limosum y n 
539 Filifactor_alocis nm 
none; Putative MGL 
with YGSC code? 
  Filifactor_Genus_probe a y; F. alocis 
662 Finegoldia_magna nm n 
318 Flavobacteriales[G-1]_sp_oral_taxon_318 
 
na 
321 Flavobacteriales[G-1]_sp_oral_taxon_321 
 
na 
320 Flavobacteriales[G-2]_sp_oral_taxon_320 
 
na 
363 Fretibacterium_fastidiosum 
 
na 
  Fretibacterium_Genus_probe 
 
none 
358_453 Fretibacterium_sp_oral_taxon_358_&_sp_oral_taxon_453 
 
na 
359_452 Fretibacterium_sp_oral_taxon_359_&_sp_oral_taxon_452 
 
na 
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360 Fretibacterium_sp_oral_taxon_360 
 
na 
361 Fretibacterium_sp_oral_taxon_361 
 
na 
362 Fretibacterium_sp_oral_taxon_362 
 
na 
  Fusobacterium_Genus_probe a y; various 
860 Fusobacterium_gonidiaformans n y 
860 Fusobacterium_gonidiaformans n y 
689_* Fusobacterium_naviforme_&_nucleatum_subsp_fusiforme 
 
y; fusiforme 
690 Fusobacterium_necrophorum y y 
420 Fusobacterium_nucleatum_subsp_animalis y y 
420 Fusobacterium_nucleatum_subsp_animalis y y 
698 Fusobacterium_nucleatum_subsp_nucleatum y y 
202 Fusobacterium_nucleatum_subsp_polymorphum y y 
200 Fusobacterium_nucleatum_subsp_vincentii n y 
201 Fusobacterium_periodonticum y y 
205 Fusobacterium_sp_oral_taxon_205 
 
na 
829 Gardnerella_vaginalis y n 
555 Gemella_bergeri y n 
  Gemella_Genus_probe a none 
626 Gemella_haemolysans y n 
46 Gemella_morbillorum y n 
46 Gemella_morbillorum y n 
757 Gemella_sanguinis y n 
871 GN02[G-1]_sp_oral_taxon_871 
 
na 
872 GN02[G-1]_sp_oral_taxon_872 
 
na 
873 GN02[G-2]_sp_oral_taxon_873 
 
na 
534 Granulicatella_adiacens_&_paradiacens y n 
596 Granulicatella_elegans y n 
535_641 Haemophilus_aegyptius_&_influenzae y n 
821 Haemophilus_ducreyi n n 
  Haemophilus_Genus_probe a none 
851_036 Haemophilus_haemolyticus_&_sp_oral_taxon_036 y n 
* Haemophilus_parahaemolyticus 
 
na 
718 Haemophilus_parainfluenzae y n 
35 Haemophilus_sp_oral_taxon_035 
 
na 
  Helicobacter_Genus_probe a none 
812 Helicobacter_pylori y n 
  Johnsonella_Genus_probe a none 
635 Johnsonella_ignava n n 
166 Johnsonella_sp_oral_taxon_166 
 
na 
777 Jonquetella_anthropi nm y 
582_012 Kingella_denitrificans_&_sp_oral_taxon_012 y n 
582_012 Kingella_denitrificans_&_sp_oral_taxon_012 y n 
646 Kingella_kingae y n 
706 Kingella_oralis y n 
459 Kingella_sp_oral_taxon_459 
 
na 
  Kytococcus_Genus_probe a none 
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  Lachnoanaerobaculum_Genus_probe a none 
82 Lachnoanaerobaculum_orale 
 
na 
494 Lachnoanaerobaculum_saburreum y none 
83 Lachnoanaerobaculum_sp_oral_taxon_083 
 
na 
89 Lachnoanaerobaculum_sp_oral_taxon_089 
 
na 
496 Lachnoanaerobaculum_sp_oral_taxon_496 
 
na 
107 Lachnoanaerobaculum_umeaense 
 
na 
88 Lachnospiraceae[G-2]_sp_oral_taxon_088 
 
na 
88 Lachnospiraceae[G-2]_sp_oral_taxon_088 
 
na 
96 Lachnospiraceae[G-2]_sp_oral_taxon_096 
 
na 
100 Lachnospiraceae[G-3]_sp_oral_taxon_100 
 
na 
100 Lachnospiraceae[G-3]_sp_oral_taxon_100 
 
na 
100 Lachnospiraceae[G-3]_sp_oral_taxon_100 
 
na 
80 Lachnospiraceae[G-5]_sp_oral_taxon_080 
 
na 
455 Lachnospiraceae[G-5]_sp_oral_taxon_455 
 
na 
90 Lachnospiraceae[G-6]_sp_oral_taxon_090 
 
na 
86 Lachnospiraceae[G-7]_sp_oral_taxon_086 
 
na 
163 Lachnospiraceae[G-7]_sp_oral_taxon_163 
 
na 
500 Lachnospiraceae[G-8]_sp_oral_taxon_500 
 
na 
558 Lactobacillus_brevis y n 
816 Lactobacillus_coleohominis n n 
608 Lactobacillus_fermentum y n 
615_819 Lactobacillus_gasseri_&_johnsonii n n 
  Lactobacillus_Genus_probe_1 a none 
  Lactobacillus_Genus_probe_2 a none 
  Lactobacillus_Genus_probe_3 a none 
  Lactobacillus_Genus_probe_4 a none 
838 Lactobacillus_iners n n 
839 Lactobacillus_jensenii y n 
424 Lactobacillus_kisonensis y n 
418 Lactobacillus_parafarraginis y n 
818 Lactobacillus_reuteri y n 
756 Lactobacillus_salivarius y n 
52 Lactobacillus_sp_oral_taxon_052 
 
na; L. composti has 
mgl 
51 Lactobacillus_vaginalis y n 
804 Lactococcus_lactis y n 
22 Lautropia_mirabilis n n 
24 Leptothrix_sp_oral_taxon_024 
 
na 
25 Leptothrix_sp_oral_taxon_025 
 
na 
563_225 Leptotrichia_buccalis_&_sp_oral_taxon_225 y n 
  Leptotrichia_Genus_probe_1 a none 
  Leptotrichia_Genus_probe_2 a none 
845 Leptotrichia_goodfellowii y n 
224_909 Leptotrichia_hofstadii_&_sp_oral_taxon_909 y n 
213 Leptotrichia_hongkongensis 
 
na 
   211 
214 Leptotrichia_shahii y n 
212 Leptotrichia_sp_oral_taxon_212 
 
na 
215 Leptotrichia_sp_oral_taxon_215 y n 
215 Leptotrichia_sp_oral_taxon_215 y n 
217 Leptotrichia_sp_oral_taxon_217 
 
na 
218 Leptotrichia_sp_oral_taxon_218 
 
na 
219 Leptotrichia_sp_oral_taxon_219 
 
na 
221 Leptotrichia_sp_oral_taxon_221 
 
na 
223 Leptotrichia_sp_oral_taxon_223 
 
na 
223 Leptotrichia_sp_oral_taxon_223 
 
na 
392 Leptotrichia_sp_oral_taxon_392 
 
na 
417 Leptotrichia_sp_oral_taxon_417 
 
na 
462 Leptotrichia_sp_oral_taxon_462 
 
na 
463 Leptotrichia_sp_oral_taxon_463 
 
na 
498 Leptotrichia_sp_oral_taxon_498 
 
na 
847 Leptotrichia_sp_oral_taxon_847 
 
na 
879 Leptotrichia_sp_oral_taxon_879 y none 
222 Leptotrichia_wadei y n 
210 Leptotrichiaceae[G-1]_sp_oral_taxon_210 
 
na 
220 Leptotrichiaceae[G-1]_sp_oral_taxon_220 
 
na 
  Leptotrichiaceae_Genus_probe a none 
  Listeria_Genus_probe a none 
614 Lysinibacillus_fusiformis y n 
  Lysinibacillus_Genus_probe a none 
122 Megasphaera_micronuciformis nm y 
123 Megasphaera_sp_oral_taxon_123 
 
na; M. 
micronuciformis and 
M. massiliensis have 
mgl 
123 Megasphaera_sp_oral_taxon_123 
 
na 
841 Megasphaera_sp_oral_taxon_841 
 
na 
185 Microbacterium_sp_oral_taxon_185 
 
na 
  Mitsuokella_Genus_probe a none 
684 Mitsuokella_multacida y n 
131 Mitsuokella_sp_oral_taxon_131 y n 
521 Mitsuokella_sp_oral_taxon_521 
 
na 
521 Mitsuokella_sp_oral_taxon_521 
 
na 
521 Mitsuokella_sp_oral_taxon_521 
 
na 
  Mobiluncus_Genus_probe a none 
830 Mobiluncus_mulieris n n 
593 Mogibacterium_diversum 
 
na 
  Mogibacterium_Genus_probe a none 
742 Mogibacterium_pumilum 
 
na 
42 Mogibacterium_timidum nm n 
504 Mollicutes[G-1]_sp_oral_taxon_504 
 
na 
906 Mollicutes[G-2]_sp_oral_taxon_906 
 
na 
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833_* Moraxella_catarrhalis_&_nonliquefaciens n n 
  Moraxella_Genus_probe a none 
  Mycobacterium_Genus_probe a none 
823 Mycobacterium_leprae y n 
561 Mycoplasma_buccale 
 
na; M. putrefaciens 
has MGL 
606 Mycoplasma_faucium 
 
na 
607 Mycoplasma_fermentans nm n 
616 Mycoplasma_genitalium nm n 
  Mycoplasma_Genus_probe a 
none; M. putrefaciens 
has MGL 
632 Mycoplasma_hominis nm n 
656 Mycoplasma_lipophilum 
 
na 
704 Mycoplasma_orale nm n 
732 Mycoplasma_pneumoniae nm n 
754 Mycoplasma_salivarium nm n 
13 Neisseria_bacilliformis y n 
598 Neisseria_elongata y n 
610 Neisseria_flavescens y n 
610 Neisseria_flavescens y n 
  Neisseria_Genus_probe a none 
621 Neisseria_gonorrhoeae y n 
649 Neisseria_lactamica y n 
669 Neisseria_meningitidis y n 
014_016 Neisseria_oralis_&_sp_oral_taxon_016 
 
na 
729 Neisseria_pharyngis 
 
na 
729 Neisseria_pharyngis 
 
na 
764 Neisseria_sicca y n 
18 Neisseria_sp_oral_taxon_018 
 
na 
20 Neisseria_sp_oral_taxon_020 y n 
499 Neisseria_sp_oral_taxon_499 
 
na 
523 Neisseria_sp_oral_taxon_523 
 
na 
476 Neisseria_subflava y n 
92 Neisseria_weaveri y n 
  Olsenella_Genus_probe a none 
806 Olsenella_profusa y n 
807 Olsenella_sp_oral_taxon_807 
 
na 
809 Olsenella_sp_oral_taxon_809 y n 
38 Olsenella_uli y n 
457 Oribacterium_sinus y n 
078_372 Oribacterium_sp_oral_taxon_078_&_sp_oral_taxon_372 y none 
102 Oribacterium_sp_oral_taxon_102 
 
na 
108 Oribacterium_sp_oral_taxon_108 y n 
108 Oribacterium_sp_oral_taxon_108 y n 
108 Oribacterium_sp_oral_taxon_108 y n 
894 Ottowia_sp_oral_taxon_894 
 
na 
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894 Ottowia_sp_oral_taxon_894 
 
na 
  Paenibacillus_Genus_probe a none 
786 Paenibacillus_sp_oral_taxon_786 y n 
586 Parascardovia_denticolens n n 
  Parvimonas_Genus_probe a none 
111 Parvimonas_micra n n 
110 Parvimonas_sp_oral_taxon_110 n n 
167 Peptococcus_sp_oral_taxon_167 
 
na 
167 Peptococcus_sp_oral_taxon_167 
 
na 
168 Peptococcus_sp_oral_taxon_168 
 
na 
548 Peptoniphilus_asaccharolyticus 
 
na; Other 
Peptoniphilus species 
have mgl 
  Peptoniphilus_Genus_probe a y 
840 Peptoniphilus_indolicus nm y 
648 Peptoniphilus_lacrimalis y n 
375 Peptoniphilus_sp_oral_taxon_375 y na 
386 Peptoniphilus_sp_oral_taxon_386 nm y 
836 Peptoniphilus_sp_oral_taxon_836 y n 
383 Peptostreptococcaceae[11][G-1]_sp_oral_taxon_383 
 
na 
91 Peptostreptococcaceae[11][G-2]_sp_oral_taxon_091 
 
na; miscellaneous 
have mgl 
91 Peptostreptococcaceae[11][G-2]_sp_oral_taxon_091 
 
na 
91 Peptostreptococcaceae[11][G-2]_sp_oral_taxon_091 
 
na 
382 Peptostreptococcaceae[11][G-3]_sp_oral_taxon_382 
 
na 
495 Peptostreptococcaceae[11][G-3]_sp_oral_taxon_495 
 
na 
103 Peptostreptococcaceae[11][G-4]_sp_oral_taxon_103 
 
na 
369 Peptostreptococcaceae[11][G-4]_sp_oral_taxon_369 
 
na 
493 Peptostreptococcaceae[11][G-5]_sp_oral_taxon_493 
 
na 
81 Peptostreptococcaceae[11][G-7]_sp_oral_taxon_081 
 
na 
106 Peptostreptococcaceae[11][G-7]_sp_oral_taxon_106 
 
na 
113 Peptostreptococcaceae[13][G-1]_sp_oral_taxon_113 n n 
790 Peptostreptococcaceae[13][G-2]_sp_oral_taxon_790 
 
na 
542 Peptostreptococcus_anaerobius n n 
  Peptostreptococcus_Genus_probe a none 
112 Peptostreptococcus_stomatis y n 
547 Porphyromonas_asaccharolytica n y 
283 Porphyromonas_catoniae n n 
283 Porphyromonas_catoniae n n 
283 Porphyromonas_catoniae n n 
283 Porphyromonas_catoniae n n 
283 Porphyromonas_catoniae n n 
283 Porphyromonas_catoniae n n 
273 Porphyromonas_endodontalis n y 
  Porphyromonas_Genus_probe_1 a y 
  Porphyromonas_Genus_probe_2 a y 
  Porphyromonas_Genus_probe_3 a y 
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619 Porphyromonas_gingivalis n y 
275 Porphyromonas_sp_oral_taxon_275 
 
na; absent in 
278/279 
275 Porphyromonas_sp_oral_taxon_275 
 
na 
275 Porphyromonas_sp_oral_taxon_275 
 
na 
277 Porphyromonas_sp_oral_taxon_277 
 
na 
277 Porphyromonas_sp_oral_taxon_277 
 
na 
278 Porphyromonas_sp_oral_taxon_278 y n 
279 Porphyromonas_sp_oral_taxon_279 y n 
279 Porphyromonas_sp_oral_taxon_279 y n 
279 Porphyromonas_sp_oral_taxon_279 y n 
284 Porphyromonas_sp_oral_taxon_284 
 
na 
285 Porphyromonas_sp_oral_taxon_285 
 
na 
395 Porphyromonas_sp_oral_taxon_395 
 
na 
785 Porphyromonas_uenonis nm y 
553 Prevotella_baroniae n n 
556 Prevotella_bivia y n 
560 Prevotella_buccae y n 
562 Prevotella_buccalis y n 
583 Prevotella_dentalis y none 
291 Prevotella_denticola y n 
600 Prevotella_enoeca y none 
600 Prevotella_enoeca y none 
782 Prevotella_fusca y none 
782 Prevotella_fusca y none 
782 Prevotella_fusca y none 
  Prevotella_Genus_probe a none 
298 Prevotella_histicola y none 
643 Prevotella_intermedia y none 
643 Prevotella_intermedia y none 
643 Prevotella_intermedia y none 
658 Prevotella_loescheii y none 
658 Prevotella_loescheii y none 
658 Prevotella_loescheii y none 
289 Prevotella_maculosa y none 
665 Prevotella_marshii 
 
na 
665 Prevotella_marshii 
 
na 
469 Prevotella_melaninogenica y n 
378 Prevotella_micans 
 
na 
378 Prevotella_micans 
 
na 
685 Prevotella_multiformis y none 
794 Prevotella_multisaccharivorax y none 
*_299 Prevotella_nanceiensis_&_sp_oral_taxon_299 
 
na 
693 Prevotella_nigrescens y n 
705 Prevotella_oralis y n 
311 Prevotella_oris y none 
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288 Prevotella_oulorum y none 
714 Prevotella_pallens y none 
714 Prevotella_pallens y none 
303 Prevotella_pleuritidis y none 
781 Prevotella_saccharolytica y none 
781 Prevotella_saccharolytica y none 
781 Prevotella_saccharolytica y none 
307 Prevotella_salivae y n 
885 Prevotella_scopos y none 
795 Prevotella_shahii y none 
292 Prevotella_sp_oral_taxon_292 
 
na 
292 Prevotella_sp_oral_taxon_292 
 
na 
293 Prevotella_sp_oral_taxon_293 
 
na 
296 Prevotella_sp_oral_taxon_296 
 
na 
300 Prevotella_sp_oral_taxon_300 
 
na 
300 Prevotella_sp_oral_taxon_300 
 
na 
301 Prevotella_sp_oral_taxon_301 
 
na 
304 Prevotella_sp_oral_taxon_304 
 
na 
305 Prevotella_sp_oral_taxon_305 
 
na 
306 Prevotella_sp_oral_taxon_306 
 
na 
309 Prevotella_sp_oral_taxon_309 
 
na 
310 Prevotella_sp_oral_taxon_310 
 
na 
315 Prevotella_sp_oral_taxon_315 
 
na 
317 Prevotella_sp_oral_taxon_317 y none 
317 Prevotella_sp_oral_taxon_317 y none 
317 Prevotella_sp_oral_taxon_317 y none 
376 Prevotella_sp_oral_taxon_376 
 
na 
396 Prevotella_sp_oral_taxon_396 
 
na 
443 Prevotella_sp_oral_taxon_443 
 
na 
472 Prevotella_sp_oral_taxon_472 y none 
475 Prevotella_sp_oral_taxon_475 
 
na 
515 Prevotella_sp_oral_taxon_515 
 
na 
526 Prevotella_sp_oral_taxon_526 
 
na 
820 Prevotella_sp_oral_taxon_820 
 
na 
572 Prevotella_veroralis y none 
191 Propionibacterium_acidifaciens y n 
530 Propionibacterium_acnes nm n 
552 Propionibacterium_avidum y none 
552 Propionibacterium_avidum y none 
  Propionibacterium_Genus_probe a y 
739 Propionibacterium_propionicum y none 
192 Propionibacterium_sp_oral_taxon_192 y none 
193 Propionibacterium_sp_oral_taxon_193 
 
na 
194 Propionibacterium_sp_oral_taxon_194 
 
na 
915 Propionibacterium_sp_oral_taxon_915 
 
na 
  Proteus_Genus_probe a y 
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676 Proteus_mirabilis y y 
536 Pseudomonas_aeruginosa y n 
612 Pseudomonas_fluorescens y y 
  Pseudomonas_Genus_probe a y 
834 Pseudomonas_otitidis y n 
32 Pseudomonas_sp_oral_taxon_032 
 
na 
538 Pseudoramibacter_alactolyticus y n 
357 Pyramidobacter_piscolens y none 
28 Rhodocyclus_sp_oral_taxon_028 
 
na 
188 Rothia_aeria nm n 
587 Rothia_dentocariosa n n 
  Rothia_Genus_probe a none 
681 Rothia_mucilaginosa y n 
  Sanguibacter_Genus_probe a none 
  Scardovia_Genus_probe a none 
642 Scardovia_inopinata n n 
195 Scardovia_wiggsiae n n 
  Selenomonas_&_Centipeda_Genus_probe a none 
124 Selenomonas_artemidis y n 
124 Selenomonas_artemidis y n 
139 Selenomonas_dianae na na 
139 Selenomonas_dianae na na 
125 Selenomonas_flueggei y n 
130 Selenomonas_noxia y n 
130 Selenomonas_noxia y n 
130_140 Selenomonas_noxia_&_sp_oral_taxon_140 
 
na 
133 Selenomonas_sp_oral_taxon_133 y n 
133 Selenomonas_sp_oral_taxon_133 y n 
134 Selenomonas_sp_oral_taxon_134 
 
na 
134 Selenomonas_sp_oral_taxon_134 
 
na 
134 Selenomonas_sp_oral_taxon_134 
 
na 
136 Selenomonas_sp_oral_taxon_136 
 
na 
136 Selenomonas_sp_oral_taxon_136 
 
na 
137 Selenomonas_sp_oral_taxon_137 y n 
137 Selenomonas_sp_oral_taxon_137 y n 
137 Selenomonas_sp_oral_taxon_137 y n 
138 Selenomonas_sp_oral_taxon_138 y n 
143 Selenomonas_sp_oral_taxon_143 
 
na 
146 Selenomonas_sp_oral_taxon_146 
 
na 
149 Selenomonas_sp_oral_taxon_149 y n 
388 Selenomonas_sp_oral_taxon_388 
 
na 
442 Selenomonas_sp_oral_taxon_442 
 
na 
478 Selenomonas_sp_oral_taxon_478 y none 
478 Selenomonas_sp_oral_taxon_478 y none 
501 Selenomonas_sp_oral_taxon_501 
 
na 
151 Selenomonas_sputigena y n 
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151 Selenomonas_sputigena y n 
151 Selenomonas_sputigena y n 
151 Selenomonas_sputigena y n 
151 Selenomonas_sputigena y n 
151_143 Selenomonas_sputigena_&_sp_oral_taxon_143 
 
na 
95 Shuttleworthia_satelles y n 
683 Simonsiella_muelleri y n 
602 Slackia_exigua y n 
  Slackia_Genus_probe a 
none; S. 
heliotrinireducens 
has MGL 
844 Sneathia_amnionii 
 
na 
837 Sneathia_sanguinegens 
 
na 
678 Solobacterium_moorei y n 
  Sphingomonas_Genus_probe a 
none; S. 
parapaucimobilis has 
MGL 
345 SR1[G-1]_sp_oral_taxon_345 
 
na 
874 SR1[G-1]_sp_oral_taxon_874 
 
na 
875 SR1[G-1]_sp_oral_taxon_875 
 
na 
  SR1_Genus_probe a none 
550_* Staphylococcus_aureus_&_gallinarum y n 
  Staphylococcus_Genus_probe a none 
*_076 Staphylococcus_pasteuri_&_warneri y pasteuri not found 
663 Stenotrophomonas_maltophilia y n 
663 Stenotrophomonas_maltophilia y n 
419 Stomatobaculum_longum y none 
97 Stomatobaculum_sp_oral_taxon_097 
 
na 
373 Stomatobaculum_sp_oral_taxon_373 
 
na 
910 Stomatobaculum_sp_oral_taxon_910 
 
na 
537 Streptococcus_agalactiae y n 
543 Streptococcus_anginosus y n 
576 Streptococcus_constellatus y n 
578 Streptococcus_cristatus y n 
594 Streptococcus_downei y n 
  Streptococcus_Genus_probe a y; S. penumoniae 
622_758 Streptococcus_gordonii_&_sanguinis y n 
644 Streptococcus_intermedius y n 
686 Streptococcus_mutans y n 
411 Streptococcus_parasanguinis_II y n 
734_* Streptococcus_pneumoniae_&_pseudopneumoniae y y 
745 Streptococcus_pyogenes y n 
755_021 Streptococcus_salivarius_&_vestibularis y n 
758 Streptococcus_sanguinis y n 
768 Streptococcus_sobrinus y n 
64 Streptococcus_sp_oral_taxon_064 
 
na; S. pneumoniae 
has mgl 
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66 Streptococcus_sp_oral_taxon_066 y n 
68 Streptococcus_sp_oral_taxon_068 
 
na 
69 Streptococcus_sp_oral_taxon_069 
 
na 
431 Streptococcus_sp_oral_taxon_431 
 
na 
486 Streptococcus_sp_oral_taxon_486 
 
na 
487 Streptococcus_sp_oral_taxon_487 
 
na 
435 Syntrophomonadaceae[8][G-1]_sp_oral_taxon_435 
 
na 
613 Tannerella_forsythia n n 
  Tannerella_Genus_probe a none 
286 Tannerella_sp_oral_taxon_286 y none 
808 Tannerella_sp_oral_taxon_808 
 
na 
916 Tannerella_sp_oral_taxon_916 
 
na 
916 Tannerella_sp_oral_taxon_916 
 
na 
916 Tannerella_sp_oral_taxon_916 
 
na 
916 Tannerella_sp_oral_taxon_916 
 
na 
346 TM7[G-1]_sp_oral_taxon_346 
 
na 
347 TM7[G-1]_sp_oral_taxon_347 
 
na 
348 TM7[G-1]_sp_oral_taxon_348 
 
na 
348 TM7[G-1]_sp_oral_taxon_348 
 
na 
349 TM7[G-1]_sp_oral_taxon_349 
 
na 
352 TM7[G-1]_sp_oral_taxon_352 
 
na 
353 TM7[G-1]_sp_oral_taxon_353 
 
na 
488 TM7[G-1]_sp_oral_taxon_488 
 
na 
350 TM7[G-2]_sp_oral_taxon_350 
 
na 
351 TM7[G-3]_sp_oral_taxon_351 
 
na 
355 TM7[G-4]_sp_oral_taxon_355 
 
na 
356 TM7[G-5]_sp_oral_taxon_356 
 
na 
437 TM7[G-5]_sp_oral_taxon_437 
 
na 
  TM7_Genus_probe 
 
none 
541 Treponema_amylovorum 
 
na 
584 Treponema_denticola n y 
584 Treponema_denticola n y 
  Treponema_Genus_probe_1 a none 
  Treponema_Genus_probe_2 a yes 
  Treponema_Genus_probe_3 a yes 
  Treponema_Genus_probe_4 a yes 
  Treponema_Genus_probe_5 a yes 
653 Treponema_lecithinolyticum y n 
664 Treponema_maltophilum y n 
805 Treponema_pallidum n n 
724 Treponema_parvum 
 
na 
725 Treponema_pectinovorum 
 
na; T. phagedenis; T. 
pedis; T. putidum 
743 Treponema_putidum 
 
y 
769 Treponema_socranskii y none 
769 Treponema_socranskii y none 
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769 Treponema_socranskii y none 
769 Treponema_socranskii y none 
226 Treponema_sp_oral_taxon_226 
 
na 
227 Treponema_sp_oral_taxon_227 
 
na 
228 Treponema_sp_oral_taxon_228 
 
na 
228 Treponema_sp_oral_taxon_228 
 
na 
230 Treponema_sp_oral_taxon_230 
 
na 
231_237 Treponema_sp_oral_taxon_231_&_sp_oral_taxon_237 
 
na 
232 Treponema_sp_oral_taxon_232 
 
na 
234 Treponema_sp_oral_taxon_234 
 
na 
235 Treponema_sp_oral_taxon_235 
 
na 
236 Treponema_sp_oral_taxon_236 
 
na 
238 Treponema_sp_oral_taxon_238 
 
na 
239 Treponema_sp_oral_taxon_239 
 
na 
242 Treponema_sp_oral_taxon_242 
 
na 
246 Treponema_sp_oral_taxon_246 
 
na 
247 Treponema_sp_oral_taxon_247 
 
na 
249 Treponema_sp_oral_taxon_249 
 
na 
250 Treponema_sp_oral_taxon_250 
 
na 
252 Treponema_sp_oral_taxon_252 
 
na 
253 Treponema_sp_oral_taxon_253 
 
na 
254 Treponema_sp_oral_taxon_254 
 
na 
255 Treponema_sp_oral_taxon_255 
 
na 
256 Treponema_sp_oral_taxon_256 
 
na 
257 Treponema_sp_oral_taxon_257 
 
na 
258 Treponema_sp_oral_taxon_258 
 
na 
260 Treponema_sp_oral_taxon_260 
 
na 
262 Treponema_sp_oral_taxon_262 
 
na 
262 Treponema_sp_oral_taxon_262 
 
na 
263 Treponema_sp_oral_taxon_263 
 
na 
264 Treponema_sp_oral_taxon_264 
 
na 
265 Treponema_sp_oral_taxon_265 
 
na 
268 Treponema_sp_oral_taxon_268 
 
na 
268 Treponema_sp_oral_taxon_268 
 
na 
269 Treponema_sp_oral_taxon_269 
 
na 
270 Treponema_sp_oral_taxon_270 
 
na 
271 Treponema_sp_oral_taxon_271 
 
na 
490 Treponema_sp_oral_taxon_490 
 
na 
508 Treponema_sp_oral_taxon_508 
 
na 
508 Treponema_sp_oral_taxon_508 
 
na 
517 Treponema_sp_oral_taxon_517 
 
na 
518 Treponema_sp_oral_taxon_518 
 
na 
29 Treponema_vincentii n n 
832 Turicella_otitidis y n 
717 Variovorax_paradoxus n n 
524 Veillonella_atypica y n 
   220 
524_160 Veillonella_atypica_&_dispar y n 
887 Veillonella_denticariosi 
 
na 
887 Veillonella_denticariosi 
 
na 
160 Veillonella_dispar y n 
  Veillonella_Genus_probe y y; V. ratti 
161 Veillonella_parvula y n 
161 Veillonella_parvula y n 
158 Veillonella_rogosae 
 
na 
780 Veillonella_sp_oral_taxon_780 y n 
917 Veillonella_sp_oral_taxon_917 
 
na 
129 Veillonellaceae[G-1]_sp_oral_taxon_129 
 
na 
132_150 
Veillonellaceae[G-
1]_sp_oral_taxon_132_&_sp_oral_taxon_150  
na 
135 Veillonellaceae[G-1]_sp_oral_taxon_135 
 
na 
145 Veillonellaceae[G-1]_sp_oral_taxon_145 
 
na 
148 Veillonellaceae[G-1]_sp_oral_taxon_148 
 
na 
155 Veillonellaceae[G-1]_sp_oral_taxon_155 
 
na 
155 Veillonellaceae[G-1]_sp_oral_taxon_155 
 
na 
483 Veillonellaceae[G-1]_sp_oral_taxon_483 
 
na 
918 Veillonellaceae[G-1]_sp_oral_taxon_918 
 
na 
  Veillonellaceae_probe_1 y none 
  Veillonellaceae_probe_2 y none 
  Yersinia_Genus_probe y y; Y. pestis 
 
 
